1
|
Branagan A, Murphy C, O'Sullivan A, Bodnarova I, Feyereislova S, Berka I, Miletin J, Stranak Z. Influence of gastric residual assessment in preterm neonates on time to achieve enteral feeding (the GRASS trial)-Multi-centre, assessor-blinded randomised clinical trial. Eur J Pediatr 2024; 183:2325-2332. [PMID: 38427039 PMCID: PMC11035479 DOI: 10.1007/s00431-024-05483-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/20/2023] [Revised: 02/09/2024] [Accepted: 02/12/2024] [Indexed: 03/02/2024]
Abstract
PURPOSE Gastric residual measurement is routinely performed in premature infants prior to feeding despite a lack of evidence of benefit. We aimed to evaluate if the exclusion of routine gastric residual measurement and evaluation has an impact on the time taken to achieve full enteral feeding in preterm neonates. METHODS International multi-centre randomised controlled trial. Clinically stable, appropriate for gestational age infants between 26+0 and 30+6 weeks of gestation and less than 1.5 kg birth weight were eligible. Infants were randomised to the intervention arm (no monitoring of gastric aspirates) or control arm (routine care). Primary outcome was the achievement of enteral feeds of 100 ml/kg/day by day 5 of life. RESULTS Ninety-five infants were recruited with 88 included in an intention-to-treat analysis, 45 in the intervention arm and 43 in the control arm. There was no imbalance in baseline characteristics. Thirty-three (73.3%) infants in the intervention group and 32 infants (74.4%) in the control group reached full feeds by day 5 of life (p = 0.91) with no difference in median time to full feeds. There were no statistically significant differences in survival or the major morbidities of prematurity. CONCLUSION There was no difference in time to attainment of enteral feeds of 100 ml/kg/day in premature infants when gastric residuals were not monitored. In the absence of a clinical benefit to routine monitoring, it may be appropriate to discontinue this practice and only monitor residuals when clinical concern of feeding intolerance or gastrointestinal pathology arises in this group of patients. TRIAL REGISTRATION NCT03111329- https://clinicaltrials.gov/ . Registered 06/04/2017. WHAT IS KNOWN • Previous randomized trials have shown little benefit to the performance of routine assessment of gastric residuals in preterm infants. Despite this, they continue to be performed due to concerns from observational data regarding development of NEC. Meta-analysis to date has failed to answer the question regarding NEC. WHAT IS NEW • In very low birth weight infants who are fed using modern feeding practice of faster feed advancement, to minimize use of central access and parenteral nutrition, exclusion of routine checks of gastric residuals did not increase the proportion of infants reaching full enteral feeds by day 5. No harm was seen when residual checks were not performed. • In the absence of a clinical benefit to the routine performance of gastric residuals in very low birth weight infants, it may be appropriate to discontinue their use and instead check residuals when clinical concern of pathology arises.
Collapse
Affiliation(s)
- A Branagan
- The Coombe Women and Infants University Hospital, Dublin 8, Ireland.
| | - C Murphy
- The Coombe Women and Infants University Hospital, Dublin 8, Ireland
| | - A O'Sullivan
- The Coombe Women and Infants University Hospital, Dublin 8, Ireland
| | - I Bodnarova
- Institute for the Care of Mother and Child, Prague, Czech Republic
| | - S Feyereislova
- Institute for the Care of Mother and Child, Prague, Czech Republic
| | - I Berka
- Institute for the Care of Mother and Child, Prague, Czech Republic
- 3rd School of Medicine, Charles University, Prague, Czech Republic
| | - J Miletin
- The Coombe Women and Infants University Hospital, Dublin 8, Ireland
- Institute for the Care of Mother and Child, Prague, Czech Republic
- UCD School of Medicine, University College Dublin, Dublin, Ireland
- 2nd Faculty of Medicine, Motol University Hospital, Prague, Czech Republic
| | - Z Stranak
- Institute for the Care of Mother and Child, Prague, Czech Republic
- 3rd School of Medicine, Charles University, Prague, Czech Republic
| |
Collapse
|
2
|
Wisner KL, Murphy C, Thomas MM. Prioritizing Maternal Mental Health in Addressing Morbidity and Mortality. JAMA Psychiatry 2024; 81:521-526. [PMID: 38381408 DOI: 10.1001/jamapsychiatry.2023.5648] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/22/2024]
Abstract
Importance The rate of maternal mortality in the United States is 2-fold to 3-fold greater than that in other high-income countries. While many national initiatives have been developed to combat maternal mortality, these efforts often fail to include mental illness. Objective To highlight the underrecognized contribution of mental illness to maternal mortality, which is nearly double that of postpartum hemorrhage. Evidence Review A topic outline was developed to include challenges in measuring perinatal mental conditions and mortality rates; contributions of social determinants of health to mental conditions and mortality; perinatal psychiatric disorder characterization; mechanisms by which maternal mental illness increases mortality, specifically, suicide and addictive disorders; access limitations and care "deserts"; prenatal stress and its impact on reproductive outcomes; increasing clinician expertise through cross-disciplinary education; intervention sites and models; and asserting that mental health is fundamental to maternal health. Publications in the last 3 years were prioritized, particularly those relating to policy. References were selected through consensus. Sources were PubMed, Ovid, direct data published on government websites, and health policy sources such as the Policy Center for Maternal Mental Health. Findings Priority was given to recent sources. Citations from 2022-2023 numbered 26; within the last 5 years, 14; and historical references, 15. Recommendations to address each topic area serve as concluding statements for each section. To mitigate the contributions of mental illness to the maternal mortality risk, a coordinated effort is required across professional and governmental organizations. Conclusions and Relevance Concrete programmatic and policy changes are needed to reduce perinatal stress and address trauma, standardize the collection of social determinant of health data among perinatal patients, increase access to reproductive psychiatry curricula among prescribers, reduce perinatal mental health and obstetrical deserts, institute paid parental leave, and support seamless integration of perinatal and behavioral health care. Moreover, instead of focusing on a relatively minor portion of the contributors to health that current medical practice targets, fortifying the social foundation strengthens the prospects for the health of families for our current and future generations.
Collapse
Affiliation(s)
- Katherine L Wisner
- Developing Brain Institute, Children's National Hospital, George Washington University School of Medicine and Health Sciences, Washington, DC
| | - Caitlin Murphy
- Department of Health Policy and Management, Milken Institute of Public Health, George Washington University, Washington, DC
| | - Megan M Thomas
- Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Kansas School of Medicine, Kansas City
| |
Collapse
|
3
|
Murphy C. Improving shared decision-making: extreme-risk patient outcomes post-emergency laparotomy. Anaesthesia 2024; 79:214-215. [PMID: 37946622 DOI: 10.1111/anae.16165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/11/2023] [Indexed: 11/12/2023]
Affiliation(s)
- C Murphy
- Beaumont Hospital, Dublin, Ireland
| |
Collapse
|
4
|
Pham ML, Van Horn K, Zarate E, Pickering E, Murphy C, Bryant K. A multicenter evaluation of Copan's Colibrí™, an automated instrument for MALDI TOF MS target application for bacterial identification. Diagn Microbiol Infect Dis 2024; 108:116098. [PMID: 37890307 DOI: 10.1016/j.diagmicrobio.2023.116098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2023] [Revised: 08/24/2023] [Accepted: 09/26/2023] [Indexed: 10/29/2023]
Abstract
The Colibrí™ is a new instrument that automates picking and placement of colonies on target plates for MALDI identification. This study compared the performance of the Colibrí™ to standard manual spotting using the VITEK® MS for bacterial identification. Colonies were selected from cultures of urine, wound, respiratory, and positive blood cultures. The Colibrí™ sampled the colonies, transferred them to a MALDI target slide, and overlayed each spot with matrix. Manual spotting was then performed using the same or similar colonies. A total of 444 bacteria were compared. Identification was achieved with both methods for 432 organisms with only 2 discrepant results, overall agreement of 99.54%. Twelve organisms (2.70%) gave no identification using Colibrí™. The Colibrí™ provides automation to a manual process with a high accuracy. Use of the Colibrí™ instrumentation provides an opportunity to reallocate technologist time to more complicated tasks and provides complete traceability from plating to organism identification.
Collapse
Affiliation(s)
- My Lien Pham
- Kaiser Permanente, Southern California Permanente Medical Group, Regional Reference Laboratories, Chino Hills, CA, USA
| | - Kenneth Van Horn
- Kaiser Permanente, Southern California Permanente Medical Group, Regional Reference Laboratories, Chino Hills, CA, USA.
| | | | | | | | - Kendall Bryant
- Kaiser Permanente, Airport Way Regional Laboratory, Portland, OR, USA
| |
Collapse
|
5
|
Esteban J, Salar-Vidal L, Schmitt BH, Waggoner A, Laurent F, Abad L, Bauer TW, Mazariegos I, Balada-Llasat JM, Horn J, Wolk DM, Jefferis A, Hermans M, Verhoofstad I, Butler-Wu SM, Umali-Wilcox M, Murphy C, Cabrera B, Craft D, von Bredow B, Leber A, Everhart K, Dien Bard J, Flores II, Daly J, Barr R, Holmberg K, Graue C, Kensinger B. Multicenter evaluation of the BIOFIRE Joint Infection Panel for the detection of bacteria, yeast, and AMR genes in synovial fluid samples. J Clin Microbiol 2023; 61:e0035723. [PMID: 37877730 PMCID: PMC10662359 DOI: 10.1128/jcm.00357-23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2023] [Accepted: 09/07/2023] [Indexed: 10/26/2023] Open
Abstract
The bioMérieux BIOFIRE Joint Infection (JI) Panel is a multiplex in vitro diagnostic test for the simultaneous and rapid (~1 h) detection of 39 potential pathogens and antimicrobial resistance (AMR) genes directly from synovial fluid (SF) samples. Thirty-one species or groups of microorganisms are included in the kit, as well as several AMR genes. This study, performed to evaluate the BIOFIRE JI Panel for regulatory clearance, provides data from a multicenter evaluation of 1,544 prospectively collected residual SF samples with performance compared to standard-of-care (SOC) culture for organisms or polymerase chain reaction (PCR) and sequencing for AMR genes. The BIOFIRE JI Panel demonstrated a sensitivity of 90.9% or greater for all but six organisms and a positive percent agreement (PPA) of 100% for all AMR genes. The BIOFIRE JI Panel demonstrated a specificity of 98.5% or greater for detection of all organisms and a negative percent agreement (NPA) of 95.7% or greater for all AMR genes. The BIOFIRE JI Panel provides an improvement over SOC culture, with a substantially shorter time to result for both organisms and AMR genes with excellent sensitivity/PPA and specificity/NPA, and is anticipated to provide timely and actionable diagnostic information for joint infections in a variety of clinical scenarios.
Collapse
Affiliation(s)
- Jaime Esteban
- IIS-Fundacion Jimenez Diaz, CIBERINFEC-CIBER de Enfermedades Infecciosas, Madrid, Spain
| | - Llanos Salar-Vidal
- IIS-Fundacion Jimenez Diaz, CIBERINFEC-CIBER de Enfermedades Infecciosas, Madrid, Spain
| | - Bryan H. Schmitt
- Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Amy Waggoner
- Indiana University School of Medicine, Indianapolis, Indiana, USA
| | | | | | | | | | | | - Jared Horn
- The Ohio State University Wexner Medical Center, Columbus, Ohio, USA
| | | | | | | | | | | | | | - Caitlin Murphy
- University of Nebraska Medical Center Omaha, Omaha, Nebraska, USA
| | - Barbara Cabrera
- University of Nebraska Medical Center Omaha, Omaha, Nebraska, USA
| | - David Craft
- The Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA
| | | | - Amy Leber
- Nationwide Children’s Hospital, Columbus, Ohio, USA
| | | | | | | | - Judy Daly
- Primary Children’s Hospital, Salt Lake City, Utah, USA
| | - Rebecca Barr
- Primary Children’s Hospital, Salt Lake City, Utah, USA
| | | | | | | |
Collapse
|
6
|
Galvan C, Flores A, Cerrillos V, Avila I, Murphy C, Zheng W, To TT, Christofk HR, Lowry WE. Defining metabolic flexibility in hair follicle stem cell induced squamous cell carcinoma. bioRxiv 2023:2023.10.16.562128. [PMID: 37905122 PMCID: PMC10614763 DOI: 10.1101/2023.10.16.562128] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/02/2023]
Abstract
Among the numerous changes associated with the transformation to cancer, cellular metabolism is one of the first discovered and most prominent[1, 2]. However, despite the knowledge that nearly every cancer is associated with the strong upregulation of various metabolic pathways, there has yet to be much clinical progress on the treatment of cancer by targeting a single metabolic enzyme directly[3-6]. We previously showed that inhibition of glycolysis through lactate dehydrogenase (LDHA) deletion in cancer cells of origin had no effect on the initiation or progression of cutaneous squamous cell carcinoma[7], suggesting that these cancers are metabolically flexible enough to produce the necessary metabolites required for sustained growth in the absence of glycolysis. Here we focused on glutaminolysis, another metabolic pathway frequently implicated as important for tumorigenesis in correlative studies. We genetically blocked glutaminolysis through glutaminase (GLS) deletion in cancer cells of origin, and found that this had little effect on tumorigenesis, similar to what we previously showed for blocking glycolysis. Tumors with genetic deletion of glutaminolysis instead upregulated lactate consumption and utilization for the TCA cycle, providing further evidence of metabolic flexibility. We also found that the metabolic flexibility observed upon inhibition of glycolysis or glutaminolysis is due to post-transcriptional changes in the levels of plasma membrane lactate and glutamine transporters. To define the limits of metabolic flexibility in cancer initiating hair follicle stem cells, we genetically blocked both glycolysis and glutaminolysis simultaneously and found that frank carcinoma was not compatible with abrogation of both of these carbon utilization pathways. These data point towards metabolic flexibility mediated by regulation of nutrient consumption, and suggest that treatment of cancer through metabolic manipulation will require multiple interventions on distinct pathways.
Collapse
|
7
|
Murphy C, Baskind S, Aladangady N, Banerjee J. Measuring gut perfusion and blood flow in neonates using ultrasound Doppler of the superior mesenteric artery: a narrative review. Front Pediatr 2023; 11:1154611. [PMID: 37601136 PMCID: PMC10433905 DOI: 10.3389/fped.2023.1154611] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/30/2023] [Accepted: 05/02/2023] [Indexed: 08/22/2023] Open
Abstract
The gut is a relatively silent organ in utero but takes on a major role after birth for the absorption and digestion of feed for adequate nutrition and growth. The neonatal circulation undergoes a transition period after birth, and gut perfusion increases rapidly to satisfy the oxygen demand and consumption. If this process is compromised at any stage, preterm and fetal growth restricted infants are at particular risk of gut tissue injury secondary to hypoxia, leading to necrotizing enterocolitis. Feeding can also be a challenge in these high-risk groups due to gut dysmotility. Superior mesenteric artery (SMA) Doppler is a safe, bedside investigation that could rapidly aid clinicians with feeding strategies and in monitoring high-risk infants. This article aims to establish normal patterns of gut blood flow velocity in neonates using SMA Doppler and reviews how it might be used clinically in pathologic states.
Collapse
Affiliation(s)
- C. Murphy
- Neonatal Intensive Care Unit, Homerton Healthcare NHS Foundation Trust, London, United Kingdom
- Neonatal Intensive Care Unit, Queen Mary University of London, London, United Kingdom
| | - S. Baskind
- Neonatal Intensive Care Unit, Homerton Healthcare NHS Foundation Trust, London, United Kingdom
| | - N. Aladangady
- Neonatal Intensive Care Unit, Homerton Healthcare NHS Foundation Trust, London, United Kingdom
- Neonatal Intensive Care Unit, Queen Mary University of London, London, United Kingdom
| | - J. Banerjee
- Neonatal Intensive Care Unit, Imperial College Healthcare NHS Trust, London, United Kingdom
- Neonatal Intensive Care Unit, Imperial College London, London, United Kingdom
| |
Collapse
|
8
|
Taylor A, Davidson G, Boyce M, Murphy C, Doole S, Rogers C, Fraser I. Background levels of body fluids and DNA on the shaft of the penis and associated underpants in the absence of sexual activity. Sci Justice 2023; 63:529-536. [PMID: 37453785 DOI: 10.1016/j.scijus.2023.06.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/06/2023] [Revised: 04/18/2023] [Accepted: 06/14/2023] [Indexed: 07/18/2023]
Abstract
This study examines the background of blood, saliva, semen and autosomal DNA on penile swabs and underpants from males in the absence of recent sexual activity. Based on the data collected by the AFSP Body Fluid Forum, the results of this study show that; there is a very low expectation of detecting blood on penile swabs and male underpants; a low expectation of detecting saliva on penile swabs and male underpants; and spermatozoa would be expected in less than a quarter of penile swabs and three quarters of male underpants. As none of the samples had detectable levels of DNA which were suitable for meaningful comparison that did not match the donor or their partner, the expectation of detecting a DNA profile from the cellular background on penile swabs or underpants from a male who has not been involved in recent sexual intercourse is very low. The results of this study are extremely informative when evaluating the significance of blood, saliva, semen and DNA detected on the penile swabs and underpants of males in cases of alleged sexual assault.
Collapse
Affiliation(s)
- A Taylor
- Formerly of Forensic Science Northern Ireland, 151 Belfast Road, Carrickfergus, Co. Antrim BT38 8PL, Northern Ireland
| | - G Davidson
- Cellmark Forensic Services, Buckshaw Link, Ordnance Road, Buckshaw Village, Chorley, Lancashire PR7 7EL, United Kingdom.
| | - M Boyce
- Formerly of Key Forensic Services, 207C Cavendish Place, Birchwood Park, Warrington WA3 6WU, United Kingdom
| | - C Murphy
- Department of Justice and Equality, Forensic Science Ireland, Garda Headquarters, Phoenix Park, Dublin 8, Ireland.
| | - S Doole
- Eurofins Forensic Services, Sir Alec Jeffreys Building, Peel Avenue, Calderpark, Wakefield WF2 7UA, United Kingdom.
| | - C Rogers
- SPA Forensic Services, Scottish Crime Campus, Craignethan Drive, Gartcosh G69 8AE. United Kingdom.
| | - I Fraser
- Forensic Science Northern Ireland, 151 Belfast Road, Carrickfergus, Co. Antrim BT38 8PL, Northern Ireland.
| |
Collapse
|
9
|
Stark Z, Morrice E, Murphy C, Wittich W, Johnson AP. The effects of simulated and actual visual impairment on the Montreal Cognitive Assessment. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2023; 30:523-535. [PMID: 35341447 DOI: 10.1080/13825585.2022.2055739] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/10/2023]
Abstract
Many cognitive assessments include a visual component; however, adults may experience a decline in visual acuity with age. Scores on cognitive assessments of adults with visual impairments are typically lower than adults with normal vision, however, it is unclear if these lower scores are a consequence of cognitive or visual impairment. We measured the impact of simulated visual impairment on a cognitive screening measure. Undergraduate students were administered the Montreal Cognitive Assessment (MoCA) under three vision conditions (20/20, simulated 20/80, simulated 20/200). We found a main effect of vision condition on test performance such that there is a statistically significant difference between scores on the 20/20 and 20/80 conditions and 20/200. However, no differences were observed between 20/80 and 20/200. Participants' performance decreased with simulated impairments. A secondary between-subject analysis was conducted on a sample of older adults with and without vision impairment; no differences were found.
Collapse
Affiliation(s)
- Zoey Stark
- Department of Psychology, Concordia University, Montreal, Quebec Canada
| | - Elliot Morrice
- Department of Psychology, Concordia University, Montreal, Quebec Canada
- CRIR/Centre de réadaptation Lethbridge-Layton-Mackay Réhabilitation Centredu Centre Intégré Universitaire de Santé et Services Sociaux (CIUSSS) Centre ouest de l'ile de Montréal, Montéal, Quebec Canada
| | - Caitlin Murphy
- CRIR/Centre de réadaptation Lethbridge-Layton-Mackay Réhabilitation Centredu Centre Intégré Universitaire de Santé et Services Sociaux (CIUSSS) Centre ouest de l'ile de Montréal, Montéal, Quebec Canada
| | - Walter Wittich
- CRIR/Centre de réadaptation Lethbridge-Layton-Mackay Réhabilitation Centredu Centre Intégré Universitaire de Santé et Services Sociaux (CIUSSS) Centre ouest de l'ile de Montréal, Montéal, Quebec Canada
- École d'optométrie, Université de Montréal, Montréal, Quebec Canada
- CRIR/Institut Nazareth et Louis-Braille du CISSS de la Montérégie-Centre, Longueuil, Quebec Canada
| | - Aaron P Johnson
- Department of Psychology, Concordia University, Montreal, Quebec Canada
- CRIR/Centre de réadaptation Lethbridge-Layton-Mackay Réhabilitation Centredu Centre Intégré Universitaire de Santé et Services Sociaux (CIUSSS) Centre ouest de l'ile de Montréal, Montéal, Quebec Canada
| |
Collapse
|
10
|
Fox A, Smith A, Murphy C, Bussmann N, McCallion N. How can we improve the retention of doctors. Ir Med J 2023; 116:741. [PMID: 36976614] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/17/2023]
|
11
|
Fox A, Smith A, Murphy C, Bussmann N, McCallion N. How can we improve retention of doctors. Ir Med J 2023; 116:741. [PMID: 37010476] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Subscribe] [Scholar Register] [Indexed: 04/04/2023]
|
12
|
Chan A, Day D, Hui R, McCarthy N, Wilson R, Faltaos D, Shaw M, Murphy C. Abstract P3-07-15: Preliminary data from a Phase 1b dose escalation study of OP-1250, an oral CERAN, in combination with palbociclib in patients with advanced and/or metastatic estrogen receptor (ER)-positive, HER2-negative breast cancer. Cancer Res 2023. [DOI: 10.1158/1538-7445.sabcs22-p3-07-15] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/06/2023]
Abstract
Abstract
Background: OP-1250 is a small molecule oral complete estrogen receptor antagonist (CERAN) that binds the ligand binding domain of the ER and completely blocks ER-driven transcriptional activity. CDK4/6 inhibitors in combination with endocrine therapy have improved progression free survival and overall survival for patients (pts) with metastatic breast cancer (MBC) in the first- and second-line settings. However, most patients will progress and newer combinations such as with OP-1250 may provide improved clinical outcome. OP-1250 potently inactivates both wild-type ER and mutant forms of ER. The latter confers ligand independent activity and is a mechanism of resistance to standard of care endocrine therapies. In preclinical studies, OP-1250 in combination with palbociclib demonstrated synergistic activity in models of wild-type ER and those containing ESR1 activating mutations, and in models of brain metastasis. A Phase 1/2 monotherapy study of OP-1250 is ongoing in MBC subjects who have received 1 or more prior endocrine therapies (NCT04505826). Monotherapy is well tolerated and the recommended phase 2 dose is 120 mg QD. The aim of this combination trial is to define the maximum tolerated dose (MTD), safety, tolerability, and pharmacokinetics (PK) of OP-1250 in combination with palbociclib. Methods: Eligibility criteria include pts with MBC or locally advanced breast cancer who have received no more than 1 prior line of endocrine therapy (prior CDK4/6 inhibitors and one line of chemotherapy are permitted) and measurable or non-measurable disease. Using a 3+3 design, cohorts are sequentially enrolled, and pts receive escalating doses of OP-1250 orally QD continuously in combination with 125 mg of palbociclib orally for 21 of 28 days. Pts are evaluable for dose limiting toxicities (DLTs) if >75% of both treatments were administered within the first 28-day treatment cycle. Blood is collected for PK on cycle 1 days 1, 2 and cycle 2 days 15, 16 for OP-1250 and cycle 1 day 15 for palbociclib. PK profiles, exposure parameters, and drug-drug interactions (DDIs) are assessed. Pts are monitored for adverse events (AE) and tumor assessments (RECIST 1.1) are conducted every two cycles. Results: As of July 7, 2022, 9 pts were evaluable for DLTs after 28 days of treatment in dose levels 30 mg, 60 mg, and 90 mg of OP-1250 in combination with palbociclib. No DLTs occurred at any of the dose levels. As of May 13, 2022, of the 7 pt safety data set, the most common Grade 1/2 treatment emergent adverse events (TEAE), which occurred in 2 patients, were nausea, gastroesophageal reflux, vomiting, and fatigue. Grade 3 neutropenia occurred in 4 pts and all were attributed to palbociclib by the investigator. No Grade 4 events were observed. OP-1250 was highly bioavailable and showed dose proportional exposure in combination with palbociclib. The single and multiple dose exposure of OP-1250 was consistent with that observed in the monotherapy study, indicating an absence of effect of palbociclib on OP-1250 PK. 90 mg steady-state evaluation is ongoing. Palbociclib concentrations at steady state did not demonstrate a meaningful difference from published exposure parameters for the three dose levels evaluated, indicating an absence of DDI. Conclusions: In the first three cohorts of OP-1250 and palbociclib, the combination was well tolerated and no DLTs occurred. There were no clinically significant DDIs observed between OP-1250 and palbociclib at the doses evaluated and exposure of each drug was consistent with observed monotherapy exposure levels. Dose escalation of OP-1250 continues to 120 mg, to be followed by dose expansion. Updated data will be presented. (NCT05266105)
Citation Format: Arlene Chan, Daphne Day, Rina Hui, Nicole McCarthy, Rosalind Wilson, Demiana Faltaos, Morena Shaw, Caitlin Murphy. Preliminary data from a Phase 1b dose escalation study of OP-1250, an oral CERAN, in combination with palbociclib in patients with advanced and/or metastatic estrogen receptor (ER)-positive, HER2-negative breast cancer [abstract]. In: Proceedings of the 2022 San Antonio Breast Cancer Symposium; 2022 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2023;83(5 Suppl):Abstract nr P3-07-15.
Collapse
Affiliation(s)
- Arlene Chan
- 1Breast Cancer Research Centre – Western Australia, Hollywood Consulting Centre, Nedlands, WA 6009, Australia, Perth, Australia
| | - Daphne Day
- 2Medicine Monash Health, Clayton, VIC 3168, Australia
| | - Rina Hui
- 3Westmead Hospital, Westmead, NSW 2145, Australia
| | - Nicole McCarthy
- 4Icon Cancer Center, Wesley Medical Centre, Auchenflower, Australia
| | | | | | | | - Caitlin Murphy
- 8Barwon Health, Andrew Love Cancer Centre, Geelong, VIC 3220, Australia
| |
Collapse
|
13
|
Murphy C, Fernández Robledo JA, van Walsum GP. Perkinsus marinus in bioreactor: growth and a cost-reduced growth medium. J Ind Microbiol Biotechnol 2023; 50:kuad023. [PMID: 37669897 PMCID: PMC10500546 DOI: 10.1093/jimb/kuad023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2023] [Accepted: 08/25/2023] [Indexed: 09/07/2023]
Abstract
Perkinsus marinus (Perkinsea) is an osmotrophic facultative intracellular marine protozoan responsible for "Dermo" disease in the eastern oyster, Crassostrea virginica. In 1993 in vitro culture of P. marinus was developed in the absence of host cells. Compared to most intracellular protozoan parasites, the availability of P. marinus to grow in the absence of host cells has provided the basis to explore its use as a heterologous expression system. As the genetic toolbox is becoming available, there is also the need for larger-scale cultivation and lower-cost media formulations. Here, we took an industrial approach to scaled-up growth from a small culture flask to bioreactors, which required developing new cultivation parameters, including aeration, mixing, pH, temperature control, and media formulation. Our approach also enabled more real-time data collection on growth. The bioreactor cultivation method showed similar or accelerated growth rates of P. marinus compared to culture in T-flasks. Redox measurements indicated sufficient oxygen availability throughout the cultivation. Replacing fetal bovine serum with chicken serum showed no differences in the growth rate and a 60% reduction in the medium cost. This study opens the door to furthering P. marinus as a valid heterologous expression system by showing the ability to grow in bioreactors. ONE-SENTENCE SUMMARY Perkinsus marinus, a microbial parasite of oysters that could be useful for developing vaccines for humans, has been shown to grow well in laboratory equipment that can be expanded to commercial scale using a less expensive growth formula than usual laboratory practice.
Collapse
Affiliation(s)
- Caitlin Murphy
- Department of Chemical and Biomedical Engineering, University of Maine, Orono, ME, USA
| | | | - G Peter van Walsum
- Department of Chemical and Biomedical Engineering, University of Maine, Orono, ME, USA
| |
Collapse
|
14
|
Ledbetter-Cho K, O'Reilly M, Watkins L, Lang R, Lim N, Davenport K, Murphy C. The Effects of a Teacher-Implemented Video-Enhanced Activity Schedule Intervention on the Mathematical Skills and Collateral Behaviors of Students with Autism. J Autism Dev Disord 2023; 53:553-568. [PMID: 32285232 DOI: 10.1007/s10803-020-04495-3] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
This study used a multiple probe design to evaluate the effects of a teacher-implemented video-schedule intervention on the mathematical skills and untargeted challenging behaviors of five elementary-school students with autism. Results indicated that the intervention was effective in improving participants' academic performance, and a decrease in the level of challenging behaviors and stereotypy was observed for participants following the introduction of intervention. Additionally, academic gains generalized across academic problems and to a small group setting, suggesting that this technology-based intervention is an efficient use of instructional time. Future research targeting a variety of academic skills and examining intervention implementation by additional practitioners (e.g., teaching assistants) is warranted.
Collapse
Affiliation(s)
| | - Mark O'Reilly
- University of Texas At Austin, Austin, TX, 78712, USA
| | - Laci Watkins
- University of Alabama, Tuscaloosa, AL, 35487, USA
| | - Russell Lang
- Texas State University, San Marcos, TX, 79666, USA
| | - Nataly Lim
- University of Texas At Austin, Austin, TX, 78712, USA
| | | | | |
Collapse
|
15
|
Murphy C, Sherwin A, Lavelle A. Autonomy vs. the environment: nitrous oxide use in obstetrics, an ongoing challenge. Anaesthesia 2023; 78:654-655. [PMID: 36715244 DOI: 10.1111/anae.15976] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/10/2023] [Indexed: 01/31/2023]
Affiliation(s)
- C Murphy
- St James's Hospital, Dublin, Ireland
| | - A Sherwin
- St James's Hospital, Dublin, Ireland
| | - A Lavelle
- St James's Hospital, Dublin, Ireland
| |
Collapse
|
16
|
Petersen B, Khalili-Mahani N, Murphy C, Sawchuk K, Phillips N, Li KZH, Hebblethwaite S. The association between information and communication technologies, loneliness and social connectedness: A scoping review. Front Psychol 2023; 14:1063146. [PMID: 37034933 PMCID: PMC10075275 DOI: 10.3389/fpsyg.2023.1063146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2022] [Accepted: 03/03/2023] [Indexed: 04/11/2023] Open
Abstract
Older adults are at a higher risk of loneliness, compared to other demographics. The use of Internet Communication and Technologies (ICTs) among older adults is steadily increasing and given ICTs provide a means of enhancing social connectedness suggests they may have positive effects on reducing loneliness. Therefore, the aim of this scoping review was to examine the research that explores how ICTs may be implicated in mitigating loneliness and increasing social connectedness among older adults. After the examination of 54 articles, we identified three major themes within the literature: (1) ICTs were associated with a reduction in loneliness and increase in wellbeing. (2) ICTs promoted social connectedness by facilitating conversations. (3) Factors such as training, self-efficacy, self-esteem, autonomy, and the design/features, or affordances, of ICTs contribute toward the associations between ICT use and wellbeing. The heterogeneity of methodologies, statistical reporting, the small sample sizes of interventional and observational studies, and the diversity of the experimental contexts underline the challenges of quantitative research in this field and highlights the necessity of tailoring ICT interventions to the needs and contexts of the older users.
Collapse
Affiliation(s)
- Berkley Petersen
- Laboratory for Adult Development and Cognitive Aging, Department of Psychology, Concordia University, Montreal, QC, Canada
- *Correspondence: Berkley Petersen,
| | - Najmeh Khalili-Mahani
- Media Health Lab, Department of Design and Computation Arts, Milieux Institute for Arts, Culture and Technology, Concordia University, Montreal, QC, Canada
- McGill Centre for Integrative Neuroscience, McGill University, Montreal, QC, Canada
| | - Caitlin Murphy
- Centre for Interdisciplinary Research in Rehabilitation (CRIR), Lethbridge-Layton-Mackay Rehabilitation Centre, Montreal, QC, Canada
| | - Kim Sawchuk
- Aging and Communication Technologies (ACT), Department of Communication Studies, Concordia University, Montreal, QC, Canada
| | - Natalie Phillips
- Laboratory of Cognition, Aging and Psychophysiology (CAP), Department of Psychology, Concordia University, Montreal, QC, Canada
| | - Karen Z. H. Li
- Laboratory for Adult Development and Cognitive Aging, Department of Psychology, Concordia University, Montreal, QC, Canada
| | | |
Collapse
|
17
|
Murphy C, Bray X, Martin R. Recruitment and organising 3rd year pharmacy undergraduates into summer placements in primary care in Southwest England. International Journal of Pharmacy Practice 2022. [DOI: 10.1093/ijpp/riac089.040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2022]
Abstract
Abstract
Introduction
Primary care is facing a workforce shortage, especially in Southwest England (SW).1 Funding for clinical pharmacist roles in GP has an impact on community pharmacy with pharmacists leaving to take up PCN positions.2 SW has higher rate of vacancies in than nationally.3 Oriel data showed that fill rate for split foundation training placements in GP is high, however, in SW is significantly low.
Aim
To increase recruitment of future pharmacists in SW by offering pharmacy undergraduates paid 5-week summer placements in GP or GP/community pharmacy partnership, gaining primary care experience, showcasing benefits of cross-sector working and encouraging development of partnerships for increased cross-sector training placements.
Objectives
Students enjoy SW area placement, Students recommend placement to other students, Students preference GP foundation placement, Supervisors express interest in a summer placement for 2022, Supervisors express interest in the GP split trainee pharmacist programme.
Methods
Expressions of interest (EOIs) sought from primary care placements in SW and 16 sites selected. Applicants shortlisted and interviewed online. 16 offered placements based on preference of location. Funding by HEE South reimbursed for student’s wages. Planning booklets provided to GPs, workbooks to students and online induction attended. During the placement, students completed an audit and case-based discussion, shadowed healthcare professionals, assisted administration and pharmacy tasks and practised basic procedural skills. Students attended end-of-placement event to share learning and sent questionnaire focusing on enjoyment of the placement and likelihood of returning to the Southwest and primary care for future employment. Supervisors sent questionnaire separately focusing on likelihood to partake in future. Questionnaires were sent, completed and analysed via Jisc. Ethics approval was not required.
Results
10 students and 11 supervisors completed the survey. 60% students enjoyed SW. 90% students would recommend placement to other students and 90% would like to see them in other areas. 70% students very likely to or definitely would apply for GP foundation placement. 63% supervisors benefitted from having a student and 81% would recommend having summer placement student. 55% supervisors would definitely EOI in future summer placement programme and 55% would definitely EOI in GP split foundation programme. 25% students chose GP/Community placements in SW, 18% other placements in SW, 12% GP placements in other regions. Oriel fill rates in SW increased from 36.67% in 2020 to 39.30% in 2021, GP/Community placements remained the same in 2021 at 28.2% and community placements increased in from 18.14% in 2020 to 18.75% in 2021.
Discussion/Conclusion
The students enjoyed their placements and would recommend to other students. Supervisors found having students useful and would have a student in the future. Although some students were successful in securing a placement in SW for foundation training, due to nature of Oriel it’s not possible to determine how many preferenced SW and GP split programme, this is a limitation to the evaluation. Oriel fill rates didn’t increase for SW community/GP placements as desired, however this was a very small cohort. This pilot will be repeated summer 2022 so fill rates can be evaluated in 2023.
References
1. NHS. The NHS Long Term Plan. Long Term Plan. [Online] 2019. Available from: https://www.longtermplan.nhs.uk/wp-content/uploads/2019/08/nhs-long-term-plan-version-1.2.pdf.
2. BMA. Investment and Evolution: A five year gramework for GP contract reform to implement the NHS long term plan. England NHS. [Online] 2019. Available from: https://www.england.nhs.uk/wp-content/uploads/2019/01/gp-contract-2019.pdf.
3. Community Pharmacy Workforce Development Group. A Review of the Community Pharmacy Workforce. Community Pharmacy Workforce. [Online] 2021. Available from: https://communitypharmacyworkforce.files.wordpress.com/2021/06/cpwdg-report-a-review-of-the-community-pharmacy-workforce-final.pdf.
Collapse
|
18
|
Ruhotina M, Murphy C, Wilcox A, Kashani SM. Time for an Education Revamp? A Cross-Sectional Multi-Institute Survey of FMIGS Program Directors and Fellows’ Didactics Experiences. J Minim Invasive Gynecol 2022. [DOI: 10.1016/j.jmig.2022.09.088] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
19
|
Munro F, Murphy C. 283 AN EXPLORATION OF THE IRISH NATIONAL FRAILTY EDUCATION PROGRAMME ON PRACTICE: A FRAILTY FACILITATOR'S PERSPECTIVE. Age Ageing 2022. [DOI: 10.1093/ageing/afac218.250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Frailty is associated with a range of adverse outcomes in older adults requiring prevention, early detection and management. Interprofessional collaboration in education and practice can facilitate integrated care for older people in the management of frailty. In Ireland, an interprofessional National Frailty Education Programme (NFEP) is delivered in partnership between the National Clinical Programme for Older People (NCPOP) and The Irish Longitudinal Study on Ageing (TILDA). On completion of the NFEP, Frailty Facilitators return to their regional/local frailty networks to deliver the programme to healthcare professionals across disciplines and settings. The aim of this study is to explore the impact of the National Frailty Education Programme on practice.
Methods
A qualitative exploratory approach was adopted to elicit the perspectives of Frailty Facilitators on the impact of the NFEP on practice. Purposive sampling was employed across frailty networks nationwide. Focus groups were conducted, and data were analysed using thematic analysis.
Results
Twenty-four participants from five frailty networks took part in five focus groups across Ulster, Leinster and Connaught. Frailty Facilitators collaborated to deliver education on frailty in their local networks following the NFEP. Management support particularly that provided by the Centres for Midwifery and Nurse Education was deemed a significant enabler of frailty education. Strong interprofessional alliances were developed that enhanced communication between primary and secondary care settings in the care of older people. The medical profession were noted to have low participation in the frailty networks. The results revealed widespread use of frailty instruments for assessment and a shared understanding and language on frailty.
Conclusion
The NFEP had a clear impact on Frailty Facilitator’s practice. Conceptualisation and reflection on frailty related practice was in evidence across the frailty networks thus enabling multidisciplinary teams to manage the care of an older person with frailty in an integrated way.
Collapse
Affiliation(s)
- F Munro
- Health Service Executive , Dublin, Ireland
| | - C Murphy
- Dublin City University School of Nursing, Psychotherapy and Community Health, , Dublin, Ireland
| |
Collapse
|
20
|
Murphy C, Duggan E, Knight S, Davis J, Zuniga RG, Connolly E, Kenny RA, McCarthy S, Romero-Ortuno R. 34 RELATIONSHIP BETWEEN SERUM CAROTENOID CONCENTRATIONS AND FRAILTY, PROBABLE SARCOPENIA, AND PHYSICAL FUNCTION IN THE IRISH LONGITUDINAL STUDY ON AGEING (TILDA). Age Ageing 2022. [DOI: 10.1093/ageing/afac218.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Lutein and zeaxanthin are antioxidant and anti-inflammatory carotenoids derived from foods such as fruit and vegetables. Serum concentrations of Lutein (Ls) and Zeaxanthin (Zs) reflect habitual dietary intake. This study examined the cross-sectional and longitudinal relationships between Ls and Zs and frailty, probable sarcopenia, and indices of physical function in TILDA.
Methods
The cross-sectional analysis included n=4672 community-dwelling adults aged ≥50 years with Ls and Zs at Wave 1 (2010). For the longitudinal analyses, changes in usual gait speed (at Wave 3, 2014), grip strength (Wave 4, 2016) and Timed Up-and-Go (TUG; Wave 5, 2018), incident probable sarcopenia (defined as grip strength <27 kg in men, <16 kg in women, at Wave 4) and incident frailty (Fried, at Wave 5) were determined. Multivariable linear and logistic regression analyses were adjusted for age, sex, waist circumference, education, malnutrition, smoking, chronic disease, alcohol intake and physical activity.
Results
Cross-sectionally, Ls and Zs were positively associated with gait speed (B [95% CI] per 100-nmol/L higher concentration: Ls 0.67 [0.22, 1.12], Zs 1.3 [0.21, 2.48] cm/s) and inversely associated with TUG time (Ls –0.07 [-0.11, –0.02], Zs –0.14 [-0.25, –0.03] s) and with frailty (OR: Ls 0.61 [0.42, 0.87], Zs 0.23 [0.08, 0.68]), all p <0.05), but not with grip strength or probable sarcopenia. Longitudinally, Ls was inversely associated incident frailty (OR 0.85 [0.04, 0.84], p=0.03), whereas Zs was not (0.83 [0.56, 1.23], p=0.36). Neither Ls or Zs were related to changes in physical function measures or incident probable sarcopenia (p>0.05).
Conclusion
Cross-sectionally, lower Ls and Zs were independently associated with frailty, slower gait speed and worse TUG performance. However, Wave 1 Ls and Zs were not predictive of changes in these outcomes over 4-8 years of follow up, with the exception of Ls which was inversely associated with incident frailty after 8 years.
Collapse
Affiliation(s)
- C Murphy
- Trinity College Dublin The Irish Longitudinal Study on Ageing (TILDA), , Dublin, Ireland
- Teagasc Food Research Centre , Dublin, Ireland
| | - E Duggan
- Trinity College Dublin The Irish Longitudinal Study on Ageing (TILDA), , Dublin, Ireland
- Trinity College Dublin School of Medicine, , Dublin, Ireland
| | - S Knight
- Trinity College Dublin The Irish Longitudinal Study on Ageing (TILDA), , Dublin, Ireland
- Trinity College Dublin School of Medicine, , Dublin, Ireland
| | - J Davis
- Trinity College Dublin The Irish Longitudinal Study on Ageing (TILDA), , Dublin, Ireland
- Trinity College Dublin School of Medicine, , Dublin, Ireland
| | - RG Zuniga
- Trinity College Dublin The Irish Longitudinal Study on Ageing (TILDA), , Dublin, Ireland
- Trinity College Dublin School of Medicine, , Dublin, Ireland
| | - E Connolly
- Trinity College Dublin The Irish Longitudinal Study on Ageing (TILDA), , Dublin, Ireland
- Trinity College Dublin School of Medicine, , Dublin, Ireland
| | - RA Kenny
- Trinity College Dublin The Irish Longitudinal Study on Ageing (TILDA), , Dublin, Ireland
- Trinity College Dublin School of Medicine, , Dublin, Ireland
| | - S McCarthy
- Teagasc Food Research Centre , Dublin, Ireland
| | - R Romero-Ortuno
- Trinity College Dublin The Irish Longitudinal Study on Ageing (TILDA), , Dublin, Ireland
- Trinity College Dublin School of Medicine, , Dublin, Ireland
| |
Collapse
|
21
|
Murphy C, Timon C, Heffernan E, Hopper L, Gallagher P, Hussey P. 67 TECHNOLOGY TO SUPPORT INDEPENDENT LIVING AT HOME: ONLINE SURVEY OF USER NEEDS AND REQUIREMENTS. Age Ageing 2022. [DOI: 10.1093/ageing/afac218.053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Technology can play a key role in supporting older adults to live independently at home. A User Needs and Requirements study including co-design workshops and an online survey was conducted to inform the development of a technological solution aimed at supporting older adults to remain living independently at home. The online survey component is reported here.
Methods
Eligibility criteria included that respondents were older adults living at home or caregiving stakeholders providing care to older adults at home e.g. family caregivers or health/social care professionals. Recruitment took place throughout Ireland through civil society organisations and age friendly networks in local councils. Quantitative and qualitative data were gathered from June to July 2020. Descriptive statistics were applied to quantitative data and inductive thematic analysis was performed on free text responses.
Results
In total, 380 respondents completed the survey (n= 235 older adults, n=77 family caregivers, n=47 healthcare professionals and n=21 home support workers). Older adults identified key issues where technology might support them to live independently, these included, home security (33% n=77), falls (30% n=69), reduced mobility (23% n=55) and loneliness (23% n=54). Thematic analysis highlighted key areas where technology could assist stakeholders in providing care for older adults living independently, these included, remote monitoring of family members (family caregivers), communication with clients (healthcare professionals) and falls (home support workers). Older adults reported that data privacy and the cost of technology were key concerns. All groups reported a high level of willingness to use technology such as ambient sensors, wearable devices and voice activated assistants to support independent living.
Conclusion
Results of this survey provide insights into user needs and requirements in combination with results from co-design workshops to inform the design, development and trial of a technology system to support independent living at home.
Collapse
Affiliation(s)
- C Murphy
- Dublin City University School of Nursing, Psychotherapy and Community Health, , Dublin, Ireland
- Dublin City University Centre for eIntegrated Care, , Dublin, Ireland
| | - C Timon
- Dublin City University Centre for eIntegrated Care, , Dublin, Ireland
| | - E Heffernan
- Dublin City University Centre for eIntegrated Care, , Dublin, Ireland
| | - L Hopper
- Dublin City University School of Psychology, , Dublin, Ireland
- Dublin City University Centre for eIntegrated Care, , Dublin, Ireland
| | - P Gallagher
- Dublin City University School of Psychology, , Dublin, Ireland
- Dublin City University Centre for eIntegrated Care, , Dublin, Ireland
| | - P Hussey
- Dublin City University School of Nursing, Psychotherapy and Community Health, , Dublin, Ireland
- Dublin City University Centre for eIntegrated Care, , Dublin, Ireland
| |
Collapse
|
22
|
Murphy C, Keogh IJ. The Evolution of the medical record from paper to digital: an ENT perspective. J Laryngol Otol 2022:1-13. [PMID: 36217668 DOI: 10.1017/s0022215122002195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/03/2023]
Affiliation(s)
- C Murphy
- Department of Otolaryngology, University College Hospital Galway, School of Medicine, National University of Ireland Galway
| | - I J Keogh
- Department of Otolaryngology, University College Hospital Galway, School of Medicine, National University of Ireland Galway
| |
Collapse
|
23
|
German BD, Akin J, Kim SH, Murphy C, Venugopal P, Lopez-Hisijos N, Katz DA. Iatrogenic Immunodeficiency Associated Lymphoproliferative Disorder in a Patient With Inflammatory Bowel Disease. J Med Cases 2022; 13:521-524. [PMID: 36407867 PMCID: PMC9635768 DOI: 10.14740/jmc3798] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2022] [Accepted: 08/17/2022] [Indexed: 01/25/2023] Open
Abstract
Primary colorectal lymphoma is incredibly rare and cases of iatrogenic immunodeficiency associated lymphoproliferative disorder (IILPD) isolated to colorectal area are even more uncommon. Immunodeficiency associated lymphoproliferative disorders can occur in association with primary immune disorders such as inflammatory bowel diseases (IBDs) which are often treated with various immunomodulatory drugs. Of the immunomodulatory drugs, thiopurines, in particular, are known to have a significantly increased relative risk for development of IILPDs. Here we present the case of a 43-year-old Caucasian man with a 22-year history of IBD treated with longstanding immunomodulatory therapy who presented with severe rectal pain and drainage. He underwent an examination under anesthesia with rigid proctoscopy and biopsies were taken of a hard exophytic appearing tissue along the posterior wall of the rectosigmoid junction. Pathological investigation of the samples revealed IILPD. He underwent treatment with rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone (R-CHOP) and achieved complete remission. Literature demonstrates that the use of immunomodulators such as azathioprine has been shown to significantly improve the quality of life in patients with IBD. However, while the absolute risk of lymphoma for any given patient remains quite low, the relative risk of lymphoma in patients who are actively treated with thiopurines is moderate. Therefore, the decision to proceed with thiopurine treatment, especially in the setting of long-term therapy, requires extensive discussion and patient education of the risks/benefits along with closer monitoring of new or uncharacteristic symptoms.
Collapse
Affiliation(s)
- Benjamin D. German
- Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA
| | | | - Seo-Hyun Kim
- Division of Hematology, Oncology and Cellular Therapy, Rush University Medical Center, Chicago, IL, USA
| | - Caitlin Murphy
- Division of Hematology, Oncology and Cellular Therapy, Rush University Medical Center, Chicago, IL, USA
| | - Parameswaran Venugopal
- Division of Hematology, Oncology and Cellular Therapy, Rush University Medical Center, Chicago, IL, USA
| | | | - Deborah A. Katz
- Division of Hematology, Oncology and Cellular Therapy, Rush University Medical Center, Chicago, IL, USA,Corresponding Author: Deborah Katz, Division of Hematology/Oncology, Department of Internal Medicine, Rush University Medical Center, Chicago, IL 60612, USA.
| |
Collapse
|
24
|
Matulonis U, Moore K, Lorusso D, Oaknin A, Pignata S, Denys H, Colombo N, Van Gorp T, Konner J, Romeo Marin M, Harter P, Murphy C, Tu Y, Zhu F, Esteves B, Method M, Birrer M, Coleman R, O'Malley D. 592P Exposure response (ER) analysis for efficacy and safety of mirvetuximab soravtansine (MIRV) in patients with folate receptor α (FRα)-positive cancer. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.720] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
25
|
Moore K, Oza A, Colombo N, Oaknin A, Scambia G, Lorusso D, Banerjee S, Murphy C, Konner J, Lim P, Prasad-Hayes M, Monk B, Wang J, Birrer M, Vergote I. 532P Analyses of patient-reported outcomes (PROs) with mirvetuximab soravtansine (MIRV) versus standard chemotherapy in the randomized phase III FORWARD I study in ovarian cancer (GOG 3011). Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.660] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
26
|
Capinha L, Zhang Y, Holzer AK, Ückert AK, Zana M, Murphy C, Mazidi Z, Grillari J, Commandeur J, Dinnyes A, van der Water B, Leist M, Jennings P. P14-16 Application of various human in vitro systems for the confirmation of cellular targets and the molecular toxicity of glutathione conjugates of Trichloroethylene. Toxicol Lett 2022. [DOI: 10.1016/j.toxlet.2022.07.581] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
27
|
Murphy C, Duffy F, McCormick F, O'Donnell S, Fitzpatrick F, Humphreys H. Workload for infection prevention and control teams in preventing nosocomial tuberculosis. An underestimated burden. J Hosp Infect 2022; 129:115-116. [PMID: 35961479 DOI: 10.1016/j.jhin.2022.07.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2022] [Accepted: 07/25/2022] [Indexed: 10/31/2022]
Affiliation(s)
- C Murphy
- Department of Clinical Microbiology, the Royal College of Surgeons in Ireland, Dublin, Ireland.
| | - F Duffy
- Infection Prevention and Control Department, Beaumont Hospital, Dublin, Ireland
| | - F McCormick
- Infection Prevention and Control Department, Beaumont Hospital, Dublin, Ireland
| | - S O'Donnell
- Department of Clinical Microbiology, the Royal College of Surgeons in Ireland, Dublin, Ireland; Department of Microbiology, Beaumont Hospital, Dublin, Ireland
| | - F Fitzpatrick
- Department of Clinical Microbiology, the Royal College of Surgeons in Ireland, Dublin, Ireland; Department of Microbiology, Beaumont Hospital, Dublin, Ireland
| | - H Humphreys
- Department of Clinical Microbiology, the Royal College of Surgeons in Ireland, Dublin, Ireland
| |
Collapse
|
28
|
Lieberman D, Ladabaum U, Brill JV, May FP, Kim LS, Murphy C, Wender R, Teixeira K. Reducing the Burden of Colorectal Cancer: AGA Position Statements. Gastroenterology 2022; 163:520-526. [PMID: 35715380 DOI: 10.1053/j.gastro.2022.05.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/12/2022] [Revised: 04/28/2022] [Accepted: 05/03/2022] [Indexed: 12/02/2022]
Affiliation(s)
- David Lieberman
- Division of Gastroenterology, Oregon Health and Science University, Portland, Oregon.
| | - Uri Ladabaum
- Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Redwood City, California
| | - Joel V Brill
- Predictive Health, Phoenix, Arizona; University of Arizona College of Medicine, Phoenix, Arizona
| | - Folasade P May
- Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, California; University of California-Los Angeles Kaiser Permanente Center for Health Equity, Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, California; Division of Gastroenterology, Department of Medicine, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California
| | | | - Caitlin Murphy
- School of Public Health, University of Texas Health Science Center at Houston, Houston, Texas
| | - Richard Wender
- Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
| | | |
Collapse
|
29
|
Minihan B, McAuliffe E, Powell J, Wong SL, Wilkie K, Murphy C, Maher A, Power L, O'Connell NH, Dunne CP. Association between tocilizumab treatment of hyperinflammatory patients with COVID-19 in a critical care setting and elevated incidence of hospital-acquired bacterial and invasive fungal infections. J Hosp Infect 2022; 126:29-36. [PMID: 35472487 PMCID: PMC9033628 DOI: 10.1016/j.jhin.2022.04.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2022] [Revised: 04/12/2022] [Accepted: 04/14/2022] [Indexed: 12/29/2022]
Abstract
Background Tocilizumab is an interleukin-6 inhibitor that reduces mortality and the need for invasive mechanical ventilation, while increasing the possibility of successful hospital discharge for hyperinflammatory patients with severe coronavirus disease 2019 (COVID-19). No increase in adverse events or serious infections has been reported previously. Aim To describe the characteristics and outcomes of patients with severe COVID-19 in critical care who received tocilizumab, and to compare mortality and length of hospital stay for patients who received tocilizumab (N=41) with those who did not (N=33). Methods Retrospective review of data related to patients with COVID-19 who received tocilizumab in a critical care setting from 1st January to 31st December 2021. Findings Amongst COVID-19 survivors, those who had received tocilizumab had longer intensive care unit (ICU) stays (median length 21 vs 9 days) and hospital stays (45 vs 34 days) compared with those who had not received tocilizumab. Thirty-day mortality (29% vs 36%; P=0.5196) and 60-day mortality (37% and 42%; P=0.6138) were not significantly lower in patients who received tocilizumab. Serious bacterial and fungal infections occurred at higher frequency amongst patients who received tocilizumab [odds ratio (OR) 2.67, 95% confidence interval (CI) 1.04–6.86; P=0.042], and at significantly higher frequency than in non-COVID-19 ICU admissions (OR 5.26, 95% CI 3.08–9.00; P<0.0001). Conclusions In this single-centre study, patients in critical care with severe COVID-19 who received tocilizumab had a greater number of serious bacterial and fungal infections, but this may not have been a direct effect of tocilizumab treatment.
Collapse
Affiliation(s)
- B Minihan
- Department of Clinical Microbiology, University Hospital Limerick, Limerick, Ireland
| | - E McAuliffe
- Department of Clinical Microbiology, University Hospital Limerick, Limerick, Ireland
| | - J Powell
- Department of Clinical Microbiology, University Hospital Limerick, Limerick, Ireland
| | - S L Wong
- Department of Anaesthesia and Critical Care, University Hospital Limerick, Limerick, Ireland
| | - K Wilkie
- Department of Anaesthesia and Critical Care, University Hospital Limerick, Limerick, Ireland
| | - C Murphy
- Department of Anaesthesia and Critical Care, University Hospital Limerick, Limerick, Ireland
| | - A Maher
- Department of Pharmacy, University Hospital Limerick, Limerick, Ireland
| | - L Power
- Department of Clinical Microbiology, University Hospital Limerick, Limerick, Ireland
| | - N H O'Connell
- Department of Clinical Microbiology, University Hospital Limerick, Limerick, Ireland; Centre for Interventions in Infection, Inflammation & Immunity (4i), University of Limerick, Limerick, Ireland; School of Medicine, University of Limerick, Limerick, Ireland
| | - C P Dunne
- Centre for Interventions in Infection, Inflammation & Immunity (4i), University of Limerick, Limerick, Ireland; School of Medicine, University of Limerick, Limerick, Ireland.
| |
Collapse
|
30
|
Murphy C, Hartop K, Aggrey K, Bilan J, Lumsden J, Colquhoun K, Quinn T. 802 CONCURRENT PATHOLOGIES OBSERVED IN OLDER ADULTS WITH COVID-19 INFECTION. Age Ageing 2022. [PMCID: PMC9383589 DOI: 10.1093/ageing/afac037.802] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Introduction This study aimed to look at the effect of frailty and multi morbidity on short-term outcomes in patients diagnosed with COVID-19 in a hospital setting, looking specifically at the variety of concurrent pathologies diagnosed during their admission and how these affected the course of their illness and mortality. Methods The study took place at Glasgow Royal Infirmary. We retrospectively collected data from 280 patients who were admitted to the medicine for the elderly department between the 1st October and 1st December 2020 and diagnosed with COVID-19. Results In this cohort, 65% of older adults in hospital with COVID-19 had their admissions complicated by concurrent pathologies; most commonly delirium, acute kidney injury and pulmonary embolism, also increasing mortality in this group. It was also found that 39% of patients in this group had co-pathologies that were not necessarily associated with COVID-19 disease, for example AKI, AF and stroke/TIA. 35% of older adults in this group had no concurrent medical diagnoses during their admission, however this did not correlate with reduced mortality in this group. Conclusion The data highlights the vulnerability of older adults with COVID-19 infection making them more susceptible to concurrent disease and contributing to further morbidity and mortality. We also found a large number of patients had co-pathologies not associated with COVID-19 disease, highlighting the importance of considering other diagnoses in frail elderly patients.
Collapse
Affiliation(s)
- C Murphy
- Department of Medicine for the elderly; Department of Medicine for the elderly; University of Glasgow; University of Glasgow; Department of Medicine for the elderly; Department of Medicine for the elderly; Department of Medicine for the elderly
| | - K Hartop
- Department of Medicine for the elderly; Department of Medicine for the elderly; University of Glasgow; University of Glasgow; Department of Medicine for the elderly; Department of Medicine for the elderly; Department of Medicine for the elderly
| | - K Aggrey
- Department of Medicine for the elderly; Department of Medicine for the elderly; University of Glasgow; University of Glasgow; Department of Medicine for the elderly; Department of Medicine for the elderly; Department of Medicine for the elderly
| | - J Bilan
- Department of Medicine for the elderly; Department of Medicine for the elderly; University of Glasgow; University of Glasgow; Department of Medicine for the elderly; Department of Medicine for the elderly; Department of Medicine for the elderly
| | - J Lumsden
- Department of Medicine for the elderly; Department of Medicine for the elderly; University of Glasgow; University of Glasgow; Department of Medicine for the elderly; Department of Medicine for the elderly; Department of Medicine for the elderly
| | - K Colquhoun
- Department of Medicine for the elderly; Department of Medicine for the elderly; University of Glasgow; University of Glasgow; Department of Medicine for the elderly; Department of Medicine for the elderly; Department of Medicine for the elderly
| | - T Quinn
- Department of Medicine for the elderly; Department of Medicine for the elderly; University of Glasgow; University of Glasgow; Department of Medicine for the elderly; Department of Medicine for the elderly; Department of Medicine for the elderly
| |
Collapse
|
31
|
Sapena V, Enea M, Torres F, Celsa C, Rios J, Rizzo GEM, Nahon P, Mariño Z, Tateishi R, Minami T, Sangiovanni A, Forns X, Toyoda H, Brillanti S, Conti F, Degasperi E, Yu ML, Tsai PC, Jean K, El Kassas M, Shousha HI, Omar A, Zavaglia C, Nagata H, Nakagawa M, Asahina Y, Singal AG, Murphy C, Kohla M, Masetti C, Dufour JF, Merchante N, Cavalletto L, Chemello LL, Pol S, Crespo J, Calleja JL, Villani R, Serviddio G, Zanetto A, Shalaby S, Russo FP, Bielen R, Trevisani F, Cammà C, Bruix J, Cabibbo G, Reig M. Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis. Gut 2022; 71:593-604. [PMID: 33741640 DOI: 10.1136/gutjnl-2020-323663] [Citation(s) in RCA: 55] [Impact Index Per Article: 27.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/25/2020] [Revised: 01/12/2021] [Accepted: 01/29/2021] [Indexed: 02/06/2023]
Abstract
OBJECTIVE The benefit of direct-acting antivirals (DAAs) against HCV following successful treatment of hepatocellular carcinoma (HCC) remains controversial. This meta-analysis of individual patient data assessed HCC recurrence risk following DAA administration. DESIGN We pooled the data of 977 consecutive patients from 21 studies of HCV-related cirrhosis and HCC, who achieved complete radiological response after surgical/locoregional treatments and received DAAs (DAA group). Recurrence or death risk was expressed as HCC recurrence or death per 100 person-years (100PY). Propensity score-matched patients from the ITA.LI.CA. cohort (n=328) served as DAA-unexposed controls (no-DAA group). Risk factors for HCC recurrence were identified using random-effects Poisson. RESULTS Recurrence rate and death risk per 100PY in DAA-treated patients were 20 (95% CI 13.9 to 29.8, I2=74.6%) and 5.7 (2.5 to 15.3, I2=54.3), respectively. Predictive factors for recurrence were alpha-fetoprotein logarithm (relative risk (RR)=1.11, 95% CI 1.03 to 1.19; p=0.01, per 1 log of ng/mL), HCC recurrence history pre-DAA initiation (RR=1.11, 95% CI 1.07 to 1.16; p<0.001), performance status (2 vs 0, RR=4.35, 95% CI 1.54 to 11.11; 2 vs 1, RR=3.7, 95% CI 1.3 to 11.11; p=0.01) and tumour burden pre-HCC treatment (multifocal vs solitary nodule, RR=1.75, 95% CI 1.25 to 2.43; p<0.001). No significant difference was observed in RR between the DAA-exposed and DAA-unexposed groups in propensity score-matched patients (RR=0.64, 95% CI 0.37 to 1.1; p=0.1). CONCLUSION Effects of DAA exposure on HCC recurrence risk remain inconclusive. Active clinical and radiological follow-up of patients with HCC after HCV eradication with DAA is justified.
Collapse
Affiliation(s)
- Victor Sapena
- Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, Hospital Clínic de Barcelona, IDIBAPS, Universidad de Barcelona, CIBEREHD, Hospital Clinic de Barcelona, Barcelona, Spain
| | - Marco Enea
- Department of Health Promotion, Mother & Child Care, Internal Medicine & Medical Specialties, PROMISE, Gastroenterology & Hepatology Unit, University of Palermo, Palermo, Sicilia, Italy
| | - Ferran Torres
- Biostatistics and Data Management Core Facility, IDIBAPS, Hospital Clinic Barcelona, Barcelona, Spain.,Biostatistics Unit, Faculty of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain
| | - Ciro Celsa
- Department of Health Promotion, Mother & Child Care, Internal Medicine & Medical Specialties, PROMISE, Gastroenterology & Hepatology Unit, University of Palermo, Palermo, Sicilia, Italy.,Department of Surgical, Oncological and Oral Sciences (Di.Chir.On.S.), University of Palermo, Palermo, Sicilia, Italy
| | - Jose Rios
- Biostatistics and Data Management Core Facility, IDIBAPS, Hospital Clinic Barcelona, Barcelona, Spain.,Biostatistics Unit, Faculty of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain
| | - Giacomo Emanuele Maria Rizzo
- Department of Health Promotion, Mother & Child Care, Internal Medicine & Medical Specialties, PROMISE, Gastroenterology & Hepatology Unit, University of Palermo, Palermo, Sicilia, Italy
| | - Pierre Nahon
- AP-HP, Hôpital Jean Verdier, Service d'Hépatologie, Bondy; Université Paris 13, Sorbonne Paris Cité, "Equipe labellisée Ligue Contre le Cancer", F-93206 Saint-Denis; Inserm, UMR-1162, "Génomique fonctionnelle des tumeurs solides", F-75000, Bondy, France
| | - Zoe Mariño
- Liver Unit, Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, CIBEREHD, Barcelona, Spain
| | - Ryosuke Tateishi
- Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
| | - Tatsuya Minami
- Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
| | - Angelo Sangiovanni
- Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Maggiore Hospital, University of Milan, Milan, Italy.,CRC "A.M. and A. Migliavacca" Center for Liver Disease, Milan, Italy
| | - Xavier Forns
- Liver Unit, Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, CIBEREHD, Barcelona, Spain
| | - Hidenori Toyoda
- Gastroenterology, Ogaki Municipal Hospital, Ogaki, Gifu, Japan
| | - Stefano Brillanti
- Department of Medical and Surgical Sciences (DIMEC), Research Centre for the Study of Hepatitis, University of Bologna, Bologna, Italy
| | - Fabio Conti
- Department of Medical and Surgical Sciences (DIMEC), Research Centre for the Study of Hepatitis, University of Bologna, Bologna, Italy
| | - Elisabetta Degasperi
- Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Maggiore Hospital, University of Milan, Milan, Italy.,CRC "A.M. and A. Migliavacca" Center for Liver Disease, Milan, Italy
| | - Ming-Lung Yu
- Hepatobiliary Division, Department of Internal Medicine and Hepatitis, Center Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.,Faculty of Internal Medicine and Hepatitis Research Center, School of Medicine, College of Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
| | - Pei-Chien Tsai
- Hepatobiliary Division, Department of Internal Medicine and Hepatitis, Center Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
| | - Kevin Jean
- Laboratoire MESuRS (EA 4628), Conservatoire National Des Arts et Métiers, Paris, France.,Unité PACRI, Institut Pasteur, Conservatoire National des Arts et Métiers, Paris, France
| | - Mohamed El Kassas
- Endemic Medicine, Faculty of Medicine, Helwan University, Cairo, Egypt
| | - Hend Ibrahim Shousha
- Endemic Medicine and Hepato-Gastroenterology, Faculty of Medicine, Cairo University, Cairo, Egypt
| | - Ashraf Omar
- Endemic Medicine and Hepato-Gastroenterology, Faculty of Medicine, Cairo University, Cairo, Egypt
| | - Claudio Zavaglia
- Department of Hepatology and Gastroenterology, Liver Unit, Niguarda Hospital, Milano, Lombardia, Italy
| | - Hiroko Nagata
- Gastroenterology and Hepatology, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan
| | - Mina Nakagawa
- Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.,Institute of Education, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan
| | - Yasuhiro Asahina
- Department of Gastroenterology and Hepatology, Liver Disease Control, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan
| | - Amit G Singal
- Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas, USA
| | - Caitlin Murphy
- Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas, USA
| | - Mohamed Kohla
- Hepatology, National Liver Institute, Shebin El-Kom, Egypt
| | - Chiara Masetti
- Liver and Transplant Unit, Policlinico Tor Vergata, Rome, Italy
| | - Jean-François Dufour
- Hepatology, Department of Clinical Research, University Clinic for Visceral Surgery and Medicine Inselspital, Bern, Switzerland.,Hepatology, Department of Clinical Research, University of Bern, Bern, Switzerland
| | - Nicolas Merchante
- Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario de Valme, Seville, Spain
| | - Luisa Cavalletto
- Department of Medicine-DIMED, Padua University, University Hospital, Clinica Medica 5, Refering Center for Liver Diseases, Padova, Italy
| | - Liliana Lc Chemello
- Department of Medicine-DIMED, Padua University, University Hospital, Clinica Medica 5, Refering Center for Liver Diseases, Padova, Italy
| | - Stanislas Pol
- l'Agence de recherche ANRS (France REcherche Nord&Sud Sida-HIV Hépatites), Paris, France
| | - Javier Crespo
- Gastroenterology and Hepatology Service, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain.,Facultad de Medicina, Universidad de Cantabria, Santander, Cantabria, Spain
| | - Jose Luis Calleja
- Gastroenterology and Hepatology, IDIPHIM, Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Spain.,(CIBEREHD), Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red Enfermedades Hepaticas y Digestivas, Madrid, Spain
| | - Rosanna Villani
- Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy
| | - Gaetano Serviddio
- Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy
| | - Alberto Zanetto
- Gastroenterology/Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology Unit, University of Padova, Padova, Italy
| | - Sarah Shalaby
- Gastroenterology/Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology Unit, University of Padova, Padova, Italy
| | - Francesco Paolo Russo
- Gastroenterology/Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology Unit, University of Padova, Padova, Italy
| | - Rob Bielen
- Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Limburg, Belgium.,Department of Gastro-Enterology and Hepatology, Ziekenhuis Oost-Limburg, Genk, Limburg, Belgium
| | - Franco Trevisani
- Department of Medical and Surgical Sciences, Semeiotics Unit, Alma Mater Studiorum-University of Bologna, Bologna, Italy
| | - Calogero Cammà
- Department of Health Promotion, Mother & Child Care, Internal Medicine & Medical Specialties, PROMISE, Gastroenterology & Hepatology Unit, University of Palermo, Palermo, Sicilia, Italy
| | - Jordi Bruix
- Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, Hospital Clínic de Barcelona, IDIBAPS, Universidad de Barcelona, CIBEREHD, Hospital Clinic de Barcelona, Barcelona, Spain
| | - Giuseppe Cabibbo
- Department of Health Promotion, Mother & Child Care, Internal Medicine & Medical Specialties, PROMISE, Gastroenterology & Hepatology Unit, University of Palermo, Palermo, Sicilia, Italy
| | - Maria Reig
- Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, Hospital Clínic de Barcelona, IDIBAPS, Universidad de Barcelona, CIBEREHD, Hospital Clinic de Barcelona, Barcelona, Spain
| |
Collapse
|
32
|
McCreery R, Nielsen L, Clarey D, Murphy C, Van Schooneveld TC. Evaluation of cerebrospinal fluid white blood cell count criteria for use of the BioFire® FilmArray® Meningitis/Encephalitis Panel in immunocompromised and nonimmunocompromised patients. Diagn Microbiol Infect Dis 2022; 102:115605. [DOI: 10.1016/j.diagmicrobio.2021.115605] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2021] [Revised: 11/15/2021] [Accepted: 11/16/2021] [Indexed: 11/03/2022]
|
33
|
Carter B, Ramsay EA, Short R, Goodison S, Lumsden J, Khan A, Braude P, Vilches-Moraga A, Quinn TJ, McCarthy K, Hewitt J, Myint PK, Bruce E, Einarsson A, McCrorie K, Aggrey K, Bilan J, Hartrop K, Murphy C, McGovern A, Clini E, Guaraldi G, Verduri A, Bisset C, Alexander R, Kelly J, Murphy C, Mutasem TEJ, Singh S, Paxton D, Harris W, Moug S, Galbraith N, Bhatti E, Edwards J, Duffy S, Espinoza MFR, Kneen T, Dafnis A, Allafi H, Vidal MN, Price A, Pearce L, Lee T, Sangani S, Garcia M, Davey C, Jones S, Lunstone K, Cavenagh A, Silver C, Telford T, Simmons R. Prognostic value of estimated glomerular filtration rate in hospitalised older patients (over 65) with COVID-19: a multicentre, European, observational cohort study. BMC Geriatr 2022; 22:119. [PMID: 35151257 PMCID: PMC8840680 DOI: 10.1186/s12877-022-02782-5] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2021] [Accepted: 01/24/2022] [Indexed: 12/15/2022] Open
Abstract
Background The reduced renal function has prognostic significance in COVID-19 and it has been linked to mortality in the general population. Reduced renal function is prevalent in older age and thus we set out to better understand its effect on mortality. Methods Patient clinical and demographic data was taken from the COVID-19 in Older People (COPE) study during two periods (February–June 2020 and October 2020–March 2021, respectively). Kidney function on admission was measured using estimated glomerular filtration rate (eGFR). The primary outcomes were time to mortality and 28-day mortality. Secondary outcome was length of hospital stay. Data were analysed with multilevel Cox proportional hazards regression, and multilevel logistic regression and adjusted for individual patient clinical and demographic characteristics. Results One thousand eight hundred two patients (55.0% male; median [IQR] 80 [73–86] years) were included in the study. 28-day mortality was 42.3% (n = 742). 48% (n = 801) had evidence of renal impairment on admission. Using a time-to-event analysis, reduced renal function was associated with increased in-hospital mortality (compared to eGFR ≥ 60 [Stage 1&2]): eGFR 45–59 [Stage 3a] aHR = 1.26 (95%CI 1.02–1.55); eGFR 30–44 [Stage 3b] aHR = 1.41 (95%CI 1.14–1.73); eGFR 1–29 [Stage 4&5] aHR = 1.42 (95%CI 1.13–1.80). In the co-primary outcome of 28-day mortality, mortality was associated with: Stage 3a adjusted odds ratio (aOR) = 1.18 (95%CI 0.88–1.58), Stage 3b aOR = 1.40 (95%CI 1.03–1.89); and Stage 4&5 aOR = 1.65 (95%CI 1.16–2.35). Conclusion eGFR on admission is a good independent predictor of mortality in hospitalised older patients with COVID-19 population. We found evidence of a dose-response between reduced renal function and increased mortality. Supplementary Information The online version contains supplementary material available at 10.1186/s12877-022-02782-5.
Collapse
|
34
|
Wymant C, Bezemer D, Blanquart F, Ferretti L, Gall A, Hall M, Golubchik T, Bakker M, Ong SH, Zhao L, Bonsall D, de Cesare M, MacIntyre-Cockett G, Abeler-Dörner L, Albert J, Bannert N, Fellay J, Grabowski MK, Gunsenheimer-Bartmeyer B, Günthard HF, Kivelä P, Kouyos RD, Laeyendecker O, Meyer L, Porter K, Ristola M, van Sighem A, Berkhout B, Kellam P, Cornelissen M, Reiss P, Fraser C, Aubert V, Battegay M, Bernasconi E, Böni J, Braun DL, Bucher HC, Burton-Jeangros C, Calmy A, Cavassini M, Dollenmaier G, Egger M, Elzi L, Fehr J, Fellay J, Furrer H, Fux CA, Gorgievski M, Günthard H, Haerry D, Hasse B, Hirsch HH, Hoffmann M, Hösli I, Kahlert C, Kaiser L, Keiser O, Klimkait T, Kouyos R, Kovari H, Ledergerber B, Martinetti G, de Tejada BM, Marzolini C, Metzner K, Müller N, Nadal D, Nicca D, Pantaleo G, Rauch A, Regenass S, Rudin C, Schöni-Affolter F, Schmid P, Speck R, Stöckle M, Tarr P, Trkola A, Vernazza P, Weber R, Yerly S, van der Valk M, Geerlings SE, Goorhuis A, Hovius JW, Lempkes B, Nellen FJB, van der Poll T, Prins JM, Reiss P, van Vugt M, Wiersinga WJ, Wit FWMN, van Duinen M, van Eden J, Hazenberg A, van Hes AMH, Rajamanoharan S, Robinson T, Taylor B, Brewer C, Mayr C, Schmidt W, Speidel A, Strohbach F, Arastéh K, Cordes C, Pijnappel FJJ, Stündel M, Claus J, Baumgarten A, Carganico A, Ingiliz P, Dupke S, Freiwald M, Rausch M, Moll A, Schleehauf D, Smalhout SY, Hintsche B, Klausen G, Jessen H, Jessen A, Köppe S, Kreckel P, Schranz D, Fischer K, Schulbin H, Speer M, Weijsenfeld AM, Glaunsinger T, Wicke T, Bieniek B, Hillenbrand H, Schlote F, Lauenroth-Mai E, Schuler C, Schürmann D, Wesselmann H, Brockmeyer N, Jurriaans S, Gehring P, Schmalöer D, Hower M, Spornraft-Ragaller P, Häussinger D, Reuter S, Esser S, Markus R, Kreft B, Berzow D, Back NKT, Christl A, Meyer A, Plettenberg A, Stoehr A, Graefe K, Lorenzen T, Adam A, Schewe K, Weitner L, Fenske S, Zaaijer HL, Hansen S, Stellbrink HJ, Wiemer D, Hertling S, Schmidt R, Arbter P, Claus B, Galle P, Jäger H, Jä Gel-Guedes E, Berkhout B, Postel N, Fröschl M, Spinner C, Bogner J, Salzberger B, Schölmerich J, Audebert F, Marquardt T, Schaffert A, Schnaitmann E, Cornelissen MTE, Trein A, Frietsch B, Müller M, Ulmer A, Detering-Hübner B, Kern P, Schubert F, Dehn G, Schreiber M, Güler C, Schinkel CJ, Gunsenheimer-Bartmeyer B, Schmidt D, Meixenberger K, Bannert N, Wolthers KC, Peters EJG, van Agtmael MA, Autar RS, Bomers M, Sigaloff KCE, Heitmuller M, Laan LM, Ang CW, van Houdt R, Jonges M, Kuijpers TW, Pajkrt D, Scherpbier HJ, de Boer C, van der Plas A, van den Berge M, Stegeman A, Baas S, Hage de Looff L, Buiting A, Reuwer A, Veenemans J, Wintermans B, Pronk MJH, Ammerlaan HSM, van den Bersselaar DNJ, de Munnik ES, Deiman B, Jansz AR, Scharnhorst V, Tjhie J, Wegdam MCA, van Eeden A, Nellen J, Brokking W, Elsenburg LJM, Nobel H, van Kasteren MEE, Berrevoets MAH, Brouwer AE, Adams A, van Erve R, de Kruijf-van de Wiel BAFM, Keelan-Phaf S, van de Ven B, van der Ven B, Buiting AGM, Murck JL, de Vries-Sluijs TEMS, Bax HI, van Gorp ECM, de Jong-Peltenburg NC, de Mendonç A Melo M, van Nood E, Nouwen JL, Rijnders BJA, Rokx C, Schurink CAM, Slobbe L, Verbon A, Bassant N, van Beek JEA, Vriesde M, van Zonneveld LM, de Groot J, Boucher CAB, Koopmans MPG, van Kampen JJA, Fraaij PLA, van Rossum AMC, Vermont CL, van der Knaap LC, Visser E, Branger J, Douma RA, Cents-Bosma AS, Duijf-van de Ven CJHM, Schippers EF, van Nieuwkoop C, van Ijperen JM, Geilings J, van der Hut G, van Burgel ND, Leyten EMS, Gelinck LBS, Mollema F, Davids-Veldhuis S, Tearno C, Wildenbeest GS, Heikens E, Groeneveld PHP, Bouwhuis JW, Lammers AJJ, Kraan S, van Hulzen AGW, Kruiper MSM, van der Bliek GL, Bor PCJ, Debast SB, Wagenvoort GHJ, Kroon FP, de Boer MGJ, Jolink H, Lambregts MMC, Roukens AHE, Scheper H, Dorama W, van Holten N, Claas ECJ, Wessels E, den Hollander JG, El Moussaoui R, Pogany K, Brouwer CJ, Smit JV, Struik-Kalkman D, van Niekerk T, Pontesilli O, Lowe SH, Oude Lashof AML, Posthouwer D, van Wolfswinkel ME, Ackens RP, Burgers K, Schippers J, Weijenberg-Maes B, van Loo IHM, Havenith TRA, van Vonderen MGA, Kampschreur LM, Faber S, Steeman-Bouma R, Al Moujahid A, Kootstra GJ, Delsing CE, van der Burg-van de Plas M, Scheiberlich L, Kortmann W, van Twillert G, Renckens R, Ruiter-Pronk D, van Truijen-Oud FA, Cohen Stuart JWT, Jansen ER, Hoogewerf M, Rozemeijer W, van der Reijden WA, Sinnige JC, Brinkman K, van den Berk GEL, Blok WL, Lettinga KD, de Regt M, Schouten WEM, Stalenhoef JE, Veenstra J, Vrouenraets SME, Blaauw H, Geerders GF, Kleene MJ, Kok M, Knapen M, van der Meché IB, Mulder-Seeleman E, Toonen AJM, Wijnands S, Wttewaal E, Kwa D, van Crevel R, van Aerde K, Dofferhoff ASM, Henriet SSV, Ter Hofstede HJM, Hoogerwerf J, Keuter M, Richel O, Albers M, Grintjes-Huisman KJT, de Haan M, Marneef M, Strik-Albers R, Rahamat-Langendoen J, Stelma FF, Burger D, Gisolf EH, Hassing RJ, Claassen M, Ter Beest G, van Bentum PHM, Langebeek N, Tiemessen R, Swanink CMA, van Lelyveld SFL, Soetekouw R, van der Prijt LMM, van der Swaluw J, Bermon N, van der Reijden WA, Jansen R, Herpers BL, Veenendaal D, Verhagen DWM, Lauw FN, van Broekhuizen MC, van Wijk M, Bierman WFW, Bakker M, Kleinnijenhuis J, Kloeze E, Middel A, Postma DF, Schölvinck EH, Stienstra Y, Verhage AR, Wouthuyzen-Bakker M, Boonstra A, de Groot-de Jonge H, van der Meulen PA, de Weerd DA, Niesters HGM, van Leer-Buter CC, Knoester M, Hoepelman AIM, Arends JE, Barth RE, Bruns AHW, Ellerbroek PM, Mudrikova T, Oosterheert JJ, Schadd EM, van Welzen BJ, Aarsman K, Griffioen-van Santen BMG, de Kroon I, van Berkel M, van Rooijen CSAM, Schuurman R, Verduyn-Lunel F, Wensing AMJ, Bont LJ, Geelen SPM, Loeffen YGT, Wolfs TFW, Nauta N, Rooijakkers EOW, Holtsema H, Voigt R, van de Wetering D, Alberto A, van der Meer I, Rosingh A, Halaby T, Zaheri S, Boyd AC, Bezemer DO, van Sighem AI, Smit C, Hillebregt M, de Jong A, Woudstra T, Bergsma D, Meijering R, van de Sande L, Rutkens T, van der Vliet S, de Groot L, van den Akker M, Bakker Y, El Berkaoui A, Bezemer M, Brétin N, Djoechro E, Groters M, Kruijne E, Lelivelt KJ, Lodewijk C, Lucas E, Munjishvili L, Paling F, Peeck B, Ree C, Regtop R, Ruijs Y, Schoorl M, Schnörr P, Scheigrond A, Tuijn E, Veenenberg L, Visser KM, Witte EC, Ruijs Y, Van Frankenhuijsen M, Allegre T, Makhloufi D, Livrozet JM, Chiarello P, Godinot M, Brunel-Dalmas F, Gibert S, Trepo C, Peyramond D, Miailhes P, Koffi J, Thoirain V, Brochier C, Baudry T, Pailhes S, Lafeuillade A, Philip G, Hittinger G, Assi A, Lambry V, Rosenthal E, Naqvi A, Dunais B, Cua E, Pradier C, Durant J, Joulie A, Quinsat D, Tempesta S, Ravaux I, Martin IP, Faucher O, Cloarec N, Champagne H, Pichancourt G, Morlat P, Pistone T, Bonnet F, Mercie P, Faure I, Hessamfar M, Malvy D, Lacoste D, Pertusa MC, Vandenhende MA, Bernard N, Paccalin F, Martell C, Roger-Schmelz J, Receveur MC, Duffau P, Dondia D, Ribeiro E, Caltado S, Neau D, Dupont M, Dutronc H, Dauchy F, Cazanave C, Vareil MO, Wirth G, Le Puil S, Pellegrin JL, Raymond I, Viallard JF, Chaigne de Lalande S, Garipuy D, Delobel P, Obadia M, Cuzin L, Alvarez M, Biezunski N, Porte L, Massip P, Debard A, Balsarin F, Lagarrigue M, Prevoteau du Clary F, Aquilina C, Reynes J, Baillat V, Merle C, Lemoing V, Atoui N, Makinson A, Jacquet JM, Psomas C, Tramoni C, Aumaitre H, Saada M, Medus M, Malet M, Eden A, Neuville S, Ferreyra M, Sotto A, Barbuat C, Rouanet I, Leureillard D, Mauboussin JM, Lechiche C, Donsesco R, Cabie A, Abel S, Pierre-Francois S, Batala AS, Cerland C, Rangom C, Theresine N, Hoen B, Lamaury I, Fabre I, Schepers K, Curlier E, Ouissa R, Gaud C, Ricaud C, Rodet R, Wartel G, Sautron C, Beck-Wirth G, Michel C, Beck C, Halna JM, Kowalczyk J, Benomar M, Drobacheff-Thiebaut C, Chirouze C, Faucher JF, Parcelier F, Foltzer A, Haffner-Mauvais C, Hustache Mathieu M, Proust A, Piroth L, Chavanet P, Duong M, Buisson M, Waldner A, Mahy S, Gohier S, Croisier D, May T, Delestan M, Andre M, Zadeh MM, Martinot M, Rosolen B, Pachart A, Martha B, Jeunet N, Rey D, Cheneau C, Partisani M, Priester M, Bernard-Henry C, Batard ML, Fischer P, Berger JL, Kmiec I, Robineau O, Huleux T, Ajana F, Alcaraz I, Allienne C, Baclet V, Meybeck A, Valette M, Viget N, Aissi E, Biekre R, Cornavin P, Merrien D, Seghezzi JC, Machado M, Diab G, Raffi F, Bonnet B, Allavena C, Grossi O, Reliquet V, Billaud E, Brunet C, Bouchez S, Morineau-Le Houssine P, Sauser F, Boutoille D, Besnier M, Hue H, Hall N, Brosseau D, Souala F, Michelet C, Tattevin P, Arvieux C, Revest M, Leroy H, Chapplain JM, Dupont M, Fily F, Patra-Delo S, Lefeuvre C, Bernard L, Bastides F, Nau P, Verdon R, de la Blanchardiere A, Martin A, Feret P, Geffray L, Daniel C, Rohan J, Fialaire P, Chennebault JM, Rabier V, Abgueguen P, Rehaiem S, Luycx O, Niault M, Moreau P, Poinsignon Y, Goussef M, Mouton-Rioux V, Houlbert D, Alvarez-Huve S, Barbe F, Haret S, Perre P, Leantez-Nainville S, Esnault JL, Guimard T, Suaud I, Girard JJ, Simonet V, Debab Y, Schmit JL, Jacomet C, Weinberck P, Genet C, Pinet P, Ducroix S, Durox H, Denes É, Abraham B, Gourdon F, Antoniotti O, Molina JM, Ferret S, Lascoux-Combe C, Lafaurie M, Colin de Verdiere N, Ponscarme D, De Castro N, Aslan A, Rozenbaum W, Pintado C, Clavel F, Taulera O, Gatey C, Munier AL, Gazaigne S, Penot P, Conort G, Lerolle N, Leplatois A, Balausine S, Delgado J, Timsit J, Tabet M, Gerard L, Girard PM, Picard O, Tredup J, Bollens D, Valin N, Campa P, Bottero J, Lefebvre B, Tourneur M, Fonquernie L, Wemmert C, Lagneau JL, Yazdanpanah Y, Phung B, Pinto A, Vallois D, Cabras O, Louni F, Pialoux G, Lyavanc T, Berrebi V, Chas J, Lenagat S, Rami A, Diemer M, Parrinello M, Depond A, Salmon D, Guillevin L, Tahi T, Belarbi L, Loulergue P, Zak Dit Zbar O, Launay O, Silbermann B, Leport C, Alagna L, Pietri MP, Simon A, Bonmarchand M, Amirat N, Pichon F, Kirstetter M, Katlama C, Valantin MA, Tubiana R, Caby F, Schneider L, Ktorza N, Calin R, Merlet A, Ben Abdallah S, Weiss L, Buisson M, Batisse D, Karmochine M, Pavie J, Minozzi C, Jayle D, Castel P, Derouineau J, Kousignan P, Eliazevitch M, Pierre I, Collias L, Viard JP, Gilquin J, Sobel A, Slama L, Ghosn J, Hadacek B, Thu-Huyn N, Nait-Ighil L, Cros A, Maignan A, Duvivier C, Consigny PH, Lanternier F, Shoai-Tehrani M, Touam F, Jerbi S, Bodard L, Jung C, Goujard C, Quertainmont Y, Duracinsky M, Segeral O, Blanc A, Peretti D, Cheret A, Chantalat C, Dulucq MJ, Levy Y, Lelievre JD, Lascaux AS, Dumont C, Boue F, Chambrin V, Abgrall S, Kansau I, Raho-Moussa M, De Truchis P, Dinh A, Davido B, Marigot D, Berthe H, Devidas A, Chevojon P, Chabrol A, Agher N, Lemercier Y, Chaix F, Turpault I, Bouchaud O, Honore P, Rouveix E, Reimann E, Belan AG, Godin Collet C, Souak S, Mortier E, Bloch M, Simonpoli AM, Manceron V, Cahitte I, Hiraux E, Lafon E, Cordonnier F, Zeng AF, Zucman D, Majerholc C, Bornarel D, Uludag A, Gellen-Dautremer J, Lefort A, Bazin C, Daneluzzi V, Gerbe J, Jeantils V, Coupard M, Patey O, Bantsimba J, Delllion S, Paz PC, Cazenave B, Richier L, Garrait V, Delacroix I, Elharrar B, Vittecoq D, Bolliot C, Lepretre A, Genet P, Masse V, Perrone V, Boussard JL, Chardon P, Froguel E, Simon P, Tassi S, Avettand Fenoel V, Barin F, Bourgeois C, Cardon F, Chaix ML, Delfraissy JF, Essat A, Fischer H, Lecuroux C, Meyer L, Petrov-Sanchez V, Rouzioux C, Saez-Cirion A, Seng R, Kuldanek K, Mullaney S, Young C, Zucchetti A, Bevan MA, McKernan S, Wandolo E, Richardson C, Youssef E, Green P, Faulkner S, Faville R, Herman S, Care C, Blackman H, Bellenger K, Fairbrother K, Phillips A, Babiker A, Delpech V, Fidler S, Clarke M, Fox J, Gilson R, Goldberg D, Hawkins D, Johnson A, Johnson M, McLean K, Nastouli E, Post F, Kennedy N, Pritchard J, Andrady U, Rajda N, Donnelly C, McKernan S, Drake S, Gilleran G, White D, Ross J, Harding J, Faville R, Sweeney J, Flegg P, Toomer S, Wilding H, Woodward R, Dean G, Richardson C, Perry N, Gompels M, Jennings L, Bansaal D, Browing M, Connolly L, Stanley B, Estreich S, Magdy A, O'Mahony C, Fraser P, Jebakumar SPR, David L, Mette R, Summerfield H, Evans M, White C, Robertson R, Lean C, Morris S, Winter A, Faulkner S, Goorney B, Howard L, Fairley I, Stemp C, Short L, Gomez M, Young F, Roberts M, Green S, Sivakumar K, Minton J, Siminoni A, Calderwood J, Greenhough D, DeSouza C, Muthern L, Orkin C, Murphy S, Truvedi M, McLean K, Hawkins D, Higgs C, Moyes A, Antonucci S, McCormack S, Lynn W, Bevan M, Fox J, Teague A, Anderson J, Mguni S, Post F, Campbell L, Mazhude C, Russell H, Gilson R, Carrick G, Ainsworth J, Waters A, Byrne P, Johnson M, Fidler S, Kuldanek K, Mullaney S, Lawlor V, Melville R, Sukthankar A, Thorpe S, Murphy C, Wilkins E, Ahmad S, Green P, Tayal S, Ong E, Meaden J, Riddell L, Loay D, Peacock K, Blackman H, Harindra V, Saeed AM, Allen S, Natarajan U, Williams O, Lacey H, Care C, Bowman C, Herman S, Devendra SV, Wither J, Bridgwood A, Singh G, Bushby S, Kellock D, Young S, Rooney G, Snart B, Currie J, Fitzgerald M, Arumainayyagam J, Chandramani S. A highly virulent variant of HIV-1 circulating in the Netherlands. Science 2022; 375:540-545. [PMID: 35113714 DOI: 10.1126/science.abk1688] [Citation(s) in RCA: 30] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
We discovered a highly virulent variant of subtype-B HIV-1 in the Netherlands. One hundred nine individuals with this variant had a 0.54 to 0.74 log10 increase (i.e., a ~3.5-fold to 5.5-fold increase) in viral load compared with, and exhibited CD4 cell decline twice as fast as, 6604 individuals with other subtype-B strains. Without treatment, advanced HIV-CD4 cell counts below 350 cells per cubic millimeter, with long-term clinical consequences-is expected to be reached, on average, 9 months after diagnosis for individuals in their thirties with this variant. Age, sex, suspected mode of transmission, and place of birth for the aforementioned 109 individuals were typical for HIV-positive people in the Netherlands, which suggests that the increased virulence is attributable to the viral strain. Genetic sequence analysis suggests that this variant arose in the 1990s from de novo mutation, not recombination, with increased transmissibility and an unfamiliar molecular mechanism of virulence.
Collapse
Affiliation(s)
- Chris Wymant
- Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | | | - François Blanquart
- Centre for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS, INSERM, PSL Research University, Paris, France.,IAME, UMR 1137, INSERM, Université de Paris, Paris, France
| | - Luca Ferretti
- Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - Astrid Gall
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK
| | - Matthew Hall
- Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - Tanya Golubchik
- Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - Margreet Bakker
- Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
| | - Swee Hoe Ong
- Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK
| | - Lele Zhao
- Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - David Bonsall
- Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.,Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - Mariateresa de Cesare
- Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - George MacIntyre-Cockett
- Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.,Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - Lucie Abeler-Dörner
- Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - Jan Albert
- Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.,Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden
| | - Norbert Bannert
- Division for HIV and Other Retroviruses, Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany
| | - Jacques Fellay
- School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.,Swiss Institute of Bioinformatics, Lausanne, Switzerland.,Precision Medicine Unit, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
| | - M Kate Grabowski
- Department of Pathology, John Hopkins University, Baltimore, MD, USA
| | | | - Huldrych F Günthard
- Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.,Institute of Medical Virology, University of Zurich, Zurich, Switzerland
| | - Pia Kivelä
- Department of Infectious Diseases, Helsinki University Hospital, Helsinki, Finland
| | - Roger D Kouyos
- Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.,Institute of Medical Virology, University of Zurich, Zurich, Switzerland
| | | | - Laurence Meyer
- INSERM CESP U1018, Université Paris Saclay, APHP, Service de Santé Publique, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France
| | - Kholoud Porter
- Institute for Global Health, University College London, London, UK
| | - Matti Ristola
- Department of Infectious Diseases, Helsinki University Hospital, Helsinki, Finland
| | | | - Ben Berkhout
- Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
| | - Paul Kellam
- Kymab Ltd., Cambridge, UK.,Department of Infectious Diseases, Faculty of Medicine, Imperial College London, London, UK
| | - Marion Cornelissen
- Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.,Molecular Diagnostic Unit, Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
| | - Peter Reiss
- Stichting HIV Monitoring, Amsterdam, Netherlands.,Department of Global Health, Amsterdam University Medical Centers, University of Amsterdam and Amsterdam Institute for Global Health and Development, Amsterdam, Netherlands
| | - Christophe Fraser
- Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.,Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Petersen B, Murphy C, Johnson A, Li K. Measurement of Centre of Pressure Using the Wii Balance Board in Older Adults with Simulated Visual Impairment. Innov Aging 2021. [PMCID: PMC8681394 DOI: 10.1093/geroni/igab046.2478] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Postural stability is a complex skill dependent upon the coordination of motor, sensory and cognitive systems. The purpose of this project was therefore to explore how older adults’ balance performance is impacted by increased cognitive load, hearing loss, and simulated vision loss. Twenty-eight older adults between the ages of 50 and 93 years (M = 73.86, SD = 10.43) were tested. Participants underwent standard sensory acuity and cognitive functioning tests. The balance trials varied as a function of cognitive load and visual challenge resulting in five conditions: (1) eyes closed, (2) normal vision clear goggles (NV) (3) simulated low vision (20/80) goggles (LV) (4) LV and math task, (5) NV and math task. Postural stability was assessed with three key center of pressure parameters: total path length (TPL), anterior-posterior amplitude (APA) and medial-lateral amplitude (MLA). A mixed-model ANOVA using hearing acuity as a covariate revealed significant effects of complexity in sway amplitude: (APA: p < .017; MLA: p < .020), while TPL approached significance (p < .074). T-tests revealed significant (p < .05) decreases in balance performance across all 3 centre of pressure parameters when comparing single task NV to dual-task NV, NV vs. eyes closed and single task NV vs. LV dual-task. There were significant positive correlations between hearing acuity and balance (MLA) under single task NV (r = .491) and LV conditions (r = .497). Results suggest the attentional demands from increased cognitive load and sensory loss lead to decreases in older adults’ single- and dual-task balance performance.
Collapse
Affiliation(s)
| | - Caitlin Murphy
- Concordia University, Concordia University, Quebec, Canada
| | - Aaron Johnson
- Concordia University, Concordia University, Quebec, Canada
| | - Karen Li
- Concordia University, Concordia University, Quebec, Canada
| |
Collapse
|
36
|
Abudinén F, Adachi I, Adamczyk K, Aggarwal L, Ahmed H, Aihara H, Akopov N, Aloisio A, Anh Ky N, Asner DM, Atmacan H, Aushev V, Babu V, Bacher S, Bae H, Baehr S, Bahinipati S, Bambade P, Banerjee S, Bansal S, Barrett M, Baudot J, Bauer M, Baur A, Becker J, Behera PK, Bennett JV, Bernieri E, Bernlochner FU, Bertemes M, Bertholet E, Bessner M, Bettarini S, Bhardwaj V, Bianchi F, Bilka T, Bilokin S, Biswas D, Bobrov A, Bodrov D, Bolz A, Bozek A, Bračko M, Branchini P, Braun N, Briere RA, Browder TE, Budano A, Bussino S, Campajola M, Cao L, Casarosa G, Cecchi C, Červenkov D, Chang MC, Chang P, Cheaib R, Chekelian V, Chen C, Chen YT, Cheon BG, Chilikin K, Chirapatpimol K, Cho HE, Cho K, Cho SJ, Choi SK, Choudhury S, Cinabro D, Corona L, Cremaldi LM, Cunliffe S, Czank T, Dattola F, De La Cruz-Burelo E, de Marino G, De Nardo G, De Pietro G, de Sangro R, Destefanis M, Dey S, De Yta-Hernandez A, Di Canto A, Di Capua F, Dingfelder J, Doležal Z, Domínguez Jiménez I, Dong TV, Dorigo M, Dort K, Dossett D, Dubey S, Duell S, Dujany G, Ecker P, Epifanov D, Ferber T, Ferlewicz D, Finocchiaro G, Flood K, Fodor A, Forti F, Fulsom BG, Gabrielli A, Gabyshev N, Gaz A, Gellrich A, Giakoustidis G, Giordano R, Giri A, Glazov A, Gobbo B, Godang R, Goldenzweig P, Golob B, Gradl W, Graziani E, Greenwald D, Gu T, Guan Y, Gudkova K, Guilliams J, Hadjivasiliou C, Halder S, Hara K, Hara T, Hartbrich O, Hayasaka K, Hayashii H, Hazra S, Hearty C, Heredia de la Cruz I, Hernández Villanueva M, Hershenhorn A, Higuchi T, Hill EC, Hirata H, Hoek M, Hohmann M, Hsu CL, Humair T, Iijima T, Inami K, Inguglia G, Ishikawa A, Itoh R, Iwasaki M, Iwasaki Y, Jacobs WW, Jaffe DE, Jang EJ, Jia S, Jin Y, Junkerkalefeld H, Kakuno H, Kaliyar AB, Kandra J, Kang KH, Karl R, Karyan G, Kato Y, Kawasaki T, Kiesling C, Kim CH, Kim DY, Kim YK, Kim Y, Kimmel TD, Kinoshita K, Kodyš P, Koga T, Kohani S, Konno T, Korpar S, Kovalenko E, Kowalewski R, Kraetzschmar TMG, Krinner F, Križan P, Krokovny P, Kuhr T, Kumar J, Kumar M, Kumar R, Kumara K, Kurz S, Kuzmin A, Kwon YJ, Lacaprara S, Lalwani K, Lam T, Lanceri L, Lange JS, Laurenza M, Lautenbach K, Le Diberder FR, Lee SC, Leitl P, Levit D, Li C, Li LK, Libby J, Lieret K, Liptak Z, Liu QY, Liventsev D, Longo S, Lueck T, Lyu C, Manfredi R, Manoni E, Marinas C, Martini A, Matsuda T, Matsuoka K, Matvienko D, McKenna JA, Meier F, Merola M, Metzner F, Miller C, Miyabayashi K, Mizuk R, Mohanty GB, Molina-Gonzalez N, Moon H, Moser HG, Mrvar M, Murphy C, Mussa R, Nakamura I, Nakamura KR, Nakao M, Nakazawa H, Natkaniec Z, Natochii A, Nazaryan G, Niebuhr C, Niiyama M, Nisar NK, Nishida S, Nishimura K, Ogawa S, Onishchuk Y, Ono H, Onuki Y, Oskin P, Oxford ER, Ozaki H, Pakhlov P, Paladino A, Pang T, Panta A, Paoloni E, Pardi S, Park H, Park SH, Paschen B, Passeri A, Pathak A, Patra S, Paul S, Pedlar TK, Peruzzi I, Peschke R, Pestotnik R, Pham F, Piccolo M, Piilonen LE, Pinna Angioni G, Podesta-Lerma PLM, Podobnik T, Pokharel S, Polat G, Popov V, Praz C, Prell S, Prencipe E, Prim MT, Purohit MV, Purwar H, Rad N, Rados P, Raiz S, Reiter S, Remnev M, Ripp-Baudot I, Rizzo G, Rizzuto LB, Robertson SH, Roney JM, Rostomyan A, Rout N, Rozanska M, Sahoo D, Sanders DA, Sandilya S, Sangal A, Santelj L, Sato Y, Savinov V, Scavino B, Schueler J, Schwanda C, Schwartz AJ, Seino Y, Selce A, Senyo K, Serrano J, Sfienti C, Shiu JG, Shwartz B, Sibidanov A, Simon F, Sobie RJ, Soffer A, Sokolov A, Solovieva E, Spataro S, Spruck B, Starič M, Stefkova S, Stottler ZS, Stroili R, Strube J, Sumihama M, Sutcliffe W, Suzuki SY, Svidras H, Tabata M, Takizawa M, Tamponi U, Tanaka S, Tanida K, Tanigawa H, Taniguchi N, Tenchini F, Tiwary R, Tonelli D, Torassa E, Toutounji N, Trabelsi K, Tsuboyama T, Ueda I, Uehara S, Uematsu Y, Uglov T, Unger K, Unno Y, Uno K, Uno S, Urquijo P, Ushiroda Y, Usov YV, Vahsen SE, van Tonder R, Varner GS, Vinokurova A, Vitale L, Vossen A, Waheed E, Wakeling HM, Wang E, Wang MZ, Wang XL, Warburton A, Watanabe M, Welsch M, Wessel C, Wiechczynski J, Won E, Xu XP, Yabsley BD, Yamada S, Yan W, Yang SB, Ye H, Yelton J, Yin JH, Yoshihara K, Yusa Y, Zani L, Zhilich V, Zhou QD, Zhou XY, Zhukova VI, Žlebčík R. Precise Measurement of the D^{0} and D^{+} Lifetimes at Belle II. Phys Rev Lett 2021; 127:211801. [PMID: 34860075 DOI: 10.1103/physrevlett.127.211801] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/06/2021] [Accepted: 10/20/2021] [Indexed: 06/13/2023]
Abstract
We report a measurement of the D^{0} and D^{+} lifetimes using D^{0}→K^{-}π^{+} and D^{+}→K^{-}π^{+}π^{+} decays reconstructed in e^{+}e^{-}→cc[over ¯] data recorded by the Belle II experiment at the SuperKEKB asymmetric-energy e^{+}e^{-} collider. The data, collected at center-of-mass energies at or near the ϒ(4S) resonance, correspond to an integrated luminosity of 72 fb^{-1}. The results, τ(D^{0})=410.5±1.1(stat)±0.8(syst) fs and τ(D^{+})=1030.4±4.7(stat)±3.1(syst) fs, are the most precise to date and are consistent with previous determinations.
Collapse
Affiliation(s)
- F Abudinén
- INFN Sezione di Trieste, I-34127 Trieste, Italy
| | - I Adachi
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193, Japan
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - K Adamczyk
- H. Niewodniczanski Institute of Nuclear Physics, Krakow 31-342, Poland
| | - L Aggarwal
- Panjab University, Chandigarh 160014, India
| | - H Ahmed
- St. Francis Xavier University, Antigonish, Nova Scotia, B2G 2W5, Canada
| | - H Aihara
- Department of Physics, University of Tokyo, Tokyo 113-0033, Japan
| | - N Akopov
- Alikhanyan National Science Laboratory, Yerevan 0036, Armenia
| | - A Aloisio
- INFN Sezione di Napoli, I-80126 Napoli, Italy
- Dipartimento di Scienze Fisiche, Università di Napoli Federico II, I-80126 Napoli, Italy
| | - N Anh Ky
- Institute of Theoretical and Applied Research (ITAR), Duy Tan University, Hanoi 100000, Vietnam
- Institute of Physics, Vietnam Academy of Science and Technology (VAST), Hanoi, Vietnam
| | - D M Asner
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - H Atmacan
- University of Cincinnati, Cincinnati, Ohio 45221, USA
| | - V Aushev
- Taras Shevchenko National Univ. of Kiev, Kiev, Ukraine
| | - V Babu
- Deutsches Elektronen-Synchrotron, 22607 Hamburg, Germany
| | - S Bacher
- H. Niewodniczanski Institute of Nuclear Physics, Krakow 31-342, Poland
| | - H Bae
- Department of Physics, University of Tokyo, Tokyo 113-0033, Japan
| | - S Baehr
- Institut für Experimentelle Teilchenphysik, Karlsruher Institut für Technologie, 76131 Karlsruhe, Germany
| | - S Bahinipati
- Indian Institute of Technology Bhubaneswar, Satya Nagar 751007, India
| | - P Bambade
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - Sw Banerjee
- University of Louisville, Louisville, Kentucky 40292, USA
| | - S Bansal
- Panjab University, Chandigarh 160014, India
| | - M Barrett
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - J Baudot
- Université de Strasbourg, CNRS, IPHC, UMR 7178, 67037 Strasbourg, France
| | - M Bauer
- Institut für Experimentelle Teilchenphysik, Karlsruher Institut für Technologie, 76131 Karlsruhe, Germany
| | - A Baur
- Deutsches Elektronen-Synchrotron, 22607 Hamburg, Germany
| | - J Becker
- Institut für Experimentelle Teilchenphysik, Karlsruher Institut für Technologie, 76131 Karlsruhe, Germany
| | - P K Behera
- Indian Institute of Technology Madras, Chennai 600036, India
| | - J V Bennett
- University of Mississippi, University, Mississippi 38677, USA
| | - E Bernieri
- INFN Sezione di Roma Tre, I-00146 Roma, Italy
| | | | - M Bertemes
- Institute of High Energy Physics, Vienna 1050, Austria
| | - E Bertholet
- Tel Aviv University, School of Physics and Astronomy, Tel Aviv, 69978, Israel
| | - M Bessner
- University of Hawaii, Honolulu, Hawaii 96822, USA
| | - S Bettarini
- INFN Sezione di Pisa, I-56127 Pisa, Italy
- Dipartimento di Fisica, Università di Pisa, I-56127 Pisa, Italy
| | - V Bhardwaj
- Indian Institute of Science Education and Research Mohali, SAS Nagar, 140306, India
| | - F Bianchi
- INFN Sezione di Torino, I-10125 Torino, Italy
- Dipartimento di Fisica, Università di Torino, I-10125 Torino, Italy
| | - T Bilka
- Faculty of Mathematics and Physics, Charles University, 121 16 Prague, Czech Republic
| | - S Bilokin
- Ludwig Maximilians University, 80539 Munich, Germany
| | - D Biswas
- University of Louisville, Louisville, Kentucky 40292, USA
| | - A Bobrov
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090, Russian Federation
- Novosibirsk State University, Novosibirsk 630090, Russian Federation
| | - D Bodrov
- P.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119991, Russian Federation
- National Research University Higher School of Economics, Moscow 101000, Russian Federation
| | - A Bolz
- Deutsches Elektronen-Synchrotron, 22607 Hamburg, Germany
| | - A Bozek
- H. Niewodniczanski Institute of Nuclear Physics, Krakow 31-342, Poland
| | - M Bračko
- J. Stefan Institute, 1000 Ljubljana, Slovenia
- Faculty of Chemistry and Chemical Engineering, University of Maribor, 2000 Maribor, Slovenia
| | - P Branchini
- INFN Sezione di Roma Tre, I-00146 Roma, Italy
| | - N Braun
- Institut für Experimentelle Teilchenphysik, Karlsruher Institut für Technologie, 76131 Karlsruhe, Germany
| | - R A Briere
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - T E Browder
- University of Hawaii, Honolulu, Hawaii 96822, USA
| | - A Budano
- INFN Sezione di Roma Tre, I-00146 Roma, Italy
| | - S Bussino
- INFN Sezione di Roma Tre, I-00146 Roma, Italy
- Dipartimento di Matematica e Fisica, Università di Roma Tre, I-00146 Roma, Italy
| | - M Campajola
- INFN Sezione di Napoli, I-80126 Napoli, Italy
- Dipartimento di Scienze Fisiche, Università di Napoli Federico II, I-80126 Napoli, Italy
| | - L Cao
- Deutsches Elektronen-Synchrotron, 22607 Hamburg, Germany
| | - G Casarosa
- INFN Sezione di Pisa, I-56127 Pisa, Italy
- Dipartimento di Fisica, Università di Pisa, I-56127 Pisa, Italy
| | - C Cecchi
- INFN Sezione di Perugia, I-06123 Perugia, Italy
- Dipartimento di Fisica, Università di Perugia, I-06123 Perugia, Italy
| | - D Červenkov
- Faculty of Mathematics and Physics, Charles University, 121 16 Prague, Czech Republic
| | - M-C Chang
- Department of Physics, Fu Jen Catholic University, Taipei 24205, Taiwan
| | - P Chang
- Department of Physics, National Taiwan University, Taipei 10617, Taiwan
| | - R Cheaib
- Deutsches Elektronen-Synchrotron, 22607 Hamburg, Germany
| | - V Chekelian
- Max-Planck-Institut für Physik, 80805 München, Germany
| | - C Chen
- Iowa State University, Ames, Iowa 50011, USA
| | - Y-T Chen
- Department of Physics, National Taiwan University, Taipei 10617, Taiwan
| | - B G Cheon
- Department of Physics and Institute of Natural Sciences, Hanyang University, Seoul 04763, South Korea
| | - K Chilikin
- P.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119991, Russian Federation
| | | | - H-E Cho
- Department of Physics and Institute of Natural Sciences, Hanyang University, Seoul 04763, South Korea
| | - K Cho
- Korea Institute of Science and Technology Information, Daejeon 34141, South Korea
| | - S-J Cho
- Yonsei University, Seoul 03722, South Korea
| | - S-K Choi
- Gyeongsang National University, Jinju 52828, South Korea
| | - S Choudhury
- Indian Institute of Technology Hyderabad, Telangana 502285, India
| | - D Cinabro
- Wayne State University, Detroit, Michigan 48202, USA
| | - L Corona
- INFN Sezione di Pisa, I-56127 Pisa, Italy
- Dipartimento di Fisica, Università di Pisa, I-56127 Pisa, Italy
| | - L M Cremaldi
- University of Mississippi, University, Mississippi 38677, USA
| | - S Cunliffe
- Deutsches Elektronen-Synchrotron, 22607 Hamburg, Germany
| | - T Czank
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo, Kashiwa 277-8583, Japan
| | - F Dattola
- Deutsches Elektronen-Synchrotron, 22607 Hamburg, Germany
| | - E De La Cruz-Burelo
- Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional, Mexico City 07360, Mexico
| | - G de Marino
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - G De Nardo
- INFN Sezione di Napoli, I-80126 Napoli, Italy
- Dipartimento di Scienze Fisiche, Università di Napoli Federico II, I-80126 Napoli, Italy
| | - G De Pietro
- INFN Sezione di Roma Tre, I-00146 Roma, Italy
| | - R de Sangro
- INFN Laboratori Nazionali di Frascati, I-00044 Frascati, Italy
| | - M Destefanis
- INFN Sezione di Torino, I-10125 Torino, Italy
- Dipartimento di Fisica, Università di Torino, I-10125 Torino, Italy
| | - S Dey
- Tel Aviv University, School of Physics and Astronomy, Tel Aviv, 69978, Israel
| | - A De Yta-Hernandez
- Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional, Mexico City 07360, Mexico
| | - A Di Canto
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - F Di Capua
- INFN Sezione di Napoli, I-80126 Napoli, Italy
- Dipartimento di Scienze Fisiche, Università di Napoli Federico II, I-80126 Napoli, Italy
| | | | - Z Doležal
- Faculty of Mathematics and Physics, Charles University, 121 16 Prague, Czech Republic
| | | | - T V Dong
- Institute of Theoretical and Applied Research (ITAR), Duy Tan University, Hanoi 100000, Vietnam
| | - M Dorigo
- INFN Sezione di Trieste, I-34127 Trieste, Italy
| | - K Dort
- Justus-Liebig-Universität Gießen, 35392 Gießen, Germany
| | - D Dossett
- School of Physics, University of Melbourne, Victoria 3010, Australia
| | - S Dubey
- University of Hawaii, Honolulu, Hawaii 96822, USA
| | - S Duell
- University of Bonn, 53115 Bonn, Germany
| | - G Dujany
- Université de Strasbourg, CNRS, IPHC, UMR 7178, 67037 Strasbourg, France
| | - P Ecker
- Institut für Experimentelle Teilchenphysik, Karlsruher Institut für Technologie, 76131 Karlsruhe, Germany
| | - D Epifanov
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090, Russian Federation
- Novosibirsk State University, Novosibirsk 630090, Russian Federation
| | - T Ferber
- Deutsches Elektronen-Synchrotron, 22607 Hamburg, Germany
| | - D Ferlewicz
- School of Physics, University of Melbourne, Victoria 3010, Australia
| | - G Finocchiaro
- INFN Laboratori Nazionali di Frascati, I-00044 Frascati, Italy
| | - K Flood
- University of Hawaii, Honolulu, Hawaii 96822, USA
| | - A Fodor
- McGill University, Montréal, Québec, H3A 2T8, Canada
| | - F Forti
- INFN Sezione di Pisa, I-56127 Pisa, Italy
- Dipartimento di Fisica, Università di Pisa, I-56127 Pisa, Italy
| | - B G Fulsom
- Pacific Northwest National Laboratory, Richland, Washington, D.C. 99352, USA
| | - A Gabrielli
- INFN Sezione di Trieste, I-34127 Trieste, Italy
- Dipartimento di Fisica, Università di Trieste, I-34127 Trieste, Italy
| | - N Gabyshev
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090, Russian Federation
- Novosibirsk State University, Novosibirsk 630090, Russian Federation
| | - A Gaz
- INFN Sezione di Padova, I-35131 Padova, Italy
- Dipartimento di Fisica e Astronomia, Università di Padova, I-35131 Padova, Italy
| | - A Gellrich
- Deutsches Elektronen-Synchrotron, 22607 Hamburg, Germany
| | | | - R Giordano
- INFN Sezione di Napoli, I-80126 Napoli, Italy
- Dipartimento di Scienze Fisiche, Università di Napoli Federico II, I-80126 Napoli, Italy
| | - A Giri
- Indian Institute of Technology Hyderabad, Telangana 502285, India
| | - A Glazov
- Deutsches Elektronen-Synchrotron, 22607 Hamburg, Germany
| | - B Gobbo
- INFN Sezione di Trieste, I-34127 Trieste, Italy
| | - R Godang
- University of South Alabama, Mobile, Alabama 36688, USA
| | - P Goldenzweig
- Institut für Experimentelle Teilchenphysik, Karlsruher Institut für Technologie, 76131 Karlsruhe, Germany
| | - B Golob
- J. Stefan Institute, 1000 Ljubljana, Slovenia
- Faculty of Mathematics and Physics, University of Ljubljana, 1000 Ljubljana, Slovenia
| | - W Gradl
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - E Graziani
- INFN Sezione di Roma Tre, I-00146 Roma, Italy
| | - D Greenwald
- Department of Physics, Technische Universität München, 85748 Garching, Germany
| | - T Gu
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - Y Guan
- University of Cincinnati, Cincinnati, Ohio 45221, USA
| | - K Gudkova
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090, Russian Federation
- Novosibirsk State University, Novosibirsk 630090, Russian Federation
| | - J Guilliams
- University of Mississippi, University, Mississippi 38677, USA
| | - C Hadjivasiliou
- Pacific Northwest National Laboratory, Richland, Washington, D.C. 99352, USA
| | - S Halder
- Tata Institute of Fundamental Research, Mumbai 400005, India
| | - K Hara
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193, Japan
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - T Hara
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193, Japan
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - O Hartbrich
- University of Hawaii, Honolulu, Hawaii 96822, USA
| | - K Hayasaka
- Niigata University, Niigata 950-2181, Japan
| | - H Hayashii
- Nara Women's University, Nara 630-8506, Japan
| | - S Hazra
- Tata Institute of Fundamental Research, Mumbai 400005, India
| | - C Hearty
- Institute of Particle Physics (Canada), Victoria, British Columbia V8W 2Y2, Canada
- University of British Columbia, Vancouver, British Columbia, V6T 1Z1, Canada
| | - I Heredia de la Cruz
- Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional, Mexico City 07360, Mexico
- Consejo Nacional de Ciencia y Tecnología, Mexico City 03940, Mexico
| | | | - A Hershenhorn
- University of British Columbia, Vancouver, British Columbia, V6T 1Z1, Canada
| | - T Higuchi
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo, Kashiwa 277-8583, Japan
| | - E C Hill
- University of British Columbia, Vancouver, British Columbia, V6T 1Z1, Canada
| | - H Hirata
- Graduate School of Science, Nagoya University, Nagoya 464-8602, Japan
| | - M Hoek
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - M Hohmann
- School of Physics, University of Melbourne, Victoria 3010, Australia
| | - C-L Hsu
- School of Physics, University of Sydney, New South Wales 2006, Australia
| | - T Humair
- Max-Planck-Institut für Physik, 80805 München, Germany
| | - T Iijima
- Graduate School of Science, Nagoya University, Nagoya 464-8602, Japan
- Kobayashi-Maskawa Institute, Nagoya University, Nagoya 464-8602, Japan
| | - K Inami
- Graduate School of Science, Nagoya University, Nagoya 464-8602, Japan
| | - G Inguglia
- Institute of High Energy Physics, Vienna 1050, Austria
| | - A Ishikawa
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193, Japan
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - R Itoh
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193, Japan
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - M Iwasaki
- Osaka City University, Osaka 558-8585, Japan
| | - Y Iwasaki
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - W W Jacobs
- Indiana University, Bloomington, Indiana 47408, USA
| | - D E Jaffe
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - E-J Jang
- Gyeongsang National University, Jinju 52828, South Korea
| | - S Jia
- Key Laboratory of Nuclear Physics and Ion-beam Application (MOE) and Institute of Modern Physics, Fudan University, Shanghai 200443, China
| | - Y Jin
- INFN Sezione di Trieste, I-34127 Trieste, Italy
| | | | - H Kakuno
- Tokyo Metropolitan University, Tokyo 192-0397, Japan
| | - A B Kaliyar
- Tata Institute of Fundamental Research, Mumbai 400005, India
| | - J Kandra
- Faculty of Mathematics and Physics, Charles University, 121 16 Prague, Czech Republic
| | - K H Kang
- Kyungpook National University, Daegu 41566, South Korea
| | - R Karl
- Deutsches Elektronen-Synchrotron, 22607 Hamburg, Germany
| | - G Karyan
- Alikhanyan National Science Laboratory, Yerevan 0036, Armenia
| | - Y Kato
- Graduate School of Science, Nagoya University, Nagoya 464-8602, Japan
- Kobayashi-Maskawa Institute, Nagoya University, Nagoya 464-8602, Japan
| | - T Kawasaki
- Kitasato University, Sagamihara 252-0373, Japan
| | - C Kiesling
- Max-Planck-Institut für Physik, 80805 München, Germany
| | - C-H Kim
- Department of Physics and Institute of Natural Sciences, Hanyang University, Seoul 04763, South Korea
| | - D Y Kim
- Soongsil University, Seoul 06978, South Korea
| | - Y-K Kim
- Yonsei University, Seoul 03722, South Korea
| | - Y Kim
- Korea University, Seoul 02841, South Korea
| | - T D Kimmel
- Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - K Kinoshita
- University of Cincinnati, Cincinnati, Ohio 45221, USA
| | - P Kodyš
- Faculty of Mathematics and Physics, Charles University, 121 16 Prague, Czech Republic
| | - T Koga
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - S Kohani
- University of Hawaii, Honolulu, Hawaii 96822, USA
| | - T Konno
- Kitasato University, Sagamihara 252-0373, Japan
| | - S Korpar
- J. Stefan Institute, 1000 Ljubljana, Slovenia
- Faculty of Chemistry and Chemical Engineering, University of Maribor, 2000 Maribor, Slovenia
| | - E Kovalenko
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090, Russian Federation
- Novosibirsk State University, Novosibirsk 630090, Russian Federation
| | - R Kowalewski
- University of Victoria, Victoria, British Columbia, V8W 3P6, Canada
| | | | - F Krinner
- Max-Planck-Institut für Physik, 80805 München, Germany
| | - P Križan
- J. Stefan Institute, 1000 Ljubljana, Slovenia
- Faculty of Mathematics and Physics, University of Ljubljana, 1000 Ljubljana, Slovenia
| | - P Krokovny
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090, Russian Federation
- Novosibirsk State University, Novosibirsk 630090, Russian Federation
| | - T Kuhr
- Ludwig Maximilians University, 80539 Munich, Germany
| | - J Kumar
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - M Kumar
- Malaviya National Institute of Technology Jaipur, Jaipur 302017, India
| | - R Kumar
- Punjab Agricultural University, Ludhiana 141004, India
| | - K Kumara
- Wayne State University, Detroit, Michigan 48202, USA
| | - S Kurz
- Deutsches Elektronen-Synchrotron, 22607 Hamburg, Germany
| | - A Kuzmin
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090, Russian Federation
- Novosibirsk State University, Novosibirsk 630090, Russian Federation
| | - Y-J Kwon
- Yonsei University, Seoul 03722, South Korea
| | - S Lacaprara
- INFN Sezione di Padova, I-35131 Padova, Italy
| | - K Lalwani
- Malaviya National Institute of Technology Jaipur, Jaipur 302017, India
| | - T Lam
- Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - L Lanceri
- INFN Sezione di Trieste, I-34127 Trieste, Italy
| | - J S Lange
- Justus-Liebig-Universität Gießen, 35392 Gießen, Germany
| | - M Laurenza
- INFN Sezione di Roma Tre, I-00146 Roma, Italy
- Dipartimento di Matematica e Fisica, Università di Roma Tre, I-00146 Roma, Italy
| | - K Lautenbach
- Aix Marseille Université, CNRS/IN2P3, CPPM, 13288 Marseille, France
| | - F R Le Diberder
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - S C Lee
- Kyungpook National University, Daegu 41566, South Korea
| | - P Leitl
- Max-Planck-Institut für Physik, 80805 München, Germany
| | - D Levit
- Department of Physics, Technische Universität München, 85748 Garching, Germany
| | - C Li
- Liaoning Normal University, Dalian 116029, China
| | - L K Li
- University of Cincinnati, Cincinnati, Ohio 45221, USA
| | - J Libby
- Indian Institute of Technology Madras, Chennai 600036, India
| | - K Lieret
- Ludwig Maximilians University, 80539 Munich, Germany
| | - Z Liptak
- Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8530, Japan
| | - Q Y Liu
- Deutsches Elektronen-Synchrotron, 22607 Hamburg, Germany
| | - D Liventsev
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
- Wayne State University, Detroit, Michigan 48202, USA
| | - S Longo
- Deutsches Elektronen-Synchrotron, 22607 Hamburg, Germany
| | - T Lueck
- Ludwig Maximilians University, 80539 Munich, Germany
| | - C Lyu
- University of Bonn, 53115 Bonn, Germany
| | - R Manfredi
- INFN Sezione di Trieste, I-34127 Trieste, Italy
- Dipartimento di Fisica, Università di Trieste, I-34127 Trieste, Italy
| | - E Manoni
- INFN Sezione di Perugia, I-06123 Perugia, Italy
| | - C Marinas
- Instituto de Fisica Corpuscular, Paterna 46980, Spain
| | - A Martini
- Deutsches Elektronen-Synchrotron, 22607 Hamburg, Germany
| | - T Matsuda
- University of Miyazaki, Miyazaki 889-2192, Japan
| | - K Matsuoka
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - D Matvienko
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090, Russian Federation
- P.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119991, Russian Federation
- Novosibirsk State University, Novosibirsk 630090, Russian Federation
| | - J A McKenna
- University of British Columbia, Vancouver, British Columbia, V6T 1Z1, Canada
| | - F Meier
- Duke University, Durham, North Carolina 27708, USA
| | - M Merola
- INFN Sezione di Napoli, I-80126 Napoli, Italy
- Dipartimento di Scienze Fisiche, Università di Napoli Federico II, I-80126 Napoli, Italy
| | - F Metzner
- Institut für Experimentelle Teilchenphysik, Karlsruher Institut für Technologie, 76131 Karlsruhe, Germany
| | - C Miller
- University of Victoria, Victoria, British Columbia, V8W 3P6, Canada
| | | | - R Mizuk
- P.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119991, Russian Federation
- National Research University Higher School of Economics, Moscow 101000, Russian Federation
| | - G B Mohanty
- Tata Institute of Fundamental Research, Mumbai 400005, India
| | - N Molina-Gonzalez
- Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional, Mexico City 07360, Mexico
| | - H Moon
- Korea University, Seoul 02841, South Korea
| | - H-G Moser
- Max-Planck-Institut für Physik, 80805 München, Germany
| | - M Mrvar
- Institute of High Energy Physics, Vienna 1050, Austria
| | - C Murphy
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo, Kashiwa 277-8583, Japan
| | - R Mussa
- INFN Sezione di Torino, I-10125 Torino, Italy
| | - I Nakamura
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193, Japan
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - K R Nakamura
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193, Japan
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - M Nakao
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193, Japan
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - H Nakazawa
- Department of Physics, National Taiwan University, Taipei 10617, Taiwan
| | - Z Natkaniec
- H. Niewodniczanski Institute of Nuclear Physics, Krakow 31-342, Poland
| | - A Natochii
- University of Hawaii, Honolulu, Hawaii 96822, USA
| | - G Nazaryan
- Alikhanyan National Science Laboratory, Yerevan 0036, Armenia
| | - C Niebuhr
- Deutsches Elektronen-Synchrotron, 22607 Hamburg, Germany
| | - M Niiyama
- Kyoto Sangyo University, Kyoto 603-8555, Japan
| | - N K Nisar
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - S Nishida
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193, Japan
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - K Nishimura
- University of Hawaii, Honolulu, Hawaii 96822, USA
| | - S Ogawa
- Toho University, Funabashi 274-8510, Japan
| | - Y Onishchuk
- Taras Shevchenko National Univ. of Kiev, Kiev, Ukraine
| | - H Ono
- Niigata University, Niigata 950-2181, Japan
| | - Y Onuki
- Department of Physics, University of Tokyo, Tokyo 113-0033, Japan
| | - P Oskin
- P.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119991, Russian Federation
| | - E R Oxford
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - H Ozaki
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193, Japan
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - P Pakhlov
- P.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119991, Russian Federation
- Moscow Physical Engineering Institute, Moscow 115409, Russian Federation
| | - A Paladino
- INFN Sezione di Pisa, I-56127 Pisa, Italy
- Dipartimento di Fisica, Università di Pisa, I-56127 Pisa, Italy
| | - T Pang
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - A Panta
- University of Mississippi, University, Mississippi 38677, USA
| | - E Paoloni
- INFN Sezione di Pisa, I-56127 Pisa, Italy
- Dipartimento di Fisica, Università di Pisa, I-56127 Pisa, Italy
| | - S Pardi
- INFN Sezione di Napoli, I-80126 Napoli, Italy
| | - H Park
- Kyungpook National University, Daegu 41566, South Korea
| | - S-H Park
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - B Paschen
- University of Bonn, 53115 Bonn, Germany
| | - A Passeri
- INFN Sezione di Roma Tre, I-00146 Roma, Italy
| | - A Pathak
- University of Louisville, Louisville, Kentucky 40292, USA
| | - S Patra
- Indian Institute of Science Education and Research Mohali, SAS Nagar, 140306, India
| | - S Paul
- Department of Physics, Technische Universität München, 85748 Garching, Germany
| | - T K Pedlar
- Luther College, Decorah, Iowa 52101, USA
| | - I Peruzzi
- INFN Laboratori Nazionali di Frascati, I-00044 Frascati, Italy
| | - R Peschke
- University of Hawaii, Honolulu, Hawaii 96822, USA
| | - R Pestotnik
- J. Stefan Institute, 1000 Ljubljana, Slovenia
| | - F Pham
- School of Physics, University of Melbourne, Victoria 3010, Australia
| | - M Piccolo
- INFN Laboratori Nazionali di Frascati, I-00044 Frascati, Italy
| | - L E Piilonen
- Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - G Pinna Angioni
- INFN Sezione di Torino, I-10125 Torino, Italy
- Dipartimento di Fisica, Università di Torino, I-10125 Torino, Italy
| | | | - T Podobnik
- J. Stefan Institute, 1000 Ljubljana, Slovenia
| | - S Pokharel
- University of Mississippi, University, Mississippi 38677, USA
| | - G Polat
- Aix Marseille Université, CNRS/IN2P3, CPPM, 13288 Marseille, France
| | - V Popov
- National Research University Higher School of Economics, Moscow 101000, Russian Federation
| | - C Praz
- Deutsches Elektronen-Synchrotron, 22607 Hamburg, Germany
| | - S Prell
- Iowa State University, Ames, Iowa 50011, USA
| | - E Prencipe
- Justus-Liebig-Universität Gießen, 35392 Gießen, Germany
| | - M T Prim
- University of Bonn, 53115 Bonn, Germany
| | - M V Purohit
- Okinawa Institute of Science and Technology, Okinawa 904-0495, Japan
| | - H Purwar
- University of Hawaii, Honolulu, Hawaii 96822, USA
| | - N Rad
- Deutsches Elektronen-Synchrotron, 22607 Hamburg, Germany
| | - P Rados
- Institute of High Energy Physics, Vienna 1050, Austria
| | - S Raiz
- INFN Sezione di Trieste, I-34127 Trieste, Italy
- Dipartimento di Fisica, Università di Trieste, I-34127 Trieste, Italy
| | - S Reiter
- Justus-Liebig-Universität Gießen, 35392 Gießen, Germany
| | - M Remnev
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090, Russian Federation
- Novosibirsk State University, Novosibirsk 630090, Russian Federation
| | - I Ripp-Baudot
- Université de Strasbourg, CNRS, IPHC, UMR 7178, 67037 Strasbourg, France
| | - G Rizzo
- INFN Sezione di Pisa, I-56127 Pisa, Italy
- Dipartimento di Fisica, Università di Pisa, I-56127 Pisa, Italy
| | - L B Rizzuto
- J. Stefan Institute, 1000 Ljubljana, Slovenia
| | - S H Robertson
- Institute of Particle Physics (Canada), Victoria, British Columbia V8W 2Y2, Canada
- McGill University, Montréal, Québec, H3A 2T8, Canada
| | - J M Roney
- Institute of Particle Physics (Canada), Victoria, British Columbia V8W 2Y2, Canada
- University of Victoria, Victoria, British Columbia, V8W 3P6, Canada
| | - A Rostomyan
- Deutsches Elektronen-Synchrotron, 22607 Hamburg, Germany
| | - N Rout
- Indian Institute of Technology Madras, Chennai 600036, India
| | - M Rozanska
- H. Niewodniczanski Institute of Nuclear Physics, Krakow 31-342, Poland
| | - D Sahoo
- Iowa State University, Ames, Iowa 50011, USA
| | - D A Sanders
- University of Mississippi, University, Mississippi 38677, USA
| | - S Sandilya
- Indian Institute of Technology Hyderabad, Telangana 502285, India
| | - A Sangal
- University of Cincinnati, Cincinnati, Ohio 45221, USA
| | - L Santelj
- J. Stefan Institute, 1000 Ljubljana, Slovenia
- Faculty of Mathematics and Physics, University of Ljubljana, 1000 Ljubljana, Slovenia
| | - Y Sato
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - V Savinov
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - B Scavino
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - J Schueler
- University of Hawaii, Honolulu, Hawaii 96822, USA
| | - C Schwanda
- Institute of High Energy Physics, Vienna 1050, Austria
| | - A J Schwartz
- University of Cincinnati, Cincinnati, Ohio 45221, USA
| | - Y Seino
- Niigata University, Niigata 950-2181, Japan
| | - A Selce
- ENEA Casaccia, I-00123 Roma, Italy
- INFN Sezione di Roma Tre, I-00146 Roma, Italy
| | - K Senyo
- Yamagata University, Yamagata 990-8560, Japan
| | - J Serrano
- Aix Marseille Université, CNRS/IN2P3, CPPM, 13288 Marseille, France
| | - C Sfienti
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - J-G Shiu
- Department of Physics, National Taiwan University, Taipei 10617, Taiwan
| | - B Shwartz
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090, Russian Federation
- Novosibirsk State University, Novosibirsk 630090, Russian Federation
| | - A Sibidanov
- University of Hawaii, Honolulu, Hawaii 96822, USA
| | - F Simon
- Max-Planck-Institut für Physik, 80805 München, Germany
| | - R J Sobie
- Institute of Particle Physics (Canada), Victoria, British Columbia V8W 2Y2, Canada
- University of Victoria, Victoria, British Columbia, V8W 3P6, Canada
| | - A Soffer
- Tel Aviv University, School of Physics and Astronomy, Tel Aviv, 69978, Israel
| | - A Sokolov
- Institute for High Energy Physics, Protvino 142281, Russian Federation
| | - E Solovieva
- P.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119991, Russian Federation
| | - S Spataro
- INFN Sezione di Torino, I-10125 Torino, Italy
- Dipartimento di Fisica, Università di Torino, I-10125 Torino, Italy
| | - B Spruck
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - M Starič
- J. Stefan Institute, 1000 Ljubljana, Slovenia
| | - S Stefkova
- Deutsches Elektronen-Synchrotron, 22607 Hamburg, Germany
| | - Z S Stottler
- Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - R Stroili
- INFN Sezione di Padova, I-35131 Padova, Italy
- Dipartimento di Fisica e Astronomia, Università di Padova, I-35131 Padova, Italy
| | - J Strube
- Pacific Northwest National Laboratory, Richland, Washington, D.C. 99352, USA
| | - M Sumihama
- Gifu University, Gifu 501-1193, Japan
- Research Center for Nuclear Physics, Osaka University, Osaka 567-0047, Japan
| | | | - S Y Suzuki
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193, Japan
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - H Svidras
- Deutsches Elektronen-Synchrotron, 22607 Hamburg, Germany
| | - M Tabata
- Chiba University, Chiba 263-8522, Japan
| | - M Takizawa
- J-PARC Branch, KEK Theory Center, High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
- Meson Science Laboratory, Cluster for Pioneering Research, RIKEN, Saitama 351-0198, Japan
- Showa Pharmaceutical University, Tokyo 194-8543, Japan
| | - U Tamponi
- INFN Sezione di Torino, I-10125 Torino, Italy
| | - S Tanaka
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193, Japan
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - K Tanida
- Advanced Science Research Center, Japan Atomic Energy Agency, Naka 319-1195, Japan
| | - H Tanigawa
- Department of Physics, University of Tokyo, Tokyo 113-0033, Japan
| | - N Taniguchi
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - F Tenchini
- INFN Sezione di Pisa, I-56127 Pisa, Italy
- Dipartimento di Fisica, Università di Pisa, I-56127 Pisa, Italy
| | - R Tiwary
- Tata Institute of Fundamental Research, Mumbai 400005, India
| | - D Tonelli
- INFN Sezione di Trieste, I-34127 Trieste, Italy
| | - E Torassa
- INFN Sezione di Padova, I-35131 Padova, Italy
| | - N Toutounji
- School of Physics, University of Sydney, New South Wales 2006, Australia
| | - K Trabelsi
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - T Tsuboyama
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193, Japan
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - I Ueda
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193, Japan
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - S Uehara
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193, Japan
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - Y Uematsu
- Department of Physics, University of Tokyo, Tokyo 113-0033, Japan
| | - T Uglov
- P.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119991, Russian Federation
- National Research University Higher School of Economics, Moscow 101000, Russian Federation
| | - K Unger
- Institut für Experimentelle Teilchenphysik, Karlsruher Institut für Technologie, 76131 Karlsruhe, Germany
| | - Y Unno
- Department of Physics and Institute of Natural Sciences, Hanyang University, Seoul 04763, South Korea
| | - K Uno
- Niigata University, Niigata 950-2181, Japan
| | - S Uno
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193, Japan
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - P Urquijo
- School of Physics, University of Melbourne, Victoria 3010, Australia
| | - Y Ushiroda
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193, Japan
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
- Department of Physics, University of Tokyo, Tokyo 113-0033, Japan
| | - Y V Usov
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090, Russian Federation
- Novosibirsk State University, Novosibirsk 630090, Russian Federation
| | - S E Vahsen
- University of Hawaii, Honolulu, Hawaii 96822, USA
| | | | - G S Varner
- University of Hawaii, Honolulu, Hawaii 96822, USA
| | - A Vinokurova
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090, Russian Federation
- Novosibirsk State University, Novosibirsk 630090, Russian Federation
| | - L Vitale
- INFN Sezione di Trieste, I-34127 Trieste, Italy
- Dipartimento di Fisica, Università di Trieste, I-34127 Trieste, Italy
| | - A Vossen
- Duke University, Durham, North Carolina 27708, USA
| | - E Waheed
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - H M Wakeling
- McGill University, Montréal, Québec, H3A 2T8, Canada
| | - E Wang
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - M-Z Wang
- Department of Physics, National Taiwan University, Taipei 10617, Taiwan
| | - X L Wang
- Key Laboratory of Nuclear Physics and Ion-beam Application (MOE) and Institute of Modern Physics, Fudan University, Shanghai 200443, China
| | - A Warburton
- McGill University, Montréal, Québec, H3A 2T8, Canada
| | - M Watanabe
- Niigata University, Niigata 950-2181, Japan
| | - M Welsch
- University of Bonn, 53115 Bonn, Germany
| | - C Wessel
- University of Bonn, 53115 Bonn, Germany
| | - J Wiechczynski
- H. Niewodniczanski Institute of Nuclear Physics, Krakow 31-342, Poland
| | - E Won
- Korea University, Seoul 02841, South Korea
| | - X P Xu
- Soochow University, Suzhou 215006, China
| | - B D Yabsley
- School of Physics, University of Sydney, New South Wales 2006, Australia
| | - S Yamada
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - W Yan
- University of Science and Technology of China, Hefei 230026, China
| | - S B Yang
- Korea University, Seoul 02841, South Korea
| | - H Ye
- Deutsches Elektronen-Synchrotron, 22607 Hamburg, Germany
| | - J Yelton
- University of Florida, Gainesville, Florida 32611, USA
| | - J H Yin
- Korea University, Seoul 02841, South Korea
| | - K Yoshihara
- Graduate School of Science, Nagoya University, Nagoya 464-8602, Japan
| | - Y Yusa
- Niigata University, Niigata 950-2181, Japan
| | - L Zani
- Aix Marseille Université, CNRS/IN2P3, CPPM, 13288 Marseille, France
| | - V Zhilich
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090, Russian Federation
- Novosibirsk State University, Novosibirsk 630090, Russian Federation
| | - Q D Zhou
- Graduate School of Science, Nagoya University, Nagoya 464-8602, Japan
- Institute for Advanced Research, Nagoya University, Nagoya 464-8602, Japan
- Kobayashi-Maskawa Institute, Nagoya University, Nagoya 464-8602, Japan
| | - X Y Zhou
- Liaoning Normal University, Dalian 116029, China
| | - V I Zhukova
- P.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119991, Russian Federation
| | - R Žlebčík
- Faculty of Mathematics and Physics, Charles University, 121 16 Prague, Czech Republic
| |
Collapse
|
37
|
Dyer A, Murphy C, Lawlor B, Kennelly S. 18 SEDATIVE LOAD IN COMMUNITY-DWELLING OLDER ADULTS WITH MILD–MODERATE ALZHEIMER’S DISEASE: LONGITUDINAL RELATIONSHIPS WITH ADVERSE EVENTS, DELIRIUM AND FALLS. Age Ageing 2021. [DOI: 10.1093/ageing/afab219.18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/25/2023] Open
Abstract
Abstract
Background
Older adults are frequently prescribed medications with sedative effects, which are associated with numerous adverse consequences. However, the use and longitudinal associations of sedative medication use in older adults with mild–moderate Alzheimer Disease (AD), has not been explored to date.
Methods
The association between Sedative Load (SL) and adverse events, unscheduled healthcare utilisation, delirium and falls over 18 months was assessed in older adults with mild–moderate AD from 9 Countries. Additionally, the impact of SL on dementia progression was evaluated.
Results
Over half (52.35%; 267/510) of those with mild–moderate ad (72.8 ± 8.26 years, 61.89%) were prescribed a regular medication with sedation as a primary effect or prominent side effect with 17.65% (90/510) having a high SL (≥3). The most common medications contributing to SL were antidepressants, antipsychotics, anxiolytics and hypnotics. Over 18 months, greater SL was associated with adverse events (IRR 1.18, 1.14–1.23, p < 0.001)/serious adverse events (IRR 1.32, 1.18–1.49, p < 0.001) and unscheduled GP visits (IRR 1.26, 1.15–1.38, p < 0.001). Further, increasing SL was associated with greater likelihood of incident delirium (IRR 1.47, 1.25–1.73, p < 0.001) and falls (IRR 1.25, 1.06–1.48, p = 0.007) which persisted after covariate adjustment. SL was not associated with accelerated cognitive decline or ad progression.
Conclusion
Most adults with mild–moderate ad are prescribed at least one drug with a sedative effect and a significant minority have a high SL. Increasing SL was associated with a greater likelihood of experiencing adverse events, delirium and falls, highlighting the need for optimal prescribing in this vulnerable cohort.
Collapse
Affiliation(s)
- A Dyer
- Age-Related Healthcare, Trinity College Dublin , Dublin, Ireland
| | - C Murphy
- Age-Related Healthcare, Trinity College Dublin , Dublin, Ireland
| | - B Lawlor
- Global Brain Health Institute, Trinity College Dublin , Dublin, Ireland
| | - S Kennelly
- Age-Related Healthcare, Trinity College Dublin , Dublin, Ireland
| |
Collapse
|
38
|
O'Riordan F, Murphy J, Egan G, Murphy C, Ahern E. 47 DOSING OF DIRECT ORAL ANTICOAGULANTS IN OLDER ADULTS. Age Ageing 2021. [DOI: 10.1093/ageing/afab219.47] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/25/2023] Open
Abstract
Abstract
Background
Direct oral anticoagulants (DOACs) are approved for a variety of uses including prevention of stroke in non-valvular atrial fibrillation and treatment and prevention of deep vein thrombosis and pulmonary embolism. Adjustment to DOAC dosing may be required for age, weight and renal impairment. Incorrect lower dosing puts patients at risk of thromboembolic events whereas inappropriate higher dosing increases the risk of bleeding. We compared current DOAC dosing for patients admitted to our hospital and compare this against HSE best practice to determine if patients were receiving the correct dose [1].
Methods
A prospective single-centre study. Patients admitted to our hospital following a fracture and reviewed by the Orthogeriatric team between August–October 2020 were eligible for inclusion. We recorded admission DOAC dose, age, weight and renal function. We also obtained data including sex and Clinical Frailty Scale (CFS).
Results
Thirty-one patients were included. Mean age was 86 years [range 66–99] and 21(68%) were female. Apixaban was the most commonly used DOAC; 25(81%). Stroke prevention in non-valvular atrial fibrillation was the most common DOAC indication; 29(93%). Twelve patients (39%) had an inappropriate DOAC dose prescribed. Eight patients (67%) had an inappropriately low dose and 4 patients (33%) had an inappropriately high dose. The mean CFS was 5 [Range 2–7] classifying our cohort as mildly frail.
Conclusion
Our study has shown that over one-third of our patients were on an inappropriate DOAC dose on admission with the majority (67%) due to under-dosing. Many factors may have influenced dosing choices by clinicians but our findings highlight the challenges in dosing, monitoring and the overall management of DOAC therapy in older people. Further studies and research are required to establish the most accurate and effective dosing strategies for DOACs in older adults.
Reference
1. Health Service Executive [Internet]. Ireland ‘Anticoagulation Prescribing Tips’ https://www.hse.ie/eng/services/publications/clinical-strategy-and-programmes/noac-prescribing-tips-for-noacs.pdf.
Collapse
Affiliation(s)
- F O'Riordan
- Department of Geriatric Medicine, Cork University Hospital , Cork, Ireland
| | - J Murphy
- Department of Geriatric Medicine, Cork University Hospital , Cork, Ireland
| | - G Egan
- Department of Geriatric Medicine, Cork University Hospital , Cork, Ireland
| | - C Murphy
- Department of Geriatric Medicine, Cork University Hospital , Cork, Ireland
| | - E Ahern
- Department of Geriatric Medicine, Cork University Hospital , Cork, Ireland
| |
Collapse
|
39
|
Kavanagh FG, James DL, Brinkman D, Cornyn S, Murphy C, O'Neill S, O'Shea R, Affendi A, Lang B, O'Connor A, Keogh I, Lang E, Russell J, O'Brien D, Sheahan P. Safety of elective paediatric surgery during the coronavirus disease 2019 pandemic. Int J Pediatr Otorhinolaryngol 2021; 150:110861. [PMID: 34583300 PMCID: PMC8349430 DOI: 10.1016/j.ijporl.2021.110861] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/11/2021] [Revised: 07/12/2021] [Accepted: 07/27/2021] [Indexed: 01/13/2023]
Abstract
INTRODUCTION Corona-virus Disease 2019 (COVID-19) has had a huge impact on the delivery of healthcare worldwide, particularly elective surgery. There is a lack of data regarding risk of postoperative COVID-19 infection in children undergoing elective surgery, and regarding the utility of pre-operative COVID-19 testing, and preoperative "cocooning" or restriction of movements. The purpose of this present study was to examine the safety of elective paediatric Otolaryngology surgery during the COVID-19 pandemic with respect to incidence of postoperative symptomatic COVID-19 infection or major respiratory complications. MATERIALS AND METHODS Prospective cohort study of paediatric patients undergoing elective Otolaryngology surgery between September and December 2020. Primary outcome measure was incidence of symptomatic COVID-19 or major respiratory complications within the 14 days after surgery. Parents of prospectively enrolled patients were contacted 14 days after surgery and enquiry made regarding development of postoperative symptoms, COVID-19 testing, or diagnosis of COVID-19. RESULTS 302 patients were recruited. 125 (41.4%) underwent preoperative COVID-19 RT-PCR testing. 66 (21.8%) restricted movements prior to surgery. The peak 14-day COVID-19 incidence during the study was 302.9 cases per 100,000 population. No COVID-19 infections or major respiratory complications were reported in the 14 day follow-up period. CONCLUSION The results of our study support the safety of elective paediatric Otolaryngology surgery during the pandemic, in the setting of community incidence not exceeding that observed during the study period.
Collapse
Affiliation(s)
- F G Kavanagh
- Department of Otolaryngology, Head and Neck Surgery, South Infirmary Victoria University Hospital, Old Blackrock Road, Cork, Ireland; Institute of Research, Royal College of Surgeons in Ireland, 121 St. Stephens Green, Dublin, Ireland.
| | - D L James
- Department of Otolaryngology, Head and Neck Surgery, South Infirmary Victoria University Hospital, Old Blackrock Road, Cork, Ireland
| | - D Brinkman
- Department of Otolaryngology, Head and Neck Surgery, University Hospital Waterford, Waterford, Ireland
| | - S Cornyn
- Department of Otolaryngology, Children's Health Ireland @ Temple Street, Temple Street, Dublin 1, Ireland
| | - C Murphy
- Department of Otolaryngology, Head and Neck Surgery, University Hospital Galway, Galway, Ireland
| | - S O'Neill
- Department of Otolaryngology, Head and Neck Surgery, University Hospital Galway, Galway, Ireland
| | - R O'Shea
- Department of Otolaryngology, Head and Neck Surgery, South Infirmary Victoria University Hospital, Old Blackrock Road, Cork, Ireland
| | - A Affendi
- Department of Otolaryngology, Head and Neck Surgery, South Infirmary Victoria University Hospital, Old Blackrock Road, Cork, Ireland
| | - B Lang
- Department of Otolaryngology, Children's Health Ireland @ Crumlin, Cooley Road, Dublin 12, Ireland
| | - A O'Connor
- Department of Otolaryngology, Children's Health Ireland @ Temple Street, Temple Street, Dublin 1, Ireland
| | - I Keogh
- Department of Otolaryngology, Head and Neck Surgery, University Hospital Galway, Galway, Ireland
| | - E Lang
- Department of Otolaryngology, Head and Neck Surgery, University Hospital Waterford, Waterford, Ireland
| | - J Russell
- Department of Otolaryngology, Children's Health Ireland @ Crumlin, Cooley Road, Dublin 12, Ireland
| | - D O'Brien
- Department of Microbiology, South Infirmary Victoria University Hospital, Old Blackrock Road, Cork, Ireland
| | - P Sheahan
- Department of Otolaryngology, Head and Neck Surgery, South Infirmary Victoria University Hospital, Old Blackrock Road, Cork, Ireland; ENTO Research Unit, College of Medicine and Health, University College Cork, College Road, Cork, Ireland; Department of Surgery, University College Cork, College Road, Cork, Ireland
| |
Collapse
|
40
|
Murphy C, Ruhotina M, Menderes G. Robotic Cystotomy Repair and Ureteral Dissection Techniques. J Minim Invasive Gynecol 2021. [DOI: 10.1016/j.jmig.2021.09.252] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
41
|
Abudinén F, Adachi I, Adamczyk K, Ahlburg P, Aihara H, Akopov N, Aloisio A, Anh Ky N, Asner DM, Atmacan H, Aushev T, Aushev V, Baur A, Babu V, Baehr S, Bambade P, Banerjee S, Bansal S, Baudot J, Becker J, Behera PK, Bennett JV, Bernieri E, Bernlochner FU, Bertemes M, Bertholet E, Bessner M, Bettarini S, Bianchi F, Bilka T, Biswas D, Bozek A, Bračko M, Branchini P, Braun N, Browder TE, Budano A, Bussino S, Campajola M, Cao L, Casarosa G, Cecchi C, Červenkov D, Chang P, Cheaib R, Chekelian V, Chen C, Chen YT, Cheon BG, Chilikin K, Chirapatpimol K, Cho K, Cho SJ, Choudhury S, Cinabro D, Corona L, Cremaldi LM, Cunliffe S, Czank T, Dattola F, De La Cruz-Burelo E, de Marino G, De Nardo G, De Nuccio M, De Pietro G, de Sangro R, Destefanis M, Dey S, De Yta-Hernandez A, Di Canto A, Di Capua F, Dingfelder J, Doležal Z, Domínguez Jiménez I, Dong TV, Dort K, Dubey S, Duell S, Dujany G, Eidelman S, Eliachevitch M, Epifanov D, Ferber T, Ferlewicz D, Fillinger T, Finocchiaro G, Fiore S, Fodor A, Forti F, Frey A, Fulsom BG, Gabyshev N, Ganiev E, Garcia-Hernandez M, Garmash A, Gaur V, Gaz A, Gellrich A, Giordano R, Giri A, Glazov A, Gobbo B, Godang R, Goldenzweig P, Golob B, Grace P, Gradl W, Graziani E, Greenwald D, Guan Y, Gudkova K, Hadjivasiliou C, Halder S, Hara K, Hartbrich O, Hayasaka K, Hayashii H, Hazra S, Hearty C, Heredia de la Cruz I, Hernández Villanueva M, Hershenhorn A, Higuchi T, Hill EC, Hirata H, Hoek M, Hohmann M, Hsu CL, Humair T, Iijima T, Inami K, Inguglia G, Irakkathil Jabbar J, Ishikawa A, Itoh R, Iwasaki M, Iwasaki Y, Jackson P, Jacobs WW, Jaffe DE, Jin Y, Joo C, Junkerkalefeld H, Kaliyar AB, Kandra J, Kang KH, Karl R, Karyan G, Kawasaki T, Ketter C, Kichimi H, Kiesling C, Kim CH, Kim DY, Kim YK, Kimmel TD, Kodyš P, Koga T, Kohani S, Konno T, Korobov A, Korpar S, Kovalenko E, Kraetzschmar TMG, Krinner F, Križan P, Krokovny P, Kuhr T, Kumar J, Kumar M, Kumar R, Kumara K, Kunigo T, Kurz S, Kuzmin A, Kwon YJ, Lacaprara S, Lai YT, La Licata C, Lanceri L, Lange JS, Laurenza M, Lautenbach K, Le Diberder FR, Lee SC, Leitl P, Levit D, Lewis PM, Li C, Li LK, Li SX, Li YB, Libby J, Lieret K, Liptak Z, Liu QY, Liventsev D, Longo S, Lozar A, Lueck T, Lyu C, Maggiora M, Maity S, Manfredi R, Manoni E, Marcello S, Marinas C, Martini A, Masuda M, Matsuda T, Matsuoka K, Matvienko D, Meier F, Merola M, Metzner F, Milesi M, Miller C, Miyabayashi K, Miyake H, Mizuk R, Mohanty GB, Moser HG, Mrvar M, Müller FJ, Murphy C, Mussa R, Nakamura KR, Nakao M, Natkaniec Z, Natochii A, Nayak M, Nazaryan G, Niebuhr C, Nisar NK, Nishida S, Nishimura K, Ogawa S, Onishchuk Y, Ono H, Onuki Y, Oskin P, Ozaki H, Pakhlov P, Pakhlova G, Paladino A, Pang T, Panta A, Paoloni E, Pardi S, Park H, Park SH, Paschen B, Passeri A, Pathak A, Patra S, Paul S, Pedlar TK, Peruzzi I, Pestotnik R, Piccolo M, Piilonen LE, Podesta-Lerma PLM, Podobnik T, Pokharel S, Polat G, Popov V, Praz C, Prell S, Prencipe E, Prim MT, Rad N, Rados P, Raiz S, Remnev M, Ripp-Baudot I, Ritter M, Rizzo G, Rizzuto LB, Robertson SH, Rodríguez Pérez D, Roney JM, Rostomyan A, Rout N, Russo G, Sahoo D, Sanders DA, Sandilya S, Sangal A, Santelj L, Sato Y, Savinov V, Scavino B, Schueler J, Schwanda C, Schwartz AJ, Seddon RM, Seino Y, Selce A, Senyo K, Serrano J, Sevior ME, Sfienti C, Shiu JG, Shwartz B, Sibidanov A, Simon F, Sobie RJ, Soffer A, Sokolov A, Solovieva E, Spataro S, Spruck B, Starič M, Stefkova S, Stottler ZS, Stroili R, Sumihama M, Sumisawa K, Summers DJ, Sutcliffe W, Suzuki SY, Svidras H, Tabata M, Takahashi M, Takizawa M, Tamponi U, Tanaka S, Tanida K, Tanigawa H, Taniguchi N, Taras P, Tenchini F, Tonelli D, Torassa E, Toutounji N, Trabelsi K, Uchida M, Unno Y, Uno K, Uno S, Urquijo P, Ushiroda Y, Usov YV, Vahsen SE, van Tonder R, Varner GS, Varvell KE, Vinokurova A, Vitale L, Wach B, Waheed E, Wakeling HM, Wan Abdullah W, Wang MZ, Wang XL, Warburton A, Watanuki S, Webb J, Welsch M, Wessel C, Wiechczynski J, Windel H, Xu XP, Yabsley BD, Yamada S, Yan W, Yang SB, Ye H, Yelton J, Yin JH, Yook YM, Yoshihara K, Yuan CZ, Yusa Y, Zani L, Zhilich V, Zhou QD, Zhou XY, Zhukova VI. Search for B^{+}→K^{+}νν[over ¯] Decays Using an Inclusive Tagging Method at Belle II. Phys Rev Lett 2021; 127:181802. [PMID: 34767404 DOI: 10.1103/physrevlett.127.181802] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/06/2021] [Revised: 07/23/2021] [Accepted: 09/10/2021] [Indexed: 06/13/2023]
Abstract
A search for the flavor-changing neutral-current decay B^{+}→K^{+}νν[over ¯] is performed at the Belle II experiment at the SuperKEKB asymmetric energy electron-positron collider. The data sample corresponds to an integrated luminosity of 63 fb^{-1} collected at the ϒ(4S) resonance and a sample of 9 fb^{-1} collected at an energy 60 MeV below the resonance. Because the measurable decay signature involves only a single charged kaon, a novel measurement approach is used that exploits not only the properties of the B^{+}→K^{+}νν[over ¯] decay, but also the inclusive properties of the other B meson in the ϒ(4S)→BB[over ¯] event, to suppress the background from other B meson decays and light-quark pair production. This inclusive tagging approach offers a higher signal efficiency compared to previous searches. No significant signal is observed. An upper limit on the branching fraction of B^{+}→K^{+}νν[over ¯] of 4.1×10^{-5} is set at the 90% confidence level.
Collapse
Affiliation(s)
- F Abudinén
- INFN Sezione di Trieste, I-34127 Trieste
| | - I Adachi
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801
| | - K Adamczyk
- H. Niewodniczanski Institute of Nuclear Physics, Krakow 31-342
| | | | - H Aihara
- Department of Physics, University of Tokyo, Tokyo 113-0033
| | - N Akopov
- Alikhanyan National Science Laboratory, Yerevan 0036
| | - A Aloisio
- INFN Sezione di Napoli, I-80126 Napoli
- Dipartimento di Scienze Fisiche, Università di Napoli Federico II, I-80126 Napoli
| | - N Anh Ky
- Institute of Theoretical and Applied Research (ITAR), Duy Tan University, Hanoi 100000
- Institute of Physics, Vietnam Academy of Science and Technology (VAST), Hanoi
| | - D M Asner
- Brookhaven National Laboratory, Upton, New York 11973
| | - H Atmacan
- University of Cincinnati, Cincinnati, Ohio 45221
| | - T Aushev
- National Research University Higher School of Economics, Moscow 101000
| | - V Aushev
- Taras Shevchenko National University of Kiev, Kiev
| | - A Baur
- Deutsches Elektronen-Synchrotron, 22607 Hamburg
| | - V Babu
- Deutsches Elektronen-Synchrotron, 22607 Hamburg
| | - S Baehr
- Institut für Experimentelle Teilchenphysik, Karlsruher Institut für Technologie, 76131 Karlsruhe
| | - P Bambade
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay
| | - Sw Banerjee
- University of Louisville, Louisville, Kentucky 40292
| | - S Bansal
- Panjab University, Chandigarh 160014
| | - J Baudot
- Université de Strasbourg, CNRS, IPHC, UMR 7178, 67037 Strasbourg
| | - J Becker
- Institut für Experimentelle Teilchenphysik, Karlsruher Institut für Technologie, 76131 Karlsruhe
| | - P K Behera
- Indian Institute of Technology Madras, Chennai 600036
| | - J V Bennett
- University of Mississippi, University, Mississippi 38677
| | | | | | - M Bertemes
- Institute of High Energy Physics, Vienna 1050
| | - E Bertholet
- School of Physics and Astronomy, Tel Aviv University, Tel Aviv, 69978
| | - M Bessner
- University of Hawaii, Honolulu, Hawaii 96822
| | - S Bettarini
- INFN Sezione di Pisa, I-56127 Pisa
- Dipartimento di Fisica, Università di Pisa, I-56127 Pisa
| | - F Bianchi
- INFN Sezione di Torino, I-10125 Torino
- Dipartimento di Fisica, Università di Torino, I-10125 Torino
| | - T Bilka
- Faculty of Mathematics and Physics, Charles University, 121 16 Prague
| | - D Biswas
- University of Louisville, Louisville, Kentucky 40292
| | - A Bozek
- H. Niewodniczanski Institute of Nuclear Physics, Krakow 31-342
| | - M Bračko
- J. Stefan Institute, 1000 Ljubljana
- Faculty of Chemistry and Chemical Engineering, University of Maribor, 2000 Maribor
| | | | - N Braun
- Institut für Experimentelle Teilchenphysik, Karlsruher Institut für Technologie, 76131 Karlsruhe
| | - T E Browder
- University of Hawaii, Honolulu, Hawaii 96822
| | - A Budano
- INFN Sezione di Roma Tre, I-00146 Roma
| | - S Bussino
- INFN Sezione di Roma Tre, I-00146 Roma
- Dipartimento di Matematica e Fisica, Università di Roma Tre, I-00146 Roma
| | - M Campajola
- INFN Sezione di Napoli, I-80126 Napoli
- Dipartimento di Scienze Fisiche, Università di Napoli Federico II, I-80126 Napoli
| | - L Cao
- University of Bonn, 53115 Bonn
| | - G Casarosa
- INFN Sezione di Pisa, I-56127 Pisa
- Dipartimento di Fisica, Università di Pisa, I-56127 Pisa
| | - C Cecchi
- INFN Sezione di Perugia, I-06123 Perugia
- Dipartimento di Fisica, Università di Perugia, I-06123 Perugia
| | - D Červenkov
- Faculty of Mathematics and Physics, Charles University, 121 16 Prague
| | - P Chang
- Department of Physics, National Taiwan University, Taipei 10617
| | - R Cheaib
- Deutsches Elektronen-Synchrotron, 22607 Hamburg
| | - V Chekelian
- Max-Planck-Institut für Physik, 80805 München
| | - C Chen
- Iowa State University, Ames, Iowa 50011
| | - Y-T Chen
- Department of Physics, National Taiwan University, Taipei 10617
| | - B G Cheon
- Department of Physics and Institute of Natural Sciences, Hanyang University, Seoul 04763
| | - K Chilikin
- P. N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119991
| | | | - K Cho
- Korea Institute of Science and Technology Information, Daejeon 34141
| | - S-J Cho
- Yonsei University, Seoul 03722
| | - S Choudhury
- Indian Institute of Technology Hyderabad, Telangana 502285
| | - D Cinabro
- Wayne State University, Detroit, Michigan 48202
| | - L Corona
- INFN Sezione di Pisa, I-56127 Pisa
- Dipartimento di Fisica, Università di Pisa, I-56127 Pisa
| | - L M Cremaldi
- University of Mississippi, University, Mississippi 38677
| | - S Cunliffe
- Deutsches Elektronen-Synchrotron, 22607 Hamburg
| | - T Czank
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo, Kashiwa 277-8583
| | - F Dattola
- Deutsches Elektronen-Synchrotron, 22607 Hamburg
| | - E De La Cruz-Burelo
- Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional, Mexico City 07360
| | - G de Marino
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay
| | - G De Nardo
- INFN Sezione di Napoli, I-80126 Napoli
- Dipartimento di Scienze Fisiche, Università di Napoli Federico II, I-80126 Napoli
| | - M De Nuccio
- Deutsches Elektronen-Synchrotron, 22607 Hamburg
| | | | - R de Sangro
- INFN Laboratori Nazionali di Frascati, I-00044 Frascati
| | - M Destefanis
- INFN Sezione di Torino, I-10125 Torino
- Dipartimento di Fisica, Università di Torino, I-10125 Torino
| | - S Dey
- School of Physics and Astronomy, Tel Aviv University, Tel Aviv, 69978
| | - A De Yta-Hernandez
- Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional, Mexico City 07360
| | - A Di Canto
- Brookhaven National Laboratory, Upton, New York 11973
| | - F Di Capua
- INFN Sezione di Napoli, I-80126 Napoli
- Dipartimento di Scienze Fisiche, Università di Napoli Federico II, I-80126 Napoli
| | | | - Z Doležal
- Faculty of Mathematics and Physics, Charles University, 121 16 Prague
| | | | - T V Dong
- Institute of Theoretical and Applied Research (ITAR), Duy Tan University, Hanoi 100000
| | - K Dort
- Justus-Liebig-Universität Gießen, 35392 Gießen
| | - S Dubey
- University of Hawaii, Honolulu, Hawaii 96822
| | - S Duell
- University of Bonn, 53115 Bonn
| | - G Dujany
- Université de Strasbourg, CNRS, IPHC, UMR 7178, 67037 Strasbourg
| | - S Eidelman
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090
- P. N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119991
- Novosibirsk State University, Novosibirsk 630090
| | | | - D Epifanov
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090
- Novosibirsk State University, Novosibirsk 630090
| | - T Ferber
- Deutsches Elektronen-Synchrotron, 22607 Hamburg
| | - D Ferlewicz
- School of Physics, University of Melbourne, Victoria 3010
| | - T Fillinger
- Université de Strasbourg, CNRS, IPHC, UMR 7178, 67037 Strasbourg
| | - G Finocchiaro
- INFN Laboratori Nazionali di Frascati, I-00044 Frascati
| | - S Fiore
- INFN Sezione di Roma, I-00185 Roma
| | - A Fodor
- McGill University, Montréal, Québec, H3A 2T8
| | - F Forti
- INFN Sezione di Pisa, I-56127 Pisa
- Dipartimento di Fisica, Università di Pisa, I-56127 Pisa
| | - A Frey
- II. Physikalisches Institut, Georg-August-Universität Göttingen, 37073 Göttingen
| | - B G Fulsom
- Pacific Northwest National Laboratory, Richland, Washington 99352
| | - N Gabyshev
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090
- Novosibirsk State University, Novosibirsk 630090
| | - E Ganiev
- INFN Sezione di Trieste, I-34127 Trieste
- Dipartimento di Fisica, Università di Trieste, I-34127 Trieste
| | - M Garcia-Hernandez
- Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional, Mexico City 07360
| | - A Garmash
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090
- Novosibirsk State University, Novosibirsk 630090
| | - V Gaur
- Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061
| | - A Gaz
- INFN Sezione di Padova, I-35131 Padova
- Dipartimento di Fisica e Astronomia, Università di Padova, I-35131 Padova
| | - A Gellrich
- Deutsches Elektronen-Synchrotron, 22607 Hamburg
| | - R Giordano
- INFN Sezione di Napoli, I-80126 Napoli
- Dipartimento di Scienze Fisiche, Università di Napoli Federico II, I-80126 Napoli
| | - A Giri
- Indian Institute of Technology Hyderabad, Telangana 502285
| | - A Glazov
- Deutsches Elektronen-Synchrotron, 22607 Hamburg
| | - B Gobbo
- INFN Sezione di Trieste, I-34127 Trieste
| | - R Godang
- University of South Alabama, Mobile, Alabama 36688
| | - P Goldenzweig
- Institut für Experimentelle Teilchenphysik, Karlsruher Institut für Technologie, 76131 Karlsruhe
| | - B Golob
- J. Stefan Institute, 1000 Ljubljana
- Faculty of Mathematics and Physics, University of Ljubljana, 1000 Ljubljana
| | - P Grace
- Department of Physics, University of Adelaide, Adelaide, South Australia 5005
| | - W Gradl
- Johannes Gutenberg-Universität Mainz, Institut für Kernphysik, D-55099 Mainz
| | | | - D Greenwald
- Department of Physics, Technische Universität München, 85748 Garching
| | - Y Guan
- University of Cincinnati, Cincinnati, Ohio 45221
| | - K Gudkova
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090
- Novosibirsk State University, Novosibirsk 630090
| | - C Hadjivasiliou
- Pacific Northwest National Laboratory, Richland, Washington 99352
| | - S Halder
- Tata Institute of Fundamental Research, Mumbai 400005
| | - K Hara
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801
| | - O Hartbrich
- University of Hawaii, Honolulu, Hawaii 96822
| | | | | | - S Hazra
- Tata Institute of Fundamental Research, Mumbai 400005
| | - C Hearty
- Institute of Particle Physics (Canada), Victoria, British Columbia V8W 2Y2
- University of British Columbia, Vancouver, British Columbia, V6T 1Z1
| | - I Heredia de la Cruz
- Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional, Mexico City 07360
- Consejo Nacional de Ciencia y Tecnología, Mexico City 03940
| | | | - A Hershenhorn
- University of British Columbia, Vancouver, British Columbia, V6T 1Z1
| | - T Higuchi
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo, Kashiwa 277-8583
| | - E C Hill
- University of British Columbia, Vancouver, British Columbia, V6T 1Z1
| | - H Hirata
- Graduate School of Science, Nagoya University, Nagoya 464-8602
| | - M Hoek
- Johannes Gutenberg-Universität Mainz, Institut für Kernphysik, D-55099 Mainz
| | - M Hohmann
- School of Physics, University of Melbourne, Victoria 3010
| | - C-L Hsu
- School of Physics, University of Sydney, New South Wales 2006
| | - T Humair
- Max-Planck-Institut für Physik, 80805 München
| | - T Iijima
- Graduate School of Science, Nagoya University, Nagoya 464-8602
- Kobayashi-Maskawa Institute, Nagoya University, Nagoya 464-8602
| | - K Inami
- Graduate School of Science, Nagoya University, Nagoya 464-8602
| | - G Inguglia
- Institute of High Energy Physics, Vienna 1050
| | - J Irakkathil Jabbar
- Institut für Experimentelle Teilchenphysik, Karlsruher Institut für Technologie, 76131 Karlsruhe
| | - A Ishikawa
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801
| | - R Itoh
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801
| | - M Iwasaki
- Osaka City University, Osaka 558-8585
| | - Y Iwasaki
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801
| | - P Jackson
- Department of Physics, University of Adelaide, Adelaide, South Australia 5005
| | - W W Jacobs
- Indiana University, Bloomington, Indiana 47408
| | - D E Jaffe
- Brookhaven National Laboratory, Upton, New York 11973
| | - Y Jin
- INFN Sezione di Trieste, I-34127 Trieste
| | - C Joo
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo, Kashiwa 277-8583
| | | | - A B Kaliyar
- Tata Institute of Fundamental Research, Mumbai 400005
| | - J Kandra
- Faculty of Mathematics and Physics, Charles University, 121 16 Prague
| | - K H Kang
- Kyungpook National University, Daegu 41566
| | - R Karl
- Deutsches Elektronen-Synchrotron, 22607 Hamburg
| | - G Karyan
- Alikhanyan National Science Laboratory, Yerevan 0036
| | - T Kawasaki
- Kitasato University, Sagamihara 252-0373
| | - C Ketter
- University of Hawaii, Honolulu, Hawaii 96822
| | - H Kichimi
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801
| | - C Kiesling
- Max-Planck-Institut für Physik, 80805 München
| | - C-H Kim
- Department of Physics and Institute of Natural Sciences, Hanyang University, Seoul 04763
| | - D Y Kim
- Soongsil University, Seoul 06978
| | - Y-K Kim
- Yonsei University, Seoul 03722
| | - T D Kimmel
- Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061
| | - P Kodyš
- Faculty of Mathematics and Physics, Charles University, 121 16 Prague
| | - T Koga
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801
| | - S Kohani
- University of Hawaii, Honolulu, Hawaii 96822
| | - T Konno
- Kitasato University, Sagamihara 252-0373
| | - A Korobov
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090
- Novosibirsk State University, Novosibirsk 630090
| | - S Korpar
- J. Stefan Institute, 1000 Ljubljana
- Faculty of Chemistry and Chemical Engineering, University of Maribor, 2000 Maribor
| | - E Kovalenko
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090
- Novosibirsk State University, Novosibirsk 630090
| | | | - F Krinner
- Max-Planck-Institut für Physik, 80805 München
| | - P Križan
- J. Stefan Institute, 1000 Ljubljana
- Faculty of Mathematics and Physics, University of Ljubljana, 1000 Ljubljana
| | - P Krokovny
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090
- Novosibirsk State University, Novosibirsk 630090
| | - T Kuhr
- Ludwig Maximilians University, 80539 Munich
| | - J Kumar
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213
| | - M Kumar
- Malaviya National Institute of Technology Jaipur, Jaipur 302017
| | - R Kumar
- Punjab Agricultural University, Ludhiana 141004
| | - K Kumara
- Wayne State University, Detroit, Michigan 48202
| | - T Kunigo
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801
| | - S Kurz
- Deutsches Elektronen-Synchrotron, 22607 Hamburg
| | - A Kuzmin
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090
- Novosibirsk State University, Novosibirsk 630090
| | | | | | - Y-T Lai
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo, Kashiwa 277-8583
| | - C La Licata
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo, Kashiwa 277-8583
| | - L Lanceri
- INFN Sezione di Trieste, I-34127 Trieste
| | - J S Lange
- Justus-Liebig-Universität Gießen, 35392 Gießen
| | - M Laurenza
- INFN Sezione di Roma Tre, I-00146 Roma
- Dipartimento di Matematica e Fisica, Università di Roma Tre, I-00146 Roma
| | - K Lautenbach
- Aix Marseille Université, CNRS/IN2P3, CPPM, 13288 Marseille
| | | | - S C Lee
- Kyungpook National University, Daegu 41566
| | - P Leitl
- Max-Planck-Institut für Physik, 80805 München
| | - D Levit
- Department of Physics, Technische Universität München, 85748 Garching
| | | | - C Li
- Liaoning Normal University, Dalian 116029
| | - L K Li
- University of Cincinnati, Cincinnati, Ohio 45221
| | - S X Li
- Key Laboratory of Nuclear Physics and Ion-beam Application (MOE) and Institute of Modern Physics, Fudan University, Shanghai 200443
| | - Y B Li
- Key Laboratory of Nuclear Physics and Ion-beam Application (MOE) and Institute of Modern Physics, Fudan University, Shanghai 200443
| | - J Libby
- Indian Institute of Technology Madras, Chennai 600036
| | - K Lieret
- Ludwig Maximilians University, 80539 Munich
| | - Z Liptak
- Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8530
| | - Q Y Liu
- Deutsches Elektronen-Synchrotron, 22607 Hamburg
| | - D Liventsev
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801
- Wayne State University, Detroit, Michigan 48202
| | - S Longo
- Deutsches Elektronen-Synchrotron, 22607 Hamburg
| | - A Lozar
- J. Stefan Institute, 1000 Ljubljana
| | - T Lueck
- Ludwig Maximilians University, 80539 Munich
| | - C Lyu
- University of Bonn, 53115 Bonn
| | - M Maggiora
- INFN Sezione di Torino, I-10125 Torino
- Dipartimento di Fisica, Università di Torino, I-10125 Torino
| | - S Maity
- Indian Institute of Technology Bhubaneswar, Satya Nagar 751007
| | - R Manfredi
- INFN Sezione di Trieste, I-34127 Trieste
- Dipartimento di Fisica, Università di Trieste, I-34127 Trieste
| | - E Manoni
- INFN Sezione di Perugia, I-06123 Perugia
| | - S Marcello
- INFN Sezione di Torino, I-10125 Torino
- Dipartimento di Fisica, Università di Torino, I-10125 Torino
| | - C Marinas
- Instituto de Fisica Corpuscular, Paterna 46980
| | - A Martini
- Deutsches Elektronen-Synchrotron, 22607 Hamburg
| | - M Masuda
- Earthquake Research Institute, University of Tokyo, Tokyo 113-0032
- Research Center for Nuclear Physics, Osaka University, Osaka 567-0047
| | - T Matsuda
- University of Miyazaki, Miyazaki 889-2192
| | - K Matsuoka
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801
| | - D Matvienko
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090
- P. N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119991
- Novosibirsk State University, Novosibirsk 630090
| | - F Meier
- Duke University, Durham, North Carolina 27708
| | - M Merola
- INFN Sezione di Napoli, I-80126 Napoli
- Dipartimento di Scienze Fisiche, Università di Napoli Federico II, I-80126 Napoli
| | - F Metzner
- Institut für Experimentelle Teilchenphysik, Karlsruher Institut für Technologie, 76131 Karlsruhe
| | - M Milesi
- School of Physics, University of Melbourne, Victoria 3010
| | - C Miller
- University of Victoria, Victoria, British Columbia, V8W 3P6
| | | | - H Miyake
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801
| | - R Mizuk
- National Research University Higher School of Economics, Moscow 101000
- P. N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119991
| | - G B Mohanty
- Tata Institute of Fundamental Research, Mumbai 400005
| | - H-G Moser
- Max-Planck-Institut für Physik, 80805 München
| | - M Mrvar
- Institute of High Energy Physics, Vienna 1050
| | - F J Müller
- Deutsches Elektronen-Synchrotron, 22607 Hamburg
| | - C Murphy
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo, Kashiwa 277-8583
| | - R Mussa
- INFN Sezione di Torino, I-10125 Torino
| | - K R Nakamura
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801
| | - M Nakao
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801
| | - Z Natkaniec
- H. Niewodniczanski Institute of Nuclear Physics, Krakow 31-342
| | - A Natochii
- University of Hawaii, Honolulu, Hawaii 96822
| | - M Nayak
- School of Physics and Astronomy, Tel Aviv University, Tel Aviv, 69978
| | - G Nazaryan
- Alikhanyan National Science Laboratory, Yerevan 0036
| | - C Niebuhr
- Deutsches Elektronen-Synchrotron, 22607 Hamburg
| | - N K Nisar
- Brookhaven National Laboratory, Upton, New York 11973
| | - S Nishida
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801
| | - K Nishimura
- University of Hawaii, Honolulu, Hawaii 96822
| | - S Ogawa
- Toho University, Funabashi 274-8510
| | - Y Onishchuk
- Taras Shevchenko National University of Kiev, Kiev
| | - H Ono
- Niigata University, Niigata 950-2181
| | - Y Onuki
- Department of Physics, University of Tokyo, Tokyo 113-0033
| | - P Oskin
- P. N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119991
| | - H Ozaki
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801
| | - P Pakhlov
- P. N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119991
- Moscow Physical Engineering Institute, Moscow 115409
| | - G Pakhlova
- National Research University Higher School of Economics, Moscow 101000
- P. N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119991
| | - A Paladino
- INFN Sezione di Pisa, I-56127 Pisa
- Dipartimento di Fisica, Università di Pisa, I-56127 Pisa
| | - T Pang
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260
| | - A Panta
- University of Mississippi, University, Mississippi 38677
| | - E Paoloni
- INFN Sezione di Pisa, I-56127 Pisa
- Dipartimento di Fisica, Università di Pisa, I-56127 Pisa
| | - S Pardi
- INFN Sezione di Napoli, I-80126 Napoli
| | - H Park
- Kyungpook National University, Daegu 41566
| | - S-H Park
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801
| | | | - A Passeri
- INFN Sezione di Roma Tre, I-00146 Roma
| | - A Pathak
- University of Louisville, Louisville, Kentucky 40292
| | - S Patra
- Indian Institute of Science Education and Research Mohali, SAS Nagar, 140306
| | - S Paul
- Department of Physics, Technische Universität München, 85748 Garching
| | | | - I Peruzzi
- INFN Laboratori Nazionali di Frascati, I-00044 Frascati
| | | | - M Piccolo
- INFN Laboratori Nazionali di Frascati, I-00044 Frascati
| | - L E Piilonen
- Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061
| | | | | | - S Pokharel
- University of Mississippi, University, Mississippi 38677
| | - G Polat
- Aix Marseille Université, CNRS/IN2P3, CPPM, 13288 Marseille
| | - V Popov
- National Research University Higher School of Economics, Moscow 101000
| | - C Praz
- Deutsches Elektronen-Synchrotron, 22607 Hamburg
| | - S Prell
- Iowa State University, Ames, Iowa 50011
| | | | | | - N Rad
- Deutsches Elektronen-Synchrotron, 22607 Hamburg
| | - P Rados
- Deutsches Elektronen-Synchrotron, 22607 Hamburg
| | - S Raiz
- INFN Sezione di Trieste, I-34127 Trieste
- Dipartimento di Fisica, Università di Trieste, I-34127 Trieste
| | - M Remnev
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090
- Novosibirsk State University, Novosibirsk 630090
| | - I Ripp-Baudot
- Université de Strasbourg, CNRS, IPHC, UMR 7178, 67037 Strasbourg
| | - M Ritter
- Ludwig Maximilians University, 80539 Munich
| | - G Rizzo
- INFN Sezione di Pisa, I-56127 Pisa
- Dipartimento di Fisica, Università di Pisa, I-56127 Pisa
| | | | - S H Robertson
- Institute of Particle Physics (Canada), Victoria, British Columbia V8W 2Y2
- McGill University, Montréal, Québec, H3A 2T8
| | | | - J M Roney
- Institute of Particle Physics (Canada), Victoria, British Columbia V8W 2Y2
- University of Victoria, Victoria, British Columbia, V8W 3P6
| | - A Rostomyan
- Deutsches Elektronen-Synchrotron, 22607 Hamburg
| | - N Rout
- Indian Institute of Technology Madras, Chennai 600036
| | - G Russo
- INFN Sezione di Napoli, I-80126 Napoli
- Dipartimento di Scienze Fisiche, Università di Napoli Federico II, I-80126 Napoli
| | - D Sahoo
- Tata Institute of Fundamental Research, Mumbai 400005
| | - D A Sanders
- University of Mississippi, University, Mississippi 38677
| | - S Sandilya
- Indian Institute of Technology Hyderabad, Telangana 502285
| | - A Sangal
- University of Cincinnati, Cincinnati, Ohio 45221
| | - L Santelj
- J. Stefan Institute, 1000 Ljubljana
- Faculty of Mathematics and Physics, University of Ljubljana, 1000 Ljubljana
| | - Y Sato
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801
| | - V Savinov
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260
| | - B Scavino
- Johannes Gutenberg-Universität Mainz, Institut für Kernphysik, D-55099 Mainz
| | - J Schueler
- University of Hawaii, Honolulu, Hawaii 96822
| | - C Schwanda
- Institute of High Energy Physics, Vienna 1050
| | - A J Schwartz
- University of Cincinnati, Cincinnati, Ohio 45221
| | - R M Seddon
- McGill University, Montréal, Québec, H3A 2T8
| | - Y Seino
- Niigata University, Niigata 950-2181
| | - A Selce
- ENEA Casaccia, I-00123 Roma
- INFN Sezione di Roma Tre, I-00146 Roma
| | - K Senyo
- Yamagata University, Yamagata 990-8560
| | - J Serrano
- Aix Marseille Université, CNRS/IN2P3, CPPM, 13288 Marseille
| | - M E Sevior
- School of Physics, University of Melbourne, Victoria 3010
| | - C Sfienti
- Johannes Gutenberg-Universität Mainz, Institut für Kernphysik, D-55099 Mainz
| | - J-G Shiu
- Department of Physics, National Taiwan University, Taipei 10617
| | - B Shwartz
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090
- Novosibirsk State University, Novosibirsk 630090
| | - A Sibidanov
- University of Hawaii, Honolulu, Hawaii 96822
| | - F Simon
- Max-Planck-Institut für Physik, 80805 München
| | - R J Sobie
- Institute of Particle Physics (Canada), Victoria, British Columbia V8W 2Y2
- University of Victoria, Victoria, British Columbia, V8W 3P6
| | - A Soffer
- School of Physics and Astronomy, Tel Aviv University, Tel Aviv, 69978
| | - A Sokolov
- Institute for High Energy Physics, Protvino 142281
| | - E Solovieva
- P. N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119991
| | - S Spataro
- INFN Sezione di Torino, I-10125 Torino
- Dipartimento di Fisica, Università di Torino, I-10125 Torino
| | - B Spruck
- Johannes Gutenberg-Universität Mainz, Institut für Kernphysik, D-55099 Mainz
| | - M Starič
- J. Stefan Institute, 1000 Ljubljana
| | - S Stefkova
- Deutsches Elektronen-Synchrotron, 22607 Hamburg
| | - Z S Stottler
- Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061
| | - R Stroili
- INFN Sezione di Padova, I-35131 Padova
- Dipartimento di Fisica e Astronomia, Università di Padova, I-35131 Padova
| | - M Sumihama
- Gifu University, Gifu 501-1193
- Research Center for Nuclear Physics, Osaka University, Osaka 567-0047
| | - K Sumisawa
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801
| | - D J Summers
- University of Mississippi, University, Mississippi 38677
| | | | - S Y Suzuki
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801
| | - H Svidras
- Deutsches Elektronen-Synchrotron, 22607 Hamburg
| | - M Tabata
- Chiba University, Chiba 263-8522
| | - M Takahashi
- Deutsches Elektronen-Synchrotron, 22607 Hamburg
| | - M Takizawa
- J-PARC Branch, KEK Theory Center, High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801
- Meson Science Laboratory, Cluster for Pioneering Research, RIKEN, Saitama 351-0198
- Showa Pharmaceutical University, Tokyo 194-8543
| | - U Tamponi
- INFN Sezione di Torino, I-10125 Torino
| | - S Tanaka
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801
| | - K Tanida
- Advanced Science Research Center, Japan Atomic Energy Agency, Naka 319-1195
| | - H Tanigawa
- Department of Physics, University of Tokyo, Tokyo 113-0033
| | - N Taniguchi
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801
| | - P Taras
- Université de Montréal, Physique des Particules, Montréal, Québec, H3C 3J7
| | - F Tenchini
- Deutsches Elektronen-Synchrotron, 22607 Hamburg
| | - D Tonelli
- INFN Sezione di Trieste, I-34127 Trieste
| | - E Torassa
- INFN Sezione di Padova, I-35131 Padova
| | - N Toutounji
- School of Physics, University of Sydney, New South Wales 2006
| | - K Trabelsi
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay
| | - M Uchida
- Tokyo Institute of Technology, Tokyo 152-8550
| | - Y Unno
- Department of Physics and Institute of Natural Sciences, Hanyang University, Seoul 04763
| | - K Uno
- Niigata University, Niigata 950-2181
| | - S Uno
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801
| | - P Urquijo
- School of Physics, University of Melbourne, Victoria 3010
| | - Y Ushiroda
- The Graduate University for Advanced Studies (SOKENDAI), Hayama 240-0193
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801
- Department of Physics, University of Tokyo, Tokyo 113-0033
| | - Y V Usov
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090
- Novosibirsk State University, Novosibirsk 630090
| | - S E Vahsen
- University of Hawaii, Honolulu, Hawaii 96822
| | | | - G S Varner
- University of Hawaii, Honolulu, Hawaii 96822
| | - K E Varvell
- School of Physics, University of Sydney, New South Wales 2006
| | - A Vinokurova
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090
- Novosibirsk State University, Novosibirsk 630090
| | - L Vitale
- INFN Sezione di Trieste, I-34127 Trieste
- Dipartimento di Fisica, Università di Trieste, I-34127 Trieste
| | - B Wach
- Max-Planck-Institut für Physik, 80805 München
| | - E Waheed
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801
| | | | - W Wan Abdullah
- National Centre for Particle Physics, University Malaya, 50603 Kuala Lumpur
| | - M-Z Wang
- Department of Physics, National Taiwan University, Taipei 10617
| | - X L Wang
- Key Laboratory of Nuclear Physics and Ion-beam Application (MOE) and Institute of Modern Physics, Fudan University, Shanghai 200443
| | - A Warburton
- McGill University, Montréal, Québec, H3A 2T8
| | - S Watanuki
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay
| | - J Webb
- School of Physics, University of Melbourne, Victoria 3010
| | | | | | | | - H Windel
- Max-Planck-Institut für Physik, 80805 München
| | - X P Xu
- Soochow University, Suzhou 215006
| | - B D Yabsley
- School of Physics, University of Sydney, New South Wales 2006
| | - S Yamada
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801
| | - W Yan
- University of Science and Technology of China, Hefei 230026
| | | | - H Ye
- Deutsches Elektronen-Synchrotron, 22607 Hamburg
| | - J Yelton
- University of Florida, Gainesville, Florida 32611
| | - J H Yin
- Korea University, Seoul 02841
| | - Y M Yook
- Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049
| | - K Yoshihara
- Graduate School of Science, Nagoya University, Nagoya 464-8602
| | - C Z Yuan
- Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049
| | - Y Yusa
- Niigata University, Niigata 950-2181
| | - L Zani
- Aix Marseille Université, CNRS/IN2P3, CPPM, 13288 Marseille
| | - V Zhilich
- Budker Institute of Nuclear Physics SB RAS, Novosibirsk 630090
- Novosibirsk State University, Novosibirsk 630090
| | - Q D Zhou
- Graduate School of Science, Nagoya University, Nagoya 464-8602
- Kobayashi-Maskawa Institute, Nagoya University, Nagoya 464-8602
- Institute for Advanced Research, Nagoya University, Nagoya 464-8602
| | - X Y Zhou
- Liaoning Normal University, Dalian 116029
| | - V I Zhukova
- P. N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119991
| |
Collapse
|
42
|
Dawoud BES, Alderson L, Khan U, Safaei H, Murphy C, Milne S, Mannion C, Krishnan O, Parmar J. The effect of lockdown during SARS-CoV-2 pandemic on maxillofacial injuries in a level I trauma centre: a comparative study. Oral Maxillofac Surg 2021; 26:463-467. [PMID: 34618280 PMCID: PMC8495432 DOI: 10.1007/s10006-021-01007-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2020] [Accepted: 09/21/2021] [Indexed: 12/15/2022]
Abstract
INTRODUCTION The SARS-CoV-2 pandemic forced many governments to impose nation-wide lockdowns. Government legislation forced limited travel on the population with restrictions on the normal way of life to limit spread of the SARS-CoV-2 virus. The aim of this study is to explore the effects of lockdown on the presentation of maxillofacial trauma in a level I trauma centre. METHODS Comparative analysis was carried out using prospective and retrospective review of all consecutive patients admitted with any maxillofacial fracture in the lockdown period between 15th March and 15th June 2020 with the same period in 2019 to a Regional Trauma Maxillofacial Surgery Unit. Data included basic demographics and mechanism of injury including alcohol/drug influence, polytrauma, site of injury and treatment modality including escalation of care. RESULTS Across both periods, there were a total of one hundred and five (n = 105) recorded episodes of traumatic fractures with fifty-three (n = 53) in the pre-lockdown cohort and fifty-two (n = 52) in the lockdown. Included patients were significantly (p = 0.024) older during lockdown (mean age 41.44 years SD 20.70, range 5-96) with no differences in gender distribution between cohorts (p = 0.270). Patients in lockdown were more likely to be involved in polytrauma (p < 0.05) and have sustained their injury by cycling/running or any outdoor related activity (p = 0.013). Lockdown saw a significant reduction in alcohol and drug related violence (p < 0.05). Significantly more patients required operative management (p = 0.038). CONCLUSION Local lockdowns form part of the governments public health strategy for managing future outbreaks of SARS-CoV-2. Our study showed no significant reduction in volume of trauma during lockdown. It is vital that hospitals maintain trauma capacity to ensure that patients are treated in a timely manner.
Collapse
Affiliation(s)
- Basim E S Dawoud
- Oral & Maxillofacial Surgery, Northwest Deanery, Manchester University NHS Foundation Trust, Manchester, UK.
| | - L Alderson
- Leeds Dental Institute, Leeds Teaching Hospitals NHS Trust, Clarendon Way, Leeds, LS2 9LU, UK
| | - U Khan
- Leeds Dental Institute, Leeds Teaching Hospitals NHS Trust, Clarendon Way, Leeds, LS2 9LU, UK
| | - H Safaei
- Leeds Dental Institute, Leeds Teaching Hospitals NHS Trust, Clarendon Way, Leeds, LS2 9LU, UK
| | - C Murphy
- St James' Hospital, Dublin, James's Street, Dublin 8, Ireland
| | - S Milne
- Leeds Teaching Hospitals NHS Trust, Clarendon Way, Leeds, LS2 9LU, UK
| | - C Mannion
- Leeds Teaching Hospitals NHS Trust, Clarendon Way, Leeds, LS2 9LU, UK
| | - O Krishnan
- Leeds Teaching Hospitals NHS Trust, Clarendon Way, Leeds, LS2 9LU, UK
| | - J Parmar
- Leeds Teaching Hospitals NHS Trust, Clarendon Way, Leeds, LS2 9LU, UK
| |
Collapse
|
43
|
Morrice E, Murphy C, Soldano V, Addona C, Wittich W, Johnson AP. Assessing optimal colour and illumination to facilitate reading: an analysis of print size. Ophthalmic Physiol Opt 2021; 41:1209-1221. [PMID: 34549808 DOI: 10.1111/opo.12885] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2021] [Revised: 08/02/2021] [Accepted: 08/03/2021] [Indexed: 11/30/2022]
Abstract
PURPOSE This study examined how optimal colour/illumination conditions and the efficacy of the iPad, LuxIQ and Smart Bulb varied as a function of print size in younger, older and visually impaired adults. METHODS Participants with visual impairments and simulated low vision (SLV) read the MNRead using the iPad, LuxIQ and Smart Bulb. RESULTS In the impairment condition at 1.20 logMAR, the iPad (M = 9.49, 95% CI [3.18, 19.42]) and LuxIQ (M = 15.95, 95% CI [9.54, 24.86]) improved the reading speeds. At 0.80 logMAR (SLV), all devices improved reading speeds of older adults (iPad (M = 28.70, 95% CI [14.65, 42.51]); LuxIQ (M = 49.63, 95% CI [30.04, 69.68]); Smart Bulb (M = 23.11, 95% CI [3.33, 42.11])), but in younger adults only the LuxIQ (M = 13.04, 95% CI [3.21, 21.27]) did so. In the impairment condition, the iPad (M = 5.54, 95% CI [0.31, 12.13]) and LuxIQ (M = 13.90, 95% CI [7.88, 23.49]) improved reading speeds. In the SLV condition, age was a significant predictor of reading speed at 1.20 logMAR (F3,164 = 10.74, p < 0.001, Adj. R2 = 0.16). At 0.80 logMAR, age and luminance, but not colour, were significant predictors (F3,164 = 52.52, p < 0.001, Adj. R2 = 0.49). In the impairment condition, both age and lux were significant predictors of reading speed at 1.20 (F3,85 = 7.14, p < 0.001, Adj. R2 = 0.20) and 0.80 logMAR (F3,85 = 7.97, p < 0.001, Adj. R2 = 0.22), but colour was not. CONCLUSIONS Light source effectiveness and optimal colour/illumination vary as a function of print size. It appears that print size is the most important factor for improving reading speed. As print size decreases, luminance becomes crucial, and only at the smallest print sizes does the effect of colour become useful.
Collapse
Affiliation(s)
- Elliott Morrice
- Department of Psychology, Concordia University, Montreal, Quebec, Canada.,Lethbridge-Layton-Mackay Rehabilitation Centre, Integrated Health and Social Services University Network for West-Central Montreal, Montreal, Quebec, Canada
| | - Caitlin Murphy
- Department of Psychology, Concordia University, Montreal, Quebec, Canada.,Lethbridge-Layton-Mackay Rehabilitation Centre, Integrated Health and Social Services University Network for West-Central Montreal, Montreal, Quebec, Canada.,School of Optometry, University of Montreal, Montreal, Quebec, Canada
| | - Vanessa Soldano
- Department of Psychology, Concordia University, Montreal, Quebec, Canada
| | - Cynthia Addona
- Department of Psychology, Concordia University, Montreal, Quebec, Canada
| | - Walter Wittich
- Department of Psychology, Concordia University, Montreal, Quebec, Canada.,Lethbridge-Layton-Mackay Rehabilitation Centre, Integrated Health and Social Services University Network for West-Central Montreal, Montreal, Quebec, Canada.,School of Optometry, University of Montreal, Montreal, Quebec, Canada.,Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal/The Nazareth and Louis Braille Institute, Integrated Health and Social Services Centre Montérégie-Centre, Longueuil, Quebec, Canada
| | - Aaron P Johnson
- Department of Psychology, Concordia University, Montreal, Quebec, Canada.,Lethbridge-Layton-Mackay Rehabilitation Centre, Integrated Health and Social Services University Network for West-Central Montreal, Montreal, Quebec, Canada
| |
Collapse
|
44
|
Gaebel W, Lukies R, Kerst A, Stricker J, Zielasek J, Diekmann S, Trost N, Gouzoulis-Mayfrank E, Bonroy B, Cullen K, Desie K, Ewalds Mulliez AP, Gerlinger G, Günther K, Hiemstra HJ, McDaid S, Murphy C, Sander J, Sebbane D, Roelandt JL, Thorpe L, Topolska D, Van Assche E, Van Daele T, Van den Broeck L, Versluis C, Vlijter O. Upscaling e-mental health in Europe: a six-country qualitative analysis and policy recommendations from the eMEN project. Eur Arch Psychiatry Clin Neurosci 2021; 271:1005-1016. [PMID: 32393997 DOI: 10.1007/s00406-020-01133-y] [Citation(s) in RCA: 34] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/17/2020] [Accepted: 04/27/2020] [Indexed: 11/30/2022]
Abstract
E-mental health (eMH) encompasses the use of digital technologies to deliver, support, or enhance mental health services. Despite the growing evidence for the effectiveness of eMH interventions, the process of implementation of eMH solutions in healthcare remains slow throughout Europe. To address this issue, the e-Mental Health Innovation and Transnational Implementation Platform North-West Europe (eMEN) project was initiated to increase the dissemination and quality of eMH services in Europe. In this project, status analyses regarding eMH in the six participating countries (i.e., Belgium, France, Germany, Ireland, The Netherlands, and the UK) were conducted and eight recommendations for eMH were developed. Expert teams from the six participating countries conducted status analyses regarding the uptake of eMH based on a narrative literature review and stakeholder interviews. Based on these status analyses, the eMEN consortium developed eight policy recommendations to further support the implementation of eMH in Europe. The status analyses showed that the participating countries are in different stages of implementing eMH into mental healthcare. Some barriers to implementing eMH were common among countries (e.g., a limited legal and regulatory framework), while others were country-specific (e.g., fragmented, federal policies). The policy recommendations included fostering awareness, creating strong political commitment, and setting reliable standards related to ethics and data security. The eMEN project has provided the initial recommendations to guide political and regulatory processes regarding eMH. Further research is needed to establish well-tailored implementation strategies and to assess the generalizability of the recommendations beyond the countries involved in the eMEN project.
Collapse
Affiliation(s)
- Wolfgang Gaebel
- Department of Psychiatry, Medical Faculty, LVR-Klinikum Düsseldorf, Heinrich-Heine-University, Bergische Landstr. 2, 40629, Düsseldorf, Germany. .,WHO Collaborating Centre for Quality Assurance and Empowerment in Mental Health, Düsseldorf, Germany. .,LVR-Institute for Healthcare Research, Cologne, Germany.
| | - R Lukies
- LVR-Institute for Healthcare Research, Cologne, Germany
| | - A Kerst
- Department of Psychiatry, Medical Faculty, LVR-Klinikum Düsseldorf, Heinrich-Heine-University, Bergische Landstr. 2, 40629, Düsseldorf, Germany.,WHO Collaborating Centre for Quality Assurance and Empowerment in Mental Health, Düsseldorf, Germany
| | - J Stricker
- Department of Psychiatry, Medical Faculty, LVR-Klinikum Düsseldorf, Heinrich-Heine-University, Bergische Landstr. 2, 40629, Düsseldorf, Germany.,WHO Collaborating Centre for Quality Assurance and Empowerment in Mental Health, Düsseldorf, Germany
| | - J Zielasek
- LVR-Institute for Healthcare Research, Cologne, Germany
| | - S Diekmann
- LVR-Institute for Healthcare Research, Cologne, Germany
| | - N Trost
- LVR-Institute for Healthcare Research, Cologne, Germany
| | | | - B Bonroy
- Thomas More University of Applied Sciences, Geel, Belgium
| | - K Cullen
- Mental Health Reform, Dublin, Ireland
| | - K Desie
- Pulso Europe, Leuven, Belgium
| | - A P Ewalds Mulliez
- WHO Collaborating Centre for Research and Training in Mental Health-EPSM Lille-Métropole, Lille, France
| | - G Gerlinger
- German Association for Psychiatry, Psychotherapy and Psychosomatics e.V. (DGPPN), Berlin, Germany
| | - K Günther
- German Association for Psychiatry, Psychotherapy and Psychosomatics e.V. (DGPPN), Berlin, Germany
| | - H J Hiemstra
- Inserm, Clinical Epidemiology and Economic Evaluation Applied to Vulnerable Populations (ECEVE), Paris Diderot University, Paris, France
| | - S McDaid
- Mental Health Reform, Dublin, Ireland
| | - C Murphy
- Mental Health Foundation, London, UK
| | - J Sander
- German Association for Psychiatry, Psychotherapy and Psychosomatics e.V. (DGPPN), Berlin, Germany
| | - D Sebbane
- WHO Collaborating Centre for Research and Training in Mental Health-EPSM Lille-Métropole, Lille, France.,Inserm, Clinical Epidemiology and Economic Evaluation Applied to Vulnerable Populations (ECEVE), Paris Diderot University, Paris, France
| | - J L Roelandt
- WHO Collaborating Centre for Research and Training in Mental Health-EPSM Lille-Métropole, Lille, France.,Inserm, Clinical Epidemiology and Economic Evaluation Applied to Vulnerable Populations (ECEVE), Paris Diderot University, Paris, France
| | - L Thorpe
- Mental Health Foundation, London, UK
| | | | - E Van Assche
- Thomas More University of Applied Sciences, Geel, Belgium
| | - T Van Daele
- Thomas More University of Applied Sciences, Geel, Belgium
| | | | | | - O Vlijter
- Stichting Arq, Diemen, The Netherlands
| |
Collapse
|
45
|
Reilly A, Quinn C, Traynor M, Devanney S, O'Shea J, O'Connor P, Murphy C, Keogh R, O'Dwyer R, Bredin P, Hamilton S, Murphy A, Judge L, Naidoo J, Matassa C, Morris P, O'Doherty D, Breathnach O, Doyle T, Grogan L. 1728P Clinical practice audit on prescribing frequency of buccal midazolam in patients with high grade gliomas. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1700] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
46
|
Anderson S, McNicholas D, Murphy C, Cheema I, McLornan L, Davis N, Quinlan M. The impact of COVID-19 on acute urinary stone presentations: A single centre experience. EUR UROL SUPPL 2021. [PMCID: PMC8443886 DOI: 10.1016/s2666-1683(21)00225-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/04/2022] Open
|
47
|
Ng K, Bird B, Murphy C, O'Connor D, Cook J. 979P Efficacy of pembrolizumab with concomitant use of antibiotics. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1363] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
48
|
Bredin P, Murphy C, O'Dwyer R, Keogh R, Doolan A, Duignan E, Jones A, Santos M, Egan K, Murphy A, Naidoo J, Morris P, Hennessy B, Grogan L, Breathnach O. 1637P Unintended consequences for an integrated oncology ecosystem from COVID adaptations. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
49
|
Kieran R, Murphy C, Maher E, Buchalter J, Sukor S, Alken S. 1846P A permanent legacy of the pandemic? Patient and staff views of the introduction of virtual clinics to the Irish oncology service. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.734] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
50
|
Kavanagh FG, Brinkman D, James DL, O’Neill S, Murphy C, O’Riordan I, O’Flanagan G, Lang B, Keogh I, Lang E, Casserly P, Russell J, O’Brien D, Sheahan P. Outcomes of preoperative real-time polymerase chain reaction testing for SARS CoV-2 in elective otolaryngology surgical patients during the pandemic: a prospective cohort study. Br J Surg 2021; 108:znab266. [PMID: 34426824 PMCID: PMC8499765 DOI: 10.1093/bjs/znab266] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2021] [Accepted: 06/22/2021] [Indexed: 11/29/2022]
Abstract
Real-time polymerase chain reaction (RT-PCR) is used to rule out SARS-CoV-2 prior to surgery, however few studies have evaluated patients with negative testing after surgery. Some 499 patients with negative tests were followed for 14 days after surgery, 39 were retested but none developed positive RT-PCR after operation. The risk of developing a positive RT-PCR after surgery was 0.74 per cent.
Collapse
Affiliation(s)
- F G Kavanagh
- Department of Otolaryngology, Head and Neck Surgery, South Infirmary Victoria University Hospital, Cork, Republic of Ireland
- Institute of Research, Royal College of Surgeons in Ireland, Dublin, Republic of Ireland
| | - D Brinkman
- Department of Otolaryngology, Head and Neck Surgery, University Hospital Waterford, Waterford, Republic of Ireland
| | - D L James
- Department of Otolaryngology, Head and Neck Surgery, South Infirmary Victoria University Hospital, Cork, Republic of Ireland
| | - S O’Neill
- Department of Otolaryngology, Head and Neck Surgery, University Hospital Galway, Galway, Republic of Ireland
| | - C Murphy
- Department of Otolaryngology, Head and Neck Surgery, University Hospital Galway, Galway, Republic of Ireland
| | - I O’Riordan
- Department of Otolaryngology, Royal Victoria Eye and Ear Hospital, Dublin, Republic of Ireland
| | - G O’Flanagan
- Department of Otolaryngology, Royal Victoria Eye and Ear Hospital, Dublin, Republic of Ireland
| | - B Lang
- Department of Otolaryngology, Children’s Health Ireland @ Crumlin, Dublin, Republic of Ireland
| | - I Keogh
- Department of Otolaryngology, Head and Neck Surgery, University Hospital Galway, Galway, Republic of Ireland
| | - E Lang
- Department of Otolaryngology, Head and Neck Surgery, University Hospital Waterford, Waterford, Republic of Ireland
| | - P Casserly
- Department of Otolaryngology, Royal Victoria Eye and Ear Hospital, Dublin, Republic of Ireland
| | - J Russell
- Department of Otolaryngology, Children’s Health Ireland @ Crumlin, Dublin, Republic of Ireland
| | - D O’Brien
- Department of Microbiology, South Infirmary Victoria University Hospital, Cork, Republic of Ireland
| | | | - P Sheahan
- Department of Otolaryngology, Head and Neck Surgery, South Infirmary Victoria University Hospital, Cork, Republic of Ireland
- ENTO Research Unit, College of Medicine and Health, University College Cork, Cork, Republic of Ireland
- Department of Surgery, University College Cork, Cork, Republic of Ireland
| |
Collapse
|